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ABSTRACT

STRUCTURE-BASED MECHANISM OF PROTON TRANSPORT THROUGH THE INFLUENZA
A/M2 PROTEIN

Alexei Polishchuk
Supervisor: Dr. William F. DeGrado

Influenza A/M2 is a minimalistic integral membrane protein that mediates proton transport across the viral
membrane and is of interest as an antiviral drug target. This protein has been extensively studied by
electrophysiologists, biophysicists, structural biologists, and medicinal chemists, but a synthesis and unified
extension of the knowledge bases from these fields has not been undertaken. The principal aim of this
thesis is to develop a comprehensive, quantitative, structure-based mechanism that accounts for the key
functional and biophysical properties of A/M2. To demonstrate the electrophysiological equivalence of the
protein’s transmembrane domain (M2TM) and full length A/M2, proteoliposome flux experiments are
conducted as a first step. Next, high-resolution crystals of an M2TM variant are obtained; the resulting
structure and computational simulations provide a structural basis for the unusually high degree of charge
stabilization inside the M2TM helical bundle, suggest a previously unseen mechanism used by Nature to
stabilize charge in a membrane, and shed light on the likely pH-dependent structural transitions that the
protein undergoes.

Fluorescence quenching and EPR spectroscopy experiments confirm that M2

reconstituted in bilayers undergoes pH-driven changes in its conformational equilibrium that are consistent
with available structures and governed by previously reported pKa values. Mechanistic models of this
process are constructed and successfully fit to functional data. The fitting results show that proton transport
and rectification are mediated by conformational transitions between structural ensembles with different
proton affinities. Finally, the functional implications of targeted changes to the geometric and electronic
properties of the key His 37 sidechain are observed, indicating that the shape of the His 37 imidazole rings
is exquisitely tuned to mediate proton transport.
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PREFACE
Influenza A/M2 is a fascinating little protein from many perspectives. It’s inhibited by
one of the two classes of currently available anti-influenza drugs, and is thus of great
interest to the virology, public health, and pharmacology communities, especially as new
strains of the flu emerge and drug resistance among existing strains skyrockets.

A homotetramer of 97 amino acid subunits, each with only a single transmembrane
domain, A/M2 is among the smallest integral membrane proteins known and is therefore
an excellent model system to the chemical theoreticians, biophysicists, and structural
biologists studying how membrane proteins fold and assemble in the membrane.

What’s more, A/M2 is an ion transport protein (one of the most compact identified to
date) that’s exquisitely selective for protons, transports them preferentially in one
direction versus the other, and is regulated by its cargo (i.e. pH). Its electrophysiological
properties have therefore been extensively studied by the ion channel community.

The goal of this thesis is to develop a unified understanding of how the compact
structural elements of M2 can underlie its rich and complex electrophysiological
properties.

Chapter 1 summarizes the large body of A/M2 literature that has been generated by the
aforementioned fields, and points out an obstacle to an integrated approach to
xiii

understanding this protein: different scientific fields have employed different model
systems and protein fragments of different lengths.

Therefore findings from one

scientific community may not necessarily correlate with the findings of another. In
Chapter 2, we demonstrate that a small core of the protein represented by its
transmembrane domain, studied extensively by biophysicists and structural biologists,
recapitulates the relevant functional properties of the full-length protein studied by the
ion channel community. This finding paves the way for constructing a comprehensive,
structure-based transport mechanism.

In Chapter 3, we describe a new, high-resolution crystal structure of the protein’s
transmembrane segment.

The helical conformations observed in this structure are

consistent with a mechanistic hypothesis where changes in pH cause the A/M2
transmembrane helices to bend and straighten in well-defined ways. Furthermore, the
high resolution of the structure shows the sidechains and ordered water molecules that
make up the proton transport pathway in exquisite detail, suggesting a mechanism by
which M2 can stabilize an unexpectedly large number of bound protons in its core. Highlevel computational simulations on this structure confirm this stabilizing effect, and shed
light on the functional importance of the water molecules that populate the interior of the
protein’s transmembrane segment.

In Chapter 4, we test our mechanistic hypothesis with full-length protein in bilayers at
equilibrium. The detailed structures of the protein have been obtained in non-native
xiv

micelles, and most represent conformational snapshots that successfully crystallized. It is
therefore important to find out whether the protein undergoes the proposed
conformational changes in a native-like environment at equilibrium.

Fluorescence

quenching experiments and electron paramagnetic resonance spectroscopy show that
indeed, A/M2 changes its conformational ensemble in bilayers, driven by protonation
events that take place according to previously measured pKa values of its His 37
sidechains.

In Chapter 5, we quantify our mechanistic hypothesis by constructing kinetic models of
proton transport which correlate changes in conformational ensembles to proton binding
and release. We find that such a mechanism can accurately describe the
electrophysiological properties of this protein reported by two different groups, and can
also account for the unusual behavior of certain M2 mutants. From this exercise, we
learn that unidirectional, pH-regulated proton transport through M2 takes place because
different conformational states of M2 have different affinities for protons, and varying
accessibilities to proton-carrying water molecules on either side of the membrane. The
transport cycle consists of M2 conformations with high proton affinities binding protons
from water molecules at the viral exterior, and conformations with lower proton affinities
releasing them to waters at the viral interior.

Finally, in Chapter 6, we focus in on the functionally critical tetrad of His 37 residues in
the M2 transmembrane segment. Using mutagenesis with unnatural amino acids that
xv

preserve either key electronic or geometric properties of histidine while varying the other,
we find that the geometry of the imidazole ring is precisely tuned for function in the
protein, while the ring’s proton affinity can be changed with predictable functional
effects.

In summary, this thesis develops an integrated, unified explanation for how protein
structure and changes in pH underlie the highly complex electrophysiological behavior of
this model membrane protein. The relatively simple functional mechanism derived here
can be used to inform drug design efforts and further our understanding of the fascinating
biology and electrophysiology of the transmembrane proteome.

xvi

Chapter 1: Introduction and literature Review - influenza A/M2, a
minimalistic membrane protein.
1.1. The public health threat of influenza infection.
Influenza virus infection presents a significant public health threat, having resulted in epidemics
and major pandemics recorded in history for hundreds (Hirsch 1883; Thomson and Thomson
1933; Crosby 1976), and perhaps thousands of years (Langmuir, Worthen et al. 1985). Even with
recent medical advances, complications of annual epidemic influenza cause severe and
sometimes fatal illness (Thompson, Shay et al. 2003) especially among the elderly and
immunocompromised (Barker and Mullooly 1980; Glezen, Keitel et al. 1991), and can cause
substantial debility even in otherwise healthy patients (Kavet 1977; Schonenbaum 1996),
resulting in large direct and indirect economic costs (Szucs 1999). Major pandemics, which have
occurred approximately every 30-40 years in the past century, have caused significantly higher
mortality even among healthy young adults (Simonsen, Clarke et al. 1998); it is estimated that the
especially severe 1918-1920 “Spanish Flu” pandemic resulted in more deaths than did World War
1 (Wilton 1993). Unfortunately, new potential pandemic threats are on the horizon, such as the
recent worldwide outbreak of swine flu in the spring of 2009, and the persistence of highly virulent
avian influenza strains in Asia that have caused greater than 60% mortality rates in documented
human infection (de Jong 2008).

While an influenza vaccine and four antiviral drugs are now on the market, significant concerns
remain about the availability of effective treatment and prophylaxis for influenza, particularly in a
pandemic situation (Memoli, Morens et al. 2008). Vaccine production to target a new influenza
strain presently takes several months (Tripp and Tompkins 2008), and levels of resistance to
antivirals have recently increased, in some cases dramatically (Bright, Shay et al. 2006; Bright
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RA, Shay et al. 2006; Hurt, Ho et al. 2006; Monto 2008). Furthermore, vaccine effectiveness has
been shown to be lower in those most vulnerable to influenza infection (Powers and Belshe 1993;
Govaert, Thijs et al. 1994), and currently available antivirals must be given within a very narrow
time window for optimal results, which in and of themselves are generally modest (Galbraith,
Oxford et al. 1971; Nicholson, Aoki et al. 2000; Treanor, Hayden et al. 2000). Thus, there is
continuing interest and urgency in better understanding the detailed underpinnings of influenza
infection and pathogenesis, so that better therapeutic tools can be obtained (Hayden 2009). This
thesis focuses on developing a comprehensive molecular mechanism based on the structure and
function of a key influenza protein that is targeted by two currently available antiviral drugs.

1.2. The influenza virus family.
The three types of influenza viruses (A, B and C) belong to the orthomyxoviridae family. First
isolated in 1933 (Smith, Andrewes et al. 1933), influenza A viruses can infect multiple hosts,
including humans, swine, ferrets, and birds, while influenza B (Francis Jr 1940) infects humans
only, and influenza C (Taylor 1951) viruses infect humans and swine (Treanor 2005). The most
serious human disease, manifest by high fevers, body aches, fatigue and dry cough, followed on
occasion by bacterial superinfection, is caused by influenza A and, to a somewhat lesser extent,
influenza B strains (Nigg, Ecklund et al. 1942; Blaine, Luby et al. 1980). Influenza C is believed
to cause mild infection more similar to a common cold (Mogabgab 1963).

Influenza viral particles are enclosed in a lipid membrane envelope, and contain a genome made
up of 7-8 single strand RNA segments, each segment encoding for particular proteins used by the
virus. It is this segmented genome that makes influenza viruses highly problematic from the
standpoint of vaccine development and human immune response, since two genetically different
viruses infecting the same cell can swap segments to create a novel virus with a new set of
antigenic and virulence properties. This phenomenon typically does not take place with the small,
subtle changes in the genetic makeup of influenza, known as antigenic drift (Wilson and Cox
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1990), that regularly results in the annual epidemic flu and occasionally in more severe outbreaks
(Morens, Taubenberger et al. 2009). However, it has been hypothesized to underlie (Dowdle and
Schild 1976) the rare but more substantial changes, often in non-human hosts, that are known as
antigenic shifts. Antigenic shifts can lead to viruses with a novel immunological signature to
which pre-existing immunity in the population is lacking, and can therefore cause deadly
worldwide pandemic disease if the virus also has high replicative fitness and human-human
transmissibility.

1.3. Influenza virus membrane proteins are targets of vaccines and antivirals.

Figure 1.1 Schematic of influenza virus envelope and membrane proteins. Adapted from (Kaiser
2006).

The influenza virus lipid envelope (shown in schematic form in Fig. 1.1) contains three types of
membrane proteins: hemagglutinin, neuraminidase, and relatively much less abundant M2 protein
(Brooks, Butel et al. 2004). Hemagglutinin (HA or H) and neuraminidase (NA or N) are key
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antigenic determinants of the virus, and their variants are reflected in the nomenclature of
influenza virus subtypes, e.g. H1N1 or H3N2. These proteins play critical roles in the viral life
cycle and are the only targets of existing immunologic and pharmacologic anti-influenza
therapies, thus a detailed understanding of their function is key to improving treatments for
influenza infection.

Figure 1.2. Influenza virus infection cycle. Illustration from (Pinto and Lamb 2007).

In a typical viral infection cycle, outlined in Fig. 1.2 and reviewed in reference (Lagoja and De
Clercq 2008), hemagglutinin on the viral particle binds sialic acid residues on the target epithelial
cell surface.

The viral particle is endocytosed, trafficked inside an endocytic vesicle, and

eventually ends up in the cell endosome, where extraviral pH is lowered.

The M2 protein

transports protons from the endosome lumen into the viral interior, dissociating the viral RNA
genome from the matrix protein with which it is packaged. In a pH-dependent manner, the
influenza hemagglutinin undergoes a dramatic conformational change to trigger fusion of the viral
envelope and the target cell endosomal membrane. The viral RNA is then replicated in the target
cell nucleus, and newly synthesized viral proteins are trafficked in the Golgi apparatus membrane
for assembly and export. There, M2 plays its second role in the infection cycle, allowing proton
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efflux from the slightly acidic Golgi lumen to prevent premature hemagglutinin pH-triggering in
certain influenza strains (Sugrue, Bahadur et al. 1990; Sagakuchi, Leser et al. 1996). Finally, after
new viral particles are assembled and bud off from the cell surface, neuraminidase cleaves sialic
acid linkages to detach the virion from the cell membrane and allow for infection of other cells.

The influenza hemagglutinin, a large trimeric glycoprotein (Wilson, Skehel et al. 1981) used by
the virus to bind sialic acid receptors on target cells and mediate pH-triggered membrane fusion,
is the most abundant influenza envelope protein (Brooks, Butel et al. 2004) and a target of
currently available influenza vaccines (Wood 1998). However, it is highly variable between strains
(Knossow and Skehel 2006) and analyses of human clinical isolates show continuous genetic
change with time even in non-pandemic years (Bragstad, Nielsen et al. 2008). This drift is likely
caused by continuous selective pressure by pre-existing host antibodies (Webster, Laver et al.
1980), and therefore limits the antigenic precision of the annual influenza vaccine and its diseasepreventing utility.

There is thus a need for antiviral drugs that can be administered to treat

existing influenza infection or as additional prophylaxis in areas of an ongoing outbreak. The
other two influenza membrane proteins are targets of such agents.

Figure 1.3. Influenza neuraminidase inhibitors oseltamivir (left) and zanamivir (right).

The influenza neuraminidase protein, an enzyme that cleaves sialic acid linkages to free newly
synthesized virions (Compans, Dimmock et al. 1969; Colman, Varghese et al. 1983; Varghese,
Laver et al. 1983), has been successfully targeted using structure-based drug design in the 1990s
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(von Itzstein, Wu et al. 1993; von Itzstein and Thomson 2009). Efforts to date have resulted in
two commercially available inhibitors shown in Fig 1.3, oseltamivir (Tamiflu) and zanamivir
(Relenza), which are licensed to treat influenza A and B infection and are now recommended as
first line therapy (Fiore, Shay et al. 2008). These compounds target a highly conserved site in the
neuraminidase enzyme that is necessary for catalytic function, and thus were predicted to face
little clinically meaningful resistance. However, in recent years, spontaneously emerging
oseltamivir-resistant viruses have entered worldwide circulation (Lackenby, Thompson et al.
2008). More alarmingly, development of resistance during oseltamivir treatment has been
reported in cases of human infection with the highly virulent avian H5N1 influenza strain (de Jong,
Tran et al. 2005).

Figure 1.4. Influenza M2 protein inhibitors amantadine (left) and rimantadine (right).

The least abundant influenza membrane protein, M2, is the target of the oldest class of antiinfluenza drugs, the aminoadamantanes amantadine and rimantadine, shown in Fig. 1.4. The
activity of the parent compound amantadine was discovered empirically in the 1960s and
predated the identification of its protein target by some two decades (Davies, Grunert et al. 1962).
That amantadine acts on the M2 protein was inferred by sequence analysis of amantadineresistant influenza A strains, where mutations mapped to the transmembrane domain of M2 (Hay,
Wolstenholme et al. 1985). Interestingly, influenza B is naturally amantadine-insensitive (Davies,
Grunert et al. 1962), presumably because of inherent differences in the transmembrane domain
sequence of its M2 homolog BM2 (Ma, Soto et al. 2008). Amantadine (Symmetrel) and its
second-generation analog rimantadine (Flumadine) have been a mainstay of anti-influenza A
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therapy and prophylaxis for over thrity years, with low levels of naturally occurring resistance
(Ziegler, Hemphill et al. 1999). However, in recent years, resistance levels shot up dramatically to
over 90% in the United States (Bright, Shay et al. 2006), prompting the CDC to urge physicians
to avoid the use of adamantane drugs for influenza treatment and prophylaxis until further notice
(Fiore, Shay et al. 2008). While some progress has been made in generating novel M2 inhibitors
(Kurtz, Luo et al. 1995; Kolocouris, Zoidis et al. 2007; Wang, Cady et al. 2009), no new
compounds with significant activity against the most common amantadine-resistant M2 variants
have been developed.

1.4. Influenza A/M2 is a minimalistic membrane transport protein.
In addition to being a validated target for influenza antivirals, influenza A M2 (A/M2) has become
a system of interest in many other basic science fields. It has been studied as a model integral
membrane protein given its relatively small size (each amino acid strand is only 97 residues
long), self-association (the functional protein is a tetramer), and ion transport function (reviewed
in (Pinto and Lamb 2006; Pinto and Lamb 2007)). In fact, A/M2 is among the smallest known
proteins involved in ion translocation (Decoursey 2003), and is furthermore ligand-regulated.
Thus, it has been an attractive model system for the investigation of membrane protein folding,
assembly and structure, ion transport physiology, computational biology, and, of course,
pharmacology and medicinal chemistry. While much progress has been made in many of these
fronts, a definitive, unified mechanism of A/M2 transport that correlates findings from all of these
fields has not been established.

One of the key aims of this thesis is to develop such a

mechanism, combining concepts and results from electrophysiology, biophysics, and structural
biology. A sequence of a common naturally occurring A/M2 variant (A/Udorn/72 strain) and a
domain diagram of A/M2 are shown in Figures 1.5 and 1.6 to assist the reader in following the
more detailed experiments described in later sections of this chapter.
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Figure 1.5. Sequence of A/M2 (A/Udorn/72).

Figure 1.6. Domain diagram of A/M2. One half of the tetramer is shown for simplicity.

Soon after A/M2 was identified as a transmembrane protein and the target of amantadine (Hay,
Wolstenholme et al. 1985; Lamb, Zebedee et al. 1985), it was shown to mediate the pHdependent dissociation of the viral RNA from its packaging M1 or matrix protein (Zhirnov 1990;
Helenius 1992; Zhirnov 1992). A/M2 inhibition was also shown to lead to premature triggering of
hemagglutinin during its export from influenza-infected cells (Sugrue, Bahadur et al. 1990). Thus,
it was surmised that A/M2 was involved in proton transport. The minimal active form of A/M2 was
shown to be a homotetramer (Sakaguchi, Tu et al. 1997) stabilized by a pair of N-terminal
disulfide bonds, and its transmembrane domain was demonstrated to

form alpha helices in

membranes (Duff, Kelly et al. 1992). Confirmation that A/M2 transported ions across the
membrane came in 1992, when A/M2 expressed in Xenopus laevis oocytes, a model system for
the study of ion channels, and found to mediate cation currents in a pH-regulated fashion (Pinto,

8

Holsinger et al. 1992). As shown in Figure 1.7, when the pH of buffer bathing the oocytes was
lowered from ~7.5 to ~5.5, cation flux increased, although a single residue mutation in the heart
of the protein’s transmembrane domain (His37Ala) could abrogate the pH regulation. Baseline
currents were seen from oocytes injected with antisense mRNA. Chizhmakov and Hay found a
similar pH-regulating effect by expressing A/M2 in another electrophysiological model system,
murine erythroleukemia cells (Brooks, Butel et al.), and established that A/M2 is stringently (over
6

10 fold) proton-selective.

Figure 1.7. The first direct evidence that M2 functions as an ion transport protein. M2 expressed
in oocytes mediates increasing inward cation currents as bathing pH is decreased. Figure from
(Pinto, Holsinger et al. 1992).

1.5. Functional studies of influenza A/M2.
Before embarking on further discussion of detailed functional experiments on A/M2, the most
commonly used model systems for studying membrane transport proteins will be reviewed, along
with their advantages and limitations. The gold standard measurement for ion channels is of
single-channel behavior, where parameters such as per-protein current amplitude, open time and
probability, inactivation, and inhibition can be ascertained. Systems to obtain such measurements
involve application of a constant electrical potential (voltage clamp) across an electrically isolated
area (patch) of membrane containing the protein of interest (Neher and Sakmann 1976). As
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shown in Figures 1.8 and 1.9 the membrane may come from a cell expressing the protein, or from
an artificially formed planar bilayer. Unfortunately, single-channel measurements (typical results
for small membrane-spanning peptides are shown in Fig. 1.9) remain a relatively untouched holy
grail for A/M2, as its per-protein currents are extremely small and thus very difficult to measure
individually. To this end, a comparison of M2 current magnitudes with those of some other known
proton channels is shown in Figure 1.10. Therefore, the vast majority of functional studies of
A/M2 transport have relied on whole-cell or otherwise averaged measurements of the
simultaneous currents of many proteins; single channel properties have been estimated by
quantifying the amount of protein present in the system.

Figure 1.8. Diagram of a cellular patch clamp experiment. A gigaohm seal is formed between
the glass pipette to isolate a small area (patch) of the cell membrane (circled in red). If
membrane proteins are also present in the patch, their currents can be recorded (left panel).
Alternatively, the pipette may pierce the cell membrane (right panel), in which case membrane
currents from the whole cell are recorded. Illustration adapted from (Suzuki and Takeuchi 2008).

10

Figure 1.9. a) Planar bilayer electrophysiology experiment, cartoon depiction of side view. A
voltage is applied between the upper and lower compartments. b) Top view of parallel planar
bilayer systems. c) Example single-channel current recordings (seen as current spikes) of simple
channel-forming peptides. Illustration from (Suzuki and Takeuchi 2008).

11

Figure 1.10. Measured or estimated single channel currents for a variety of proton channels. M2
(light blue, near bottom of figure) is one of the slowest known proton channels with transport rates
estimated at ~10-100 protons/second (right axis). Figure from (Decoursey 2003).

Xenopus laevis (African clawed frog) oocytes are very convenient model systems for the study of
ion channels (Tammaro, Shimomura et al. 2008): they are extremely large cells often exceeding 1
mm in diameter and are therefore easy to manipulate, and can be induced to express transport
proteins of interest by intracytoplasmic injection of mRNA encoding the desired protein. However,
transport measurements with the oocyte system require special care, since expression of
heterologous proteins or voltage extremes can activate normally quiescent endogenous
membrane currents (Kowdley, Ackerman et al. 1994; Shimbo, Brassard et al. 1995), leading to
artifactual measurements. Furthermore, as living cells, the oocytes may not withstand extremes
of pH and buffer ionic compositions. Therefore, great care must be taken to ensure that observed
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currents are in fact through the protein of interest, and non-physiological conditions must be
avoided.

Other eukaryotic cells, such as CV-1 (fibroblast) and MEL (murine erythroleukemia) have also
served as model systems for expressing ion-transporting membrane proteins (Wang, Lamb et al.
1994). They have similar advantages and disadvantages as oocytes (Witchel, Milnes et al. 2002),
and may be prone to artifacts from endogenous channels or extreme conditions. While in early
studies of A/M2, these systems have been somewhat more robust in delivering M2-specific
measurements, (Chizhmakov, Geraghty et al. 1996) more recently studies in both oocytes and
CV-1/MEL cells have provided highly reliable and mutually consistent data.

Channel proteins have also been reconstituted in the membranes of unilamellar phospholipid
vesicles (Miller 1984), and this method provides a way to completely isolate the construct of
interest from other protein components that are present in cells. Ion fluxes can be determined by
spectral measurements of ion-sensitive dyes (as shown in Figure 1.11), or by ion-sensitive
electrodes. Liposome measurements are usually of bulk transport, as the properties of multiple
liposomes and proteins are averaged. This system requires a membrane of very low intrinsic
permeability, and relies on reconstitution of purified protein from a separate source. Thus, it
becomes important to ensure that the reconstitution process is efficient without loss of material,
since the protein machinery that performs membrane insertion in living cells is not present in the
liposome system. Also, it is difficult to control protein orientation once reconstituted in the
liposome bilayer (N-terminal inside or N-terminal outside) (Niu, Doctrow et al. 2009).
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Figure 1.11. Left panel: a membrane protein is reconstituted in a liposome membrane
(unilamellar membrane vesicle) that contains a pH-sensitive fluorescent dye (depicted as yellow
hexagons). Right panel: the spectral properties of the dye change in response to proton influx or
efflux from the liposome.

Finally, channel proteins can be studied in the planar lipid bilayer system, where a highly
impermeable unilamellar membrane bilayer is created in a small opening between two bathing
chambers, as reviewed in (Miller 1983) and shown diagrammatically in Figure 1.9. The protein
fragment of interest can be added to the bilayer in a number of ways; for example by injection in
detergent micelles, or by membrane fusion with liposomes or other cell membrane fragments
containing the protein. Therefore, this system also relies on efficient protein insertion.

An

electrical potential can be applied across the bilayer much like in the cell-based studies, although
this system allows the use of non-physiological buffer conditions, making such results potentially
more difficult to correlate to biological processes. It should also be kept in mind that planar lipid
bilayer recordings of small, single-channel currents are highly sensitive to inadvertent
contamination.
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Some of the first direct measurements of M2 activity came from Xenopus laevis oocytes, which
when injected with A/M2 mRNA exhibited inward whole-cell cation currents that were inhibited by
amantadine and increased by negative internal voltages and low external pH (Pinto, Holsinger et
al. 1992). Loss of the His 37 sidechain led large pH-insensitive currents, whereas other mutations
in the transmembrane domain abrogated amantadine sensitivity (Pinto, Holsinger et al. 1992),
and deletions of 3-5 residues in the transmembrane domain led to marked changes or complete
loss of activity (Holsinger, Nichani et al. 1994). In the initial oocyte channel experiments, it was
+

incorrectly concluded that M2 is selective for Na , which was also the finding in a planar lipid
bilayer study of M2 (Tosteson, Pinto et al. 1994). These erroneous findings were likely obtained
because of unrecognized endogenous oocyte currents, and pH extremes in the planar lipid
bilayer study.

Nevertheless, the stimulating effect of decreased pHout on transport activity was interpreted to
mean that A/M2 is regulated by pH, and possible sites that mediate this regulation phenomenon
were examined. The only residue in the M2 transmembrane sequence that titrated in the pH
range of A/M2 activation was His37, the mutation of which to Ala was shown in the initial oocyte
study to render M2 currents pH-insensitive (Pinto, Holsinger et al. 1992). Building on this
evidence, constructs with this residue mutated to Gly, Glu, Arg, or Lys were tested (Wang, Lamb
et al. 1995). As shown in Figure 1.12, the His37Gly and His37Glu mutants had almost completely
abrogated pH regulation and much greater estimated currents, while oocytes expressing
His37Arg and His37Lys were non-viable. Thus, it was concluded that His 37 is the pH sensing
residue of A/M2, and is the key regulator of its function via protonation from external buffer. That
a variety of mutant amino acid sidechains in terms of size and pKa led to significantly perturbed
properties suggested that both the steric and electrostatic properties of the His side chain were
important in the pH regulation of M2.
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Figure 1.12. A variety of His 37 mutants lead to loss of pH regulation of M2 currents (plotted as
current ratios above), suggesting that the properties of His 37 in the protein are highly tuned for
pH sensing. Figure from (Wang, Lamb et al. 1995).

The unique, highly tuned nature of the His 37 side chain in the function of M2 was also
demonstrated with chemical rescue experiments (Venkataraman, Lamb et al. 2005). A/M2
His37Gly and other His37 mutants expressed in oocytes were functionally “rescued” by addition
of imidazole, the histidine sidechain, to the bathing buffer, suggesting that the imidazole
noncovalently interacts with the M2 pore in a manner sufficient to restore function. Interestingly,
much larger heterocyclic molecules of a similar pKa or those of a similar size but with substantially
different pKa values were ineffective at restoring function, and some were even inhibitory.

With His 37 established as the pH sensor, focus renewed on nature of the ionic cargo transported
by A/M2. Experiments with a pH-sensitive dye entrapped in A/M2 proteoliposomes determined
that A/M2 translocated protons in an amantadine-sensitive manner (Schroeder, Ford et al. 1994);
this was also seen in oocyte experiments performed under more stringent conditions. These
findings were supported by results from A/M2 expressed in MEL cells, where it was determined
+

that the degree of A/M2 proton selectivity over Na was over 1,000,000 fold (Chizhmakov,
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Geraghty et al. 1996). This high level of proton selectivity was also demonstrated in subsequent
oocyte and proteoliposome experiments (Mould, Drury et al. 2000; Lin and Schroeder 2001).

A/M2 is inwardly rectifying: that is, proton flux from its outer, N-terminal side to the inner, Cterminal side is much faster than the reverse. It was hypothesized that a bulky residue located Cterminal to His 37 mediated this effect by sterically occluding water access to the His 37 side
chain from the C-terminal side. The only such residue in the A/M2 transmembrane domain is Trp
41, which is highly conserved in A/M2 and in its influenza B homolog BM2. As shown in part in
Figure 1.13, mutating Trp 41 to Phe in the oocyte system abrogated rectifying behavior; a similar
result was seen for a Trp41Cys mutation, while Trp41Tyr only slightly weakened the rectification
(Tang, Zaitseva et al. 2002). The steric effect of Trp 41 was also demonstrated using copper (II),
which inhibits M2 by complexing His residues or water structures in the aqueous pore when
added from the N-terminal side of A/M2, but which has no effect when injected from the Cterminal side unless the Trp 41 side chain is mutated away. Amantadine was also found to be
ineffective when added from the C-terminal side to WT A/M2 (Tang, Venkataraman et al. 2005).
Thus, the Trp 41 indole (with a requirement for large size and rich electron density, as shown by
the mutant results) forms the gate of A/M2, blocking reverse proton flow.

Figure 1.13. Currents through Xenopus oocytes expressing WT and Trp 41 mutant M2 plotted
vs. time as the oocyte exterior is washed with buffers of different pH (top panel). Inward proton
currents are negative on the y axis. The Trp41 residue of M2 prevents outward flow of protons.
Mutation of the Trp to Phe allows outward proton flow (arrow), which is also observed when the
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non-directional small molecule proton carrier FCCP is added. Figure from (Tang, Zaitseva et al.
2002).

1.6. Low resolution structural and spectroscopic studies of A/M2.
Not only did A/M2 prove to be a fruitful model system for the study of proton transport across
membranes, it was also an attractive target for the fields of structural biology, biophysics, and
bioinformatics, because of its small size, pharmacological relevance, and highly regulated
transport function. Since many biophysical and computational techniques become difficult to
apply on larger systems, interest immediately focused on a peptide representing the
transmembrane domain of M2, as the location of conserved residues important for function. This
peptide was demonstrated to form alpha helices in membranes (Duff, Kelly et al. 1992), and since
the minimal functional oligomeric state of full length M2 was shown to be tetrameric (Sakaguchi,
Tu et al. 1997), it was surmised that the transmembrane domain of the active protein is a four
helix bundle. The transmembrane peptide sequence corresponding to the A/Udorn/72 strain of
influenza is shown in Figure 1.14.

H2N-SSDPLVVAASIIGILHLILWILDRL-COOH
Figure 1.14. Transmembrane peptide (M2 TM, residues 22-46) sequence of A/Udorn/72. The
pH-sensing His 37 residue and the gating Trp 41 residue are highlighted in red.

The first detailed models of the transmembrane domain were published by Pinto et al. (Pinto,
Dieckmann et al. 1997) and Sansom et al. (Sansom, Kerr et al. 1997) in 1997.

In the former

work, a functionally defined model was constructed using cysteine-scanning mutagenesis of the
transmembrane domain of full length A/M2 expressed in Xenopus oocytes.

Functional

parameters of each mutant were assayed and scored in a perturbation index, which was then
parameterized in a periodic function (to correspond to the amino acid periodicity in an alpha helix)
as shown in the left panel of Figure 1.15. The most highly perturbing mutants were expected to
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correspond to pore-lining residues, whereas those with minimal impact on function would face
outside the helix bundle. The resulting energy-minimized model was a left-handed coiled coil with
a 15 degree helical tilt from the membrane normal.

A large N-terminal aqueous pore was

observed (shown in right panel of Figure 1.15), lined by Val 27, Ala 30, Ser 31, and Gly 34, and
blocked at the C-terminal end by the imidazole sidechains of His 37. The spaces between these
groups were insufficiently large for water or hydronium ion penetration.

At the next level of

residues, Trp 41, the pore is once again accessible to water.

Figure 1.15. Perturbation index-based structural model of A/M2 transmembrane domain. In the
left panel, functional parameters of single-residue Cys mutants (from top, reversal potential, pHout
activation, and inhibition) are combined into a perturbation index (bottom) that is parameterized
as a periodic sine function corresponding to an alpha helix. The resulting structural model, when
energy-minimized and viewed as N- to C-terminal slices along the membrane normal, shows a
large N-terminal aqueous pore lined by Val 27 (A), Ala 30, Ser 31 (B), Gly 34 (C) and blocked at
the C-terminal end by His 37 (D), before opening again at Trp 41. Figure from (Pinto, Dieckmann
et al. 1997).
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In the Sansom et al. model, simulated annealing in vacuo of template helical bundles was
followed by water solvation of the pore and molecular dynamics (MD) simulations on the
minimized, solvated, structure. (Sansom, Kerr et al. 1997) 1 ns MD runs were performed with all
His 37 groups deprotonated (neutral) and with one of the groups protonated. Models derived
from the MD simulation had average helix tilts of 21-25 degrees relative to the bilayer normal, and
pore facing residues similar to the mutagenesis model. Again, a large N-terminal aqueous pore
was seen with water wires (aligned water pathways) throughout. In the fully neutral protonation
state, the His 37 sidechains occluded the pore from the C-terminal end, but in the 1+ state, these
sidechains moved from the pore lumen to the interface, creating space for an uninterrupted water
wire throughout the transmembrane segment.
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Figure 1.16. Model of A/M2 TM domain generated by molecular dynamics simulations by
Sansom et al. Peptide helices are in blue, and water molecules (red) are linked in hydrogen
bonded networks (gray). His 37 sidechains are shown in green. (A) Neutral state with all histidine
residues deprotonated and occluding the aqueous pore. (B) Upon protonation of a single His 37,
the sidechains shift apart to allow continuous water wires to permeate through the His 37
constriction. Figure from (Sansom, Kerr et al. 1997).

The secondary and low-resolution tertiary structure of M2 was also studied using purely
biophysical methods, such as solid state NMR spectroscopy and infrared dichroism. Solid-state
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NMR is advantageous as it provides a native-like phospholipid membrane environment, where
the protein of interest is reconstituted. The sample consists of stacks of membrane bilayer “disks”
aligned in a tube, which is oriented at a fixed angle relative to the magnetic field. Unfortunately,
because of the isotropic alignment, solid state methods cannot provide high resolution structural
information, but they can be used to obtain helix orientations with respect to the membrane
normal, as well as to obtain data on dynamics via relaxation and hydrogen exchange, and to
determine distance restraints in some cases (Hong 2007; McDermott 2009).

ssNMR experiments by Cross et al. on the transmembrane domain of M2 and on the full length
protein showed that the construct is helical and takes on a variety of tilt angles with respect to the
membrane normal, ranging from 25 to 38 degrees depending on the length of the protein
fragment studied (Wang, Kim et al. 2001; Tian, Gao et al. 2003). Only one inter-helical distance
restraint, at a maximum of 3.9 Å between the π nitrogen of His 37 and the γ carbon of Trp 41,
could be reliably obtained (Nishimura, Kim et al. 2002). The resulting model (based on data
obtained at pH 7.0) has a large N-terminal aqueous pore interrupted only by the Trp 41 indoles
and is shown in Fig 1.17; however, later work by Hong et al. (Luo, Mani et al. 2007) using
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F-

labeled Trp 41 residues obtained an interhelical F-F distance restraint of nearly 12 Å at both
neutral and low pH, and was most consistent with a different Trp 41 rotamer.
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Figure 1.17. Model of the M2 transmembrane domain generated from ssNMR measurements and
a single interhelical His37-Trp41 distance restraint. (A) Model with sidechains shown. (B) Spacefilling model depicting aqueous pore, which is open near His 37 but constricted by Trp 41 indoles.
Figure from (Nishimura, Kim et al. 2002).

Structural determination of the transmembrane domain of M2 was also attempted using IR
dichroism, where samples of the transmembrane peptide were reconstituted into an aligned solidstate bilayer (Torres, Kukol et al. 2000; Torres and Arkin 2002). The differential absorption of
parallel and perpendicular-polarized infrared light by the helical amide band as well as by
isotopically labeled amino acids was used to calculate helix orientations, with resulting tilt angles
relative to the membrane normal of 30 to 35 degrees.

While the majority of structural work in the late 1990s and early 2000s was devoted to building a
secondary structure model of the M2 bundle, other investigators zeroed in on the functionally
critical dyad of M2 residues, His 37 and Trp 41, which were found to be in close geometric
proximity in earlier ssNMR experiments (Nishimura, Kim et al. 2002). Since indole and deuterated
imidazole are weakly active in UV resonance Raman (UVRR) experiments, the pH-dependent
UVRR spectra of the transmembrane peptide of M2 in bilayers were measured, which showed
concomitant, pH-driven changes in the spectra of both sidechains (Okada, Miura et al. 2001). The
spectra were most consistent with a cation-π interaction between a deuterated (positively
charged) imidazole and the indole; and it was proposed that upon deuteration, the His 37
imidazole undergoes a rotamer shift and interacts closely (<5 Å) with a Trp 41 indole on an
adjacent helix. A pH-dependent cation- π interaction of the two sidechains was also observed
using fluorescence spectroscopy in micelles (Czabotar, Martin et al. 2004), where the intrinsic
fluorescence of Trp 41 was increasingly quenched with decreasing pH, presumably by protonated
His 37.
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Figure 1.18. Model of the high-pH closed (A) and low-pH open (B) states of M2 TM based on UV
resonance Raman data, viewed C-terminal to N-terminal along the membrane normal. As pH is
lowered, His 37 changes rotamer states and interacts closely with Trp 41, resulting in opening of
the pore lumen. Figure from (Okada, Miura et al. 2001).

In summary, over the span of approximately 10 years, multiple low-resolution models of the
transmembrane domain of M2, and of the more detailed structure of the His 37 and Trp 41
sidechains, have been generated using a variety of computational and biophysical techniques.
While it is comforting to observe that all the models agreed on the basics (a parallel, left-handed
four helix bundle tilted ~15-40 degrees from the membrane normal), there remained substantial
disagreement on the fine details of the structure. For one, the findings disagreed on whether
water can fully penetrate the pore under certain conditions or is stopped by His 37, Trp 41, or a
combination of the two. There was also controversy on how the His 37 and Trp 41 side chains
are arranged relative to each other, although some form of close, pH-dependent interaction was
seen in multiple systems. Therefore, while the outlines of the M2 transmembrane domain
structure were coming into view, the resolution was too low to definitively correlate structural
phenomena to the regulation of pH-dependent currents observed in functional experiments.
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Nevertheless, multiple mechanistic hypotheses were generated, as will be discussed in the next
section.

1.7. Early mechanistic theories and experiments.
Even in the absence of high-resolution structural data, sophisticated mechanistic theories for M2
function were proposed based on the first models of the transmembrane domain helical bundle,
which were published in 1997. Two mechanistic hypotheses would dominate the literature for the
next decade, with subsequent experimental results being interpreted to support one or the other.

As discussed in the previous section, Pinto et al. built a model of the M2 transmembrane domain
based on parameterization of functional perturbations stemming from single-residue mutations in
the TM sequence (Pinto, Dieckmann et al. 1997). The large N-terminal aqueous pore in the
resulting bundle structure was occluded by His 37 imidazole rings aligned parallel to the
membrane normal.

Based on the (low) pH-cooperativity of M2 activation observed in early

functional studies (Wang, Lamb et al. 1995), it was postulated that only a single His sidechain
must be protonated to activate transport. Because the His sidechains were blocking the pore in
the computed model, it was hypothesized that all protons transported must be shuttled across the
constriction by an imidazole sidechain, and that a continuous water wire (bypassing the
imidazoles) did not form throughout the pore upon channel activation. Thus, transported protons
would be bound from water or hydronium by a neutral imidazole from the N-terminal side, and
released to water on the C-terminal side. A ring flip or tautomerization would complete the cycle.
An important corollary of this “proton shuttle” hypothesis is that, assuming relatively unimpeded
diffusion through the rest of the channel, the rate of transport would be determined by the kinetics
of proton interactions with the imidazole. With these assumptions, imidazole protonation on-rates
9

would be diffusion-limited (near 10 /(M sec)). The on-rates and off-rates can be related through
-

the proton affinity constant, the pKa = -log(Ka) = -log([A ]/[HA]) = -log(k H+,off/kH+on). This relationship
implies that the maximum off-rate, and thus the transport speed limit, would be near 1000
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protons/second assuming a typical His pKa of ~6; this maximum speed is roughly consistent with
estimates from functional studies.

A second widely accepted model was proposed from the first set of M2 TM molecular dynamics
simulations by Sansom et al. (Sansom, Kerr et al. 1997). In this work, the His 37 imidazole rings
were observed to sterically occlude the aqueous pore in the 0+, fully deprotonated state of the
channel, but moved away from each other when one of them was protonated, creating a
continuous water wire through the length of transmembrane section of M2. Thus, it was argued,
the His 37 imidazoles regulate proton transport in an electrostatic fashion. As they become
successively protonated with decreasing pHout, the positive charges repel each other to permit
proton transport along water wires. A corollary of this “electrostatic gate” mechanism is that with
sufficient His 37 protonation and repulsion, the rate of proton transport becomes limited by
diffusion along the water wires, and is thus substantially faster than in the shuttle model.

Figure 1.19. Schematics of proposed mechanisms of proton transport through M2. In the model
proposed by Pinto et al. (Pinto, Dieckmann et al. 1997) (left), the His 37 imidazole rings occlude
the pore and serve as shuttles for transiting protons which bind then dissociate from the
imidazoles. The overall transport rate is predicted to be limited by the imidazole proton off-rate.
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In the mechanism proposed by Sansom et al. (Sansom, Kerr et al. 1997) (right), protonation of
His 37 sidechains leads to their steric separation and the formation of water wires through the
entire aqueous pore. Figures obtained from respective references.

Subsequent functional and spectroscopic studies of M2 were carried out to determine which
mechanism, if either, was more robust. The proton shuttle model of Pinto et al. was supported by
numerous lines of evidence, including studies in oocytes using deuterated bathing buffer, where
the noticeably slowed kinetics of transport suggested that His 37 directly interacts with
transported protons in the M2 pore, and estimated maximum M2 currents at a relatively slow 1-10
fA (Mould, Li et al. 2000).

The matter became somewhat more complicated with the publication of data on pH-dependent
activation of full length A/M2 in MEL cells from Chizhmakov et al., where the relationship of flux to
pHout and voltage was most consistent with a two-site model (Chizhmakov, Geraghty et al. 1996),
unlike the single-site model earlier surmised in both mechanistic hypotheses.

The first

protonation step (with a pKa of ~ 7) was suggested to activate the channel, and the second (with
a pKa of ~6) to lead to proton permeation, or conduction, without explicitly favoring the gate or the
shuttle mechanism. Mathematical models of the His shuttle transport with a two-proton site
(Salom, Hill et al. 2000) or a three-proton site mechanism (Lear 2003) with only protonation and
deprotonation steps considered, fit well to the Chizhmakov data, supporting the shuttle
hypothesis.
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Figure 1.20. Quantitative mechanistic analysis (solid lines) of A/M2 functional data (raw data
from ref. (Chizhmakov, Geraghty et al. 1996)) using a two site protonation-deprotonation model.
Main panel: current-voltage ratios (current normalized to current at 0 mV) at a variety of pHin and
pHout values (triangles, pHin 5, pH out 7; circles, pHin 8, pHout 6; squares, pHin 6, pH out 8). Upper
inset: ratio of pH-dependent chord conductance g/gmax (g=I/(V-Erev), where I is the observed
current, V is the applied voltage, and Erev is the proton reversal potential at a given pH calculated
by the Nernst equation) where gmax is g at pH 4. Solid lines indicate fits of two-site model, where
protonation at the first site activates the channel, and the transported proton binds the second
site. The best fit lines are consistent with dissociation constants of pK1=6.5 and pK2=5.67.
Figure from (Lear 2003).

Other evidence was interpreted to favor the electrostatic gate mechanism, including a series of
molecular dynamics simulations with the M2 bundle solvated in an explicitly modeled lipid bilayer.
In one study, protein “breathing” motions that at times permitted continuous water wires to span
the entire transmembrane segment were seen, indicating that His 37 imidazoles may not always
occlude the transport pathway (Forrest, Kukol et al. 2000). A subsequent modeling study
(Smondyrev and Voth 2002) using an advanced, multi-state empirical valence bond potential to
more accurately model electrostatic interactions, did find a partially His-blocked pore but showed
that protons can hop between water molecules on either side of the His 37 occlusion without
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being bound by the imidazole rings, thus disfavoring the shuttle mechanism. Also, the previously
discussed UV resonance Raman results from M2 TM in liposomes suggested that all four
histidines of the bundle are protonated in a noncooperative process, with a rather low pKa of ~5.7
(Okada, Miura et al. 2001). The observation of fully protonated M2 was consistent with the
electrostatic gate mechanism, since the shuttle mechanism presumably required less than
complete protonation at pHout values that facilitated conduction.

In summary, similarly to the pursuit of a structural understanding of M2 transport, uncertainty with
respect to translocation mechanism remained the status quo for over a decade, with a handful of
studies consistent with each of the two leading hypotheses. As will be outlined in the next section,
the determination of the first high-resolution M2 structures suggested yet another paradigm for
M2 proton transport.

1.8. Entering the high-resolution era: the first detailed structures of M2 TM.
Protein structure determination using X-ray diffraction from crystals has become a mainstay
technique since Kendrew and Perutz’s pioneering results on myoglobin and hemoglobin in the
late 1950s, and the development of advanced nuclear magnetic resonance techniques (Fourier
transform spectroscopy and 2-D NMR in the late 1970s and early 1980s, and multidimensional
NMR in the late 1980s and early 1990s) led to the widespread use of solution NMR spectroscopy
in structural biology. Membrane proteins constitute roughly one-third of the human genome, but
the crystal structure of the first integral membrane protein, a holy grail for the field, was only
obtained in the mid-1980s, and the second membrane protein crystal structure was determined
only six years later. Even with the successful adaptation of solution NMR methods to detergentsolubilized membrane peptides (MacKenzie, Prestegard et al. 1997) and proteins (Arora,
Abildgaard et al. 2001), membrane protein structure determination remains a daunting task. As
of July 2009, the Protein Data Bank protein structure compendium contained over 50,000 entries,
whereas subset databases of membrane and membrane-associated protein structures contain up
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to 1,000 unique entries representing a much smaller number of nonredunant proteins. Therefore,
to this day, membrane protein structural biology remains a difficult endeavor, with multiple
experimental bottlenecks that include production of large amounts of stable protein samples,
generation of high-quality crystals by optimizing detergent micelle or cubic phase bilayer
conditions, or determining optimal fragments and experimental conditions for NMR spectroscopy.

Thus, it is of no surprise that the first high-resolution structures of influenza A/M2 were the result
of years of painstaking trial and error. Two X-ray crystal structures (Stouffer, Acharya et al. 2008)
and one solution NMR structure (Schnell and Chou 2008) were published simultaneously; the Xray structures were of variants of the M2 transmembrane peptide (residues 22-46), while the
NMR structure was of a longer fragment encompassing residues 18-60 (a domain diagram is
provided in Figure 1.6).

The highest-resolution crystal structure, an Ile33SeMet variant, was crystallized at pH 7.3 from βoctylglucoside (OG) micelles. The crystal packing was in a bilayer-like environment, indicating a
biologically relevant form. The resulting structure, at 2.05 Å resolution, was an asymmetric,
teepee-shaped four-helix bundle (Figure 1.21) with the helices close together at the N-termini but
further apart at the C-termini. Each helix had a similar tilt with respect to the membrane normal in
its N-terminal half, but the orientation of the C-terminal half varied because of the presence or
absence of kinking at the level of Gly 34. The helices whose C-terminal ends were furthest
removed from the bundle central axis were almost completely straight, whereas those ending
closer to the central axis were kinked up to 15 degrees. The overall structure was interpreted as a
snapshot of several conformations that the protein could sample. The straight-helix extreme was
labeled the “A” form, the most highly kinked helix became the “D” form, and the intermediate
forms were named “B” and “C”. All four forms had His 37 side chains oriented nearly parallel to
the membrane normal, and Trp 41 side chains faced either into the interhelical space (models AC) or into the pore (model D). Confirming UVRR (Okada, Miura et al. 2001) and fluorescence
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(Czabotar, Martin et al. 2004) observations, the His 37 imidazole from helix C interacted edge-on
with the Trp 41 sidechain from helix D in the asymmetric bundle structure; additionally, an Asp 44
– Arg 45 interhelical salt bridge was observed between the C and D helices.

Figure 1.21. 2.05 Å resolution structure of M2TM, viewed along membrane normal from Cterminal side of the bundle. The conformation of each helix in the bundle is asymmetric: each
helical form (A-D) was interpreted to represent an intermediate conformation sampled by the M2
tetramer. Key side chains are highlighted. Figure from (Stouffer, Acharya et al. 2008).

Models of the entire transmembrane domain in each conformation were constructed by applying
four-fold symmetry to each of the asymmetrically packed helices in turn. In all cases, the resulting
aqueous pore is tightly constricted near its N-terminus at the level of the Val 27 side chain, and
widens substantially at subsequent pore-lining residues Ala 30, Ser 31, and Gly 34. In a tetramer
made from the kinked, “D” form, the aqueous pore is also occluded by His 37 side chains, and is
partially occluded by the Trp 41 indoles. The C-terminal ends of the helices are held together by
Asp 44 – Arg 45 interhelical salt bridges. By contrast, in a tetramer constructed from the straight
helix “A” form, the salt bridges are broken, and the His 37 side chains are sterically separated to
allow a continuous pore from the C-terminal end of the bundle into the middle of the channel.
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Figure 1.22. Models of M2TM built by imposing four-fold rotational symmetry on helical
monomers from crystal structure. (a) Superimposition of the four resulting helical bundles
showing range of conformations sampled by M2TM tetramer. (b),(d) Tetramer built from the “A”
helix. (c),(e) Tetramer built from the “D” helix. Figure from (Stouffer, Acharya et al. 2008).

A second structure, shown in Figure 1.23, obtained from crystals of the Gly34Ala variant of M2
TM grown at pH 5.3 in the presence of the drug amantadine, was determined at a somewhat
lower resolution of 3.5 Å. The overall helical bundle shape is symmetric and very similar in
orientation to the straight-helix “A” form, with a large opening at the C-terminal end of the tetramer
that narrows down to the Val 27 constriction. An electron density consistent with the size and
shape of amantadine was observed in the center of the aqueous pore, with the drug’s
hydrophobic cage abutting against the Val 27 and Ser 31 side chains (the latter H-bonded to the
protein backbone), and the amine group pointing into the open pore towards the C-terminus. The
drug is located at the hotspot for most known amantadine resistance mutations (occurring at

32

Ser31 and Gly34), and its location is consistent with known 1:1 inhibitor:tetramer stoichiometry
measured in other experiments (Wang, Takeuchi et al. 1993).

Figure 1.23. Low pH (5.3) structure of M2 TM bound to amantadine. Left panel: structure viewed
along membrane normal from C-terminal side showing amantadine blocking the aqueous pore
near residues Gly 34 (orange), Ser 31 (blue), Ala 30 (green), and Val 27 (red). The His 37
sidechain is shown in stick form. Middle panel: Electron density omit map (2Fo-Fc contoured at
1σ) showing density corresponding to amantadine molecule. Right panel: Results of Cysscanning mutagenesis (from (Pinto, Dieckmann et al. 1997; Tang, Zaitseva et al. 2002)) showing
position-specific effect of mutants on ability of amantadine to inhibit M2. Most disruptive,
resistance-inducing mutants are at positions shown in red. Figure adapted from (Stouffer,
Acharya et al. 2008).

The solution NMR structure (Schnell and Chou 2008) (shown in Figure 1.24) features a longer
fragment of M2, encompassing the transmembrane domain and a C-terminal amphiphilic helix.
(Schnell

and

Chou

2008)

The

structure

was

determined

at

high

pH

(7.5-8.0)

in

dihexanoylphosphatidylcholine micelles, in the presence of a large excess of the inhibitor
rimantadine, which was required to stabilize the protein for structure determination. The
transmembrane domain forms a tightly packed, symmetric four-helix bundle, shaped more like a
cylinder rather than the cone seen in the crystal structures. An aqueous pore is present, lined by
the same residues as in the crystal structure. There is a constriction at the N-terminal end formed
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by the sidechains of Val 27, and two even narrower constrictions at the C-terminal end from the
His 37 and Trp 41 sidechains.

The His 37 sidechains are again oriented parallel to the

membrane normal. However, the Trp 41 indoles assume a different rotamer state compared to
the crystal structures, with the π-surface of the rings nearly aligned with the membrane normal
and facing into the pore.

An electrostatic, interhelical Arg 44 – Asp 45 interaction is again

present. While no NOEs were observed for residues 47-50, the C-terminal amphiphilic helices
formed a loosely packed tetrameric coiled coil, with the interhelical interactions mediated by
hydrophobic sidechains on each helix.

Figure 1.24. Solution NMR structure of M2 core (residues 18-60). Rimantadine (shown in
orange-red) was observed to interact with the pore exterior. (a) Ensemble of low-energy models
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derived from NMR restraints, viewed from side. (b) Ribbon view of typical structure from
ensemble in (a). (c) View of transmembrane domain bundle along membrane normal from Cterminal end showing phenyl ring of Trp 41 sidechain facing into the pore and the external
rimantadine binding site. (d) Space-filling view of external rimantadine binding site. The amine of
the rimantadine was proposed to form an electrostatic interaction with the Asp 44 sidechain.
Figure from (Schnell and Chou 2008).

Surprisingly, in this structure an external rimantadine binding site was found, and no definitive
drug signal was obtained from the predicted internal amantadine site observed in the crystal
structures. Instead, the C-terminal exterior of each transmembrane helix (near residues 43-46) is
noncovalently interacting with a loosely ordered rimantadine molecule, at a site not typically
associated with resistance mutations. While some membrane proteins are inhibited in such an
allosteric fashion, the more likely explanation for this result is the enormous excess of
rimantadine used with respect to the protein (40x) and to the detergent (~13 mol %), which leads
to the population of weak, nonspecific binding sites.

However, the absence of the drug from its

expected, internal, location must also be explained, and is likely due to a combination of
limitations of the NMR technique, including rotational averaging of drug-pore NOE signals (one
drug to four symmetric helices), which reduces their amplitude four-fold.

Furthermore, the

magnitude and direction (positive or negative) of NOEs depends on the timescale of the target
molecule motion, and transitions through a zero point at intermediate timescale regimes. Thus, it
is possible that the internally bound rimantadine moves at a timescale at which drug-protein
NOEs are undetectable; a possibility supported by the lack of water-protein NOEs in the area of
the pore from the NMR structure that corresponds to the internal drug binding site. Very strong
evidence for the inside-pore binding site was also provided by subsequent experiments from the
Lamb and Pinto labs, where the homologous, naturally amantadine-insensitive influenza B BM2
protein was rendered partially amantadine-sensitive in Xenopus oocytes by replacing its N-
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terminal TM sequence with that of A/M2, while leaving the proposed C-terminal, external binding
site intact (Jing, Ma et al. 2008).

What new inferences can be made about transport mechanism from the high-resolution
structures? To begin with, it is difficult to conclude whether the structures support either one of
the two mechanistic hypotheses discussed above.

While the neutral-high pH forms (NMR and

the crystal “D” form) have the pore occluded by His residues and would therefore be consistent
with the shuttle mechanism proposed by Pinto et al. (Pinto, Dieckmann et al. 1997), the low pH
amantadine-bound structure, and the very similar, apo, “A” model from the neutral pH crystal,
show a C-terminal open pore more consistent with the electrostatic gate (Sansom, Kerr et al.
1997) mechanism. A key question is the extent to which these forms are populated at the pH
values at which conduction through M2 is observed. The answer is somewhat elusive, since the
crystals took many months to grow (allowing for slow chemical changes in the crystallization
buffer) and in some cases were grown in the presence of transition metals, which may influence
pH in unpredictable ways. Thus, it is possible that these low pH conformations may be sampled
by the protein rarely, if at all, under physiological conduction conditions.

However, a comparison of the pH-dependent helix configurations and pore water accessibilities of
the different structures gives rise to another attractive hypothesis: that the M2 transmembrane
domain functions not as a channel but as a classical transporter, as an extension of the shuttle
model. As shown in Figure 1.25, the Val 27 constriction is somewhat more open at high pH,
allowing access of water to the His 37 residues, at which point the pore is occluded and the helix
bundle stabilized at the C-terminal end by Asp 44 - Arg 45 interhelical salt bridges. As the Nterminal pH is decreased, the His side chain is protonated, favoring a conformational transition to
a form where the Val 27 sphincter is tightly closed, cutting off access to the N-terminal waters, but
the His 37 sidechain is now highly exposed to water molecules from the C-terminal side of the
membrane as the C-terminal helix ends (and the salt bridges holding them together) come apart.
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The His 37 imidazole can now be deprotonated from the C-terminal side, which favors a return to
the N-open form.

This hypothesis was supported by the results of molecular dynamics

simulations where the transmembrane domain crystal structures were placed into a lipid bilayer,
and various protonation states of His 37 explored (Khurana, Dal Peraro et al. 2009). In the
neutral, fully deprotonated state, M2 assumed an Nopen-Cclosed conformation, with His 37 residues
occluding the pore at the C-terminal end, but the Val 27 sidechains loosely packed at the Nterminal end. As the protein protonation state increased to 2+ or greater, the Val 27 sidechains
closed the N-terminal pore more tightly, while the His 37 and Trp 41 sidechains moved apart to
open the pore on the C-terminal side. Additional support for this mechanism comes from disulfide
cross-linking studies on transmembrane domain Cys mutants of full length M2 (Bauer, Pinto et al.
1999), where decreased cross-linking of residues at the C-terminal end of the TM domain was
seen when pH was lowered.

Figure 1.25. Analysis of helix tilt and pore water accessibility from structures and models of
M2TM at various pH values. Top panel: as external pH is lowered, the pore radius at the level of
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Val 27 decreases, while increasing at the level of His 37 and Trp 41. Bottom panels: view along
membrane normal from N-terminal and C-terminal sides showing configuration of Val 27, His 37,
and Trp 41 sidechains. Figure from (Khurana, Dal Peraro et al. 2009).

However, this hypothesis has a number of potential pitfalls: for one, the NMR structure was
solved with an additional C-terminal amphiphilic helix, while the X-ray structures were of the
transmembrane domain alone. It is possible that the presence of this second helix affects the
conformational space that the transmembrane domain can sample, and this helix’s role in
transport, if any, is poorly defined. Secondly, the molecular dynamics simulations that supported
this mechanism were of a duration (30 ns) that precluded direct observation of deprotonation and
any slow conformational transitions. Finally, as will be explored in the following section, the force
fields used in these simulations may not accurately model the process by which protons are
bound and stabilized by the histidine residues of M2.

1.9. Solid state NMR pH titration of M2 TM in bilayers.
A landmark discovery was made in 2006 by the Cross et al., who synthesized the M2 TM peptide
with isotopic
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N labeling at either nitrogen of the His 37 sidechain, reconstituted it in bilayers, and

performed a pH titration of the system to monitor pKa values and tautomer states of the His 37
imidazoles (Hu, Fu et al. 2006). A low pKa value implies an unstably bound proton, and it was
expected that a multi-protonated M2 would be highly unstable, since a large amount of positive
charge would need to be confined to within a small, subnanometer space, and in addition be
possibly exposed to the lower dielectic environment of a phospholipid membrane interior. In fact,
Poisson-Boltzmann calculations on a structure obtained from a state of the art classical MD
simulation (Chen, Wu et al. 2007) predicted that the pKa values of the four His 37 residues would
st

be 6.6 for the 1 proton bound by the tetramer, and 6.0, 5.5 and 2.1 for the last three protons
respectively. Surprisingly, the ssNMR titration showed that the first two protons are bound stably
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with the unexpectedly high pKa values of 8.2 for each, while the third and fourth protons are
bound with pKas of 6.3 and a value less than 5.0 that was not precisely ascertained.

Figure 1.26. Results and interpretation of ssNMR pH titration of M2TM peptide. The protonation
states of the His 37 imidazoles and the predicted imidazole-imidazolium dimers in the 2+ and 3+
rd

states are shown. The first two protons are bound with a very high pKa, whereas the 3 proton is
bound in the pH range where conduction is observed. Figure from (Hu, Fu et al. 2006).

Thus, in a stunning turn of events, the measured cumulative stability of the first three protons
bound diverged from top of the line computational estimates by over four orders of magnitude!
Cross et al. hypothesized that the first two protonation events lead to a symmetric pair of
imidazole-imidazolium dimers that stabilize the two protons via low barrier hydrogen bonds, but
the nature of the doubly protonated intermediate could not be precisely ascertained.
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In all

regards, this highly unusual degree of proton stabilization requires a structural and physicochemical explanation, and adds another layer of complexity to any mechanistic theory.

1.10. Summary of the state of the field.
In summary, the past decade has seen enormous advances made in the functional
characterization of proton transport through M2, as well as in the structure determination of its
transmembrane domain. However, progress has been slower on the establishment of a
comprehensive, structure-based transport mechanism to correlate the two knowledge domains.
The recent results indicating unexpectedly high degrees of proton stabilization inside the M2 pore
that cannot be explained by classical modeling, only served to deepen the mystery. However,
before a detailed mechanism that accounts for the unusual degree of proton stability can be put
forth, a more simple question must be addressed. The vast majority of functional assays have
been performed on the full-length protein, whereas the almost all of the structural biology,
spectroscopy and computational modeling has been done on the transmembrane domain.
Therefore, before a structure-based mechanism can be proposed and tested, it becomes
imperative to determine whether the transmembrane domain can be a valid model for the
function, assembly, and inhibition of the full length protein. What, if any, are the contributions of
the non-transmembrane segments of M2 (which make up over 70% of its sequence) to proton
transport?
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Chapter 2: Validation of the M2 transmembrane domain as a
model for proton transport by full length A/M2.
Much of the material in this chapter has been published in the Proceedings of the National Academy of Sciences,
2009 Jul 28;106(30), 12283-12288. http://www.pnas.org/cgi/doi/10.1073/pnas.0905726106

2.1. Literature review of structural and functional characterization of A/M2 fragments.
The divergence of protein and environment model systems in the study of A/M2 structure,
biophysics, and electrophysiology evolved naturally. In the classical, cell-based cargo trafficking
and electrophysiological experiments that were initially used to determine M2 proton channel
activity, the genetic approaches used were readily compatible with and indeed favored
expression of the full-length protein, since little was known about the transport role of its nontransmembrane segments. In these assays, studying a larger, full-length construct was of no
disadvantage as long as its expression was robust (conversely, very short transmembrane
segments can often be difficult to express in these experimental systems). With most biophysical
approaches, however, small model systems are clearly preferred: every added atom increases
the processing time expense in computer simulations or leads to an additional signal in an
already crowded protein NMR spectrum. Success in crystallographic studies depends
enormously on choosing a well-ordered fragment that can assemble into a crystal lattice. In NMR
experiments protein length and its dynamic properties affect the tumbling and magnetic relaxation
times that determine whether an NMR experiment is interpretable. Peptides corresponding to
desired fragments are often synthesized chemically, with a marked dropoff in synthesis yields
when common methods are used for constructs longer than approximately 30 residues. Thus, it
is of no surprise that studies of M2 using biophysics and electrophysiology employed almost
exclusively the TM domain peptide or the full-length protein respectively.

Furthermore, there is often a natural divergence in the membrane “solvent” involved in structural
and functional studies. While studies of transport function necessitate incorporation of the protein
in a cell or artificial membrane, spectroscopic techniques used in biophysics often require an
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optically transparent sample, and are more difficult to use with lipid bilayer vesicles that scatter
light.

Very few high-resolution membrane protein structures have been obtained from

phospholipid bilayer or bicelle environments (Johansson, Wohri et al. 2009), the vast majority
relying instead on solubilization in lipid-mimetic detergent micelles. Therefore, while all functional
experiments were performed in bilayers, many biophysical and structural experiments on M2
were performed in detergent micelles, and those that were done in phospholipid membranes
employed arbitrarily chosen, and sometimes non-native bilayer components.

This natural divergence in techniques, constructs, and reconstitution systems has impeded the
path to a unified view of M2 structure and function. Clearly, some pharmacological questions –
such as the location of the pharmacologically relevant drug-binding site – have been so critical
that it has been essential to obtain biologically compelling answers by not only expressing the
native protein in mammalian cells, but also by demonstrating the robustness of the results
through the construction of live infectious viruses (Jing, Ma et al. 2008). However, it is not feasible
to address all questions with this level of rigor, and structural studies often need to be conducted
on fragments in membranes other than the viral envelope. It is thus important to determine the
extent to which reconstituted fragments faithfully reproduce the assembly, proton transport and
inhibition of the native protein, independent of other complicating variables such as expression,
membrane-trafficking, engagement of the matrix protein, and virus incorporation.

The earliest functional studies of the M2 transmembrane domain were published in 1992, when
Duff and Ashley (Duff and Ashley 1992) reconstituted the M2TM peptide in planar lipid bilayers
and observed proton-selective single channel currents that were inhibited by amantadine.
However, these experiments were carried out at extremely acidic pH values (~2.3 or even lower),
and thus cannot be easily correlated to the M2 transport function observed under physiological
conditions. Given the observations of Cross et al. (Hu, Fu et al. 2006), it is likely that all four His
37 residues of M2 were protonated under the conditions used by Duff and Ashley. Such highly
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acidic conditions may favor a set of conformations not populated during physiological transport, or
perhaps even lead to dissociation of the tetramer (potentially reversed by addition of amantadine)
because of a high degree of accumulated positive charge (Salom, Hill et al. 2000).

The work of Duff and Ashley (shown in Figure 2.1) was repeated by Busath et al. (Hu, Fu et al.
2006), also at a very low pH of 2.3, along with a parallel experiment on the same peptide
reconstituted in liposomes at more physiological pH values. While in both cases proton currents
were observed, the estimated per-protein conductance varied enormously between the two
systems: currents in the planar bilayer experiment (of a very similar magnitude to those seen by
Duff and Ashley) were seven orders of magnitude larger than those for the same peptide in the
liposome system (and approximately six orders of magnitude larger than those obtained for full
length A/M2 in liposomes by a different group (Lin and Schroeder 2001)). Thus, the outcome was
difficult to interpret and prompted further questions in the literature (Miller 2008).

Figure 2.1. Single-channel currents observed by Duff and Ashley (Duff and Ashley 1992) upon
incorporation of M2TM peptide (labeled “CONTROL”) into planar lipid bilayers. The currents are
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inhibited upon application of amantadine (lower traces). Note that 1 pA (the approximate scale of
7

the single channel currents shown) corresponds to approximately 10 protons per second, which
6

7

is approximately 10 -10 fold greater than estimated per-tetramer currents from liposome
experiments on M2TM (Hu, Fu et al. 2006) and full-length A/M2 (Lin and Schroeder 2001) at
physiological pH. Figure from (Duff and Ashley 1992).

A more systematic approach to investigate the function of shorter A/M2 fragments was
undertaken by Tobler et al. (Tobler, Kelly et al. 1999), where the transport properties of Cterminally truncated M2 proteins were studied in Xenopus oocytes, and their surface expression
and tetramerization were measured in HeLa T4 cells. (The reader is referred to Figure 1.6 for a
domain diagram of M2.) Constructs spanning residues 1-72 and longer (1-77, 1-82, 1-87, 1-92,
and full length A/M2) showed robust cell surface expression and formed mixtures of disulfidelinked dimers and tetramers. Shorter constructs consisting of residues 1-62 and 1-52 showed
substantially lower cell surface expression levels, especially for the latter, but nevertheless
formed dimers and tetramers.

Expression of an even shorter fragment spanning only the

ectodomain and TM domain (residues 1-45) could not be detected in the HeLa system and was
not attempted in oocytes.

When expressed in oocytes, constructs of residues 1-72 and longer showed inwardly rectifying
currents similar to those of full length A/M2, whereas rectification was less apparent for constructs
1-62 and 1-52. While most truncation mutants tested showed stable activity when exposed to
slightly lowered pH (6.2) to trigger transport, the shortest two constructs (1-62 and 1-52), and
somewhat unexpectedly, 1-82, showed progressive decreases in transport activity at this pH.

Protein specific activity was estimated by correlating flux measurements in oocytes with
expression levels in HeLa cells. Using this method, it was found that constructs of residues 1-92,
1-77 and 1-72 had apparently similar activity to that of full length protein, while 1-82, and the
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shorter 1-62 and 1-52 had lower activity. However, these measurements were not definitive,
because instead of correlating whole-cell current and protein expression in each individual
oocyte, the expression level was measured in a different cell line.

Thus it is possible that

differences in fragment expression between the oocyte and HeLa cell systems, and differences in
the propensity of each construct to activate endogenous oocyte currents, confounded the results,
especially for the shorter fragments.

From these experiments it became apparent that M2 transport function can tolerate deletions of
at least some of the C-terminal domain. One may also approach the problem from a structural
perspective, since unstructured extra-membrane segments not involved in assembly or drug
binding are less likely to be relevant for function. From this point of view, it was observed that full
length A/M2 has additional helical content not present in the transmembrane segment
(Kochendoerfer, Salom et al. 1999; Tian, Gao et al. 2003), and upon limited trypsin proteolysis of
A/M2 in dodecylphosphocholine micelles, protected fragments corresponding to residues 19-60
and 19-61 were isolated, indicating that the transmembrane domain and a domain immediately Cterminal to it form a tightly packed structure. The C-terminal end of this segment also roughly
corresponded to the C-terminal end of the truncated segment in the work of Tobler et al. where
reliable functional measurements became problematic (Tobler, Kelly et al. 1999). The presence of
a helix just C-terminal to the transmembrane domain was confirmed in the high-resolution
solution NMR structure (Schnell and Chou 2008), although its detailed conformation was less
constrained than that of the TM domain due to a paucity of NOE signals in the C-terminal region.
Comparison of thermodynamic stabilities of the transmembrane peptide and the full length protein
in micelles showed that the latter was ~ 7 kcal/mol more stable (Kochendoerfer, Salom et al.
1999), indicating that structural elements outside of the transmembrane domain contribute to
tetramer stability, though their functional role remained unclear.

However, circular dichroism

spectroscopy and analytical ultracentrifugation experiments performed by the author on a peptide
corresponding to the M2 ectodomain (residues 2-24) with cysteines mutated to serines indicated
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that this segment alone forms a monomeric random coil and does not bind amantadine with or
without detergent, suggesting that the ectodomain is unlikely to strongly contribute to noncovalent
M2 tetramer stability or drug binding (Polishchuk).

2.2. Model validation of the M2 TM domain: requirements for parity with full-length A/M2.
Prior to discussing experiments to determine whether the M2 TM domain can functionally
represent the full-length protein, it is necessary to establish a set of criteria that must be fulfilled in
order for the two constructs to be considered functionally equivalent in terms of proton transport.

First and foremost, the M2 transmembrane domain must transport protons at similar rates as full
6

length A/M2. Transport must be selective for protons by a factor of 10 or more, as observed for
full length A/M2 in mammalian cell (Chizhmakov, Geraghty et al. 1996) and liposome systems
(Lin and Schroeder 2001), and inhibitable by amantadine at ~100 µM concentrations, as seen in
oocyte (Wang, Takeuchi et al. 1993) and other experiments (Lin, Heider et al. 1997). The rate of
transport should increase with decreasing pHout at moderately acidic pH values, as it does in full
length A/M2 (Pinto, Holsinger et al. 1992; Chizhmakov, Geraghty et al. 1996).

Secondly, evidence for the highly perturbed pKa values observed for the His 37 residues in the
M2 transmembrane peptide tetramer (Hu, Fu et al. 2006) should also be obtained from full length
A/M2, in order for protonation kinetics and thermodynamics to be comparable between the two
systems. While differences in baseline thermodynamic stabilities of A/M2 and M2TM tetramers
are acceptable, these constructs must be studied under conditions where they are predominantly
tetrameric, and their thermodynamic stabilities should respond similarly to changes in pH.

2.3. A two-pronged approach to assay function of the M2 transmembrane peptide.
Together with our collaborators at the Pinto lab, we set out to test the function of progressively
shortened A/M2 constructs in two systems. The Pinto lab, with over 15 years of experience
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studying M2 in Xenopus oocytes, again turned to this technique in the current endeavor. Oocytes
are advantageous in permitting a thorough electrophysiological characterization of channel
currents, given that the experimenter can control the membrane voltage via whole-cell clamping.
However, there had previously been difficulties characterizing C-terminal truncation mutants of
A/M2 in oocytes (Tobler, Kelly et al. 1999), most likely because short fragments of M2 were not
efficiently expressed.

In contrast with oocyte experiments, proteoliposome flux measurements can in theory be
performed with any peptide that spans the bilayer, if care is taken to verify efficient reconstitution.
While detailed electrophysiological parameters such as reversal potentials are difficult to measure
using this system, it is sufficiently robust to answer the functional criteria outlined in section two of
this chapter. Therefore, the author of this thesis employed the proteoliposome assay, in parallel
with the oocyte work of Pinto et al.. As will be discussed below, only the proteoliposome assay
could be used to determine function of the 25 residue M2 TM peptide, but there was excellent
agreement between the two systems with somewhat longer fragments, giving further validity to
the results.

The oocyte assay methods and results will be described first in section four, followed by those
from proteoliposomes in section five.

2.4. Evaluating activity of M2 deletion mutants in the Xenopus oocyte assay.
The expression, functional characterization, and determination of membrane insertion and
specific activity of M2 deletion mutants were performed by Drs. Chunlong Ma and Yuki Ohigashi
in the laboratory of Dr. Lawrence Pinto at Northwestern University. To build upon the results of
Tobler et al. (Tobler, Kelly et al. 1999), each oocyte assayed electrophysiologically could also be
tested for expression and correct orientation of the desired construct by immunofluorescence. To
enable fluorescent detection of M2 molecules in the oocyte, a C-terminal FLAG epitope tag was
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added to the protein. In order to determine the impact of the FLAG tag on M2 fragment function,
oocytes injected with mRNA encoding FLAG-free constructs were also characterized. In addition,
expression

and

orientation

of

the

fragments

of

interest

was

also

measured

by

immunofluorescence in mammalian cells.

2.4.a. Oocyte current measurements – materials and methods.
pGEMHJ plasmids were constructed to contain sequences encoding WT A/M2 protein and
shortened fragments (residues 1-71, 21-71, 21-61, and 21-51) with or without a C-terminal FLAG
tag (added to full length A/M2, and fragments 21-61 and 21-51). The plasmids were linearized
using a downstream NotI restriction site. mRNA was generated from the linearized DNA by in
vitro transcription with an Ambion T7 mMESSAGE mMACHINE kit. Xenopus laevis oocytes were
obtained from surgically removed ovarian lobules of female frogs (Nasco, Fort Atkinson, WI).
Following excision, the lobules were treated with collagenase B (2 mg/mL, Roche Applied
Science) to dissociate the oocytes from follicle cells (Pinto, Holsinger et al. 1992). The oocytes
were then cultured, injected with mRNA (~50 ng), and maintained as described in Ma et al. (Ma,
Soto et al. 2008). Whole cell current was measured in oocytes 48-72 hours following mRNA
injection using two-electrode voltage clamping, with details of instrumentation and buffer
composition as described (Ma, Soto et al. 2008). During constant-voltage current measurements,
oocytes were held at -20 mV and bathed with buffers at pH 8.5 or 5.5 with or without the drug
amantadine.

Voltage ramps to determine reversal potential (the voltage at which the measured

current becomes zero) were also performed. It has previously been shown that erroneous proton
reversal potentials can be obtained because of rapid local acidification of the area near the
cytoplasmic leaflet of the oocyte membrane, leading to higher than expected apparent internal
proton concentrations (Mould, Drury et al. 2000). To minimize this effect, the oocytes were bathed
with pH 5.5 buffer and voltage ramps were performed after the measured inward current had
reached a steady maximum. Membrane voltage-ramp measurements were also made at pH 8.5.
Current-voltage relationships were plotted after subtracting the background current measured at
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pH 8.5. Because oocytes do not withstand polarization to large positive voltages (>60 mV), the
actual reversal potential could not be measured in all cells, and instead was estimated by
extrapolation of current-voltage curves measured at lower voltages.

2.4.b.

Determination

of

fragment

specific

activity

and

orientation

by

anti-FLAG

immunofluorescence.
A detailed protocol of sample preparation for immunfluorescence is provided in Ma et al. (Ma,
Soto et al. 2008). Briefly, individual oocytes on which current measurements had been performed
were fixed with 2% paraformaldehyde.

After membrane permeabilization with 0.1% saponin

(parallel experiments were also performed without saponin) and blocking of nonspecific binding
sites with nonfat milk, the FLAG tag was detected using ANTI-FLAG ® M2 monoclonal antibody
(Sigma), followed with goat-anti mouse IgG1 (γ1), and labeling with AlexaFluor ® 546 (Molecular
Probes).

Fluorescence was quantified with a PTI Image Master microfluorometer (Photon

Technologies) with an excitation wavelength of 540 nm. Fluorescence of non-injected oocytes
lacking M2 was also determined to control for the autofluorescence effect from the oocyte yolk
(Beumer, Veenstra et al. 2005).

Specific activity was calculated from the ratio of steady current that flowed at pH 5.5 to the
relative amount of protein that was expressed at the surface of the oocyte for each cell studied.
For each experiment, at least five oocytes expressing the FLAG-tagged full length A/M2 protein
and three uninjected oocytes were measured. For each uninjected cell and for each cell
expressing a given truncated mutant protein, the current was plotted against the oocyte surface
immunofluorescence for that cell, and a straight line was fitted to the plot.

For expression experiments in mammalian cells, HeLa LTR CD4 βgal cells were maintained in
Dulbecco’s Modified Eagle’s medium supplemented with 10% fetal bovine serum (FBS) at 37°C
in 5% CO2. Cells grown on cover glass were transfected with pCAGGS constructs using
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Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the manufacturer’s protocol. At 16-20
hr. post-transfection, the cells were washed and incubated with anti-FLAG monoclonal antibody
(Sigma-Aldrich, St. Louis, MO) followed by FITC conjugated goat anti-mouse antibody (Jackson
ImmunoResearch Laboratories, Inc., West Grove, PA) in the presence and absence of 0.1%
saponin. Labeled

cells

were

fixed

in

2%

formaldehyde

and

mounted

on

a

slide.

Immunofluorescence images were obtained with Zeiss LSM 5 Pascal (Zeiss Inc., Thorndale, NY).

2.4.c. Oocyte current measurements – results.
To determine the minimal part of the A/M2 protein necessary for its ion transport function, a
series of truncation mutants were constructed (Figure 2.2).

Figure 2.2. Full length and truncated construct sequences used in oocyte experiments. The
Penta Ala construct has Ala mutations to structurally important hydrophobic residues in the Cterminal amphiphilic helix (see text). Figure published in (Ma, Polishchuk et al. 2009).

The wild type A/M2 and each of the A/M2 truncation mutant proteins were expressed in oocytes
of Xenopus laevis and the amantadine-sensitive inward currents were measured using a twoelectrode voltage clamp apparatus. Ion transport activity was induced by bathing oocytes in pH
5.5 solution (Ma, Soto et al. 2008; Stouffer, Ma et al. 2008). Previously, Tobler et al. found that
the smallest construct with ion transport properties similar to those of full length A/M2 protein was
trunc72 (residues 1-71) (Tobler, Kelly et al. 1999), and the activity of this fragment was reconfirmed (Figure 2.3). The majority of the ectodomain (1-20) could also be deleted without
affecting proton transport (Figure 2.3); M2(21-71) has an inward current of equal amplitude to that
of the wild-type A/M2 protein. We next created a fragment similar to one identified as protease-
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resistant in micelles in a previous study (Kochendoerfer, Salom et al. 1999): M2(21-61), which
contains the transmembrane domain and the cytoplasmic helix (residues 47-61). This construct
still displayed the robust inward current of full length A/M2 protein, and of M2(21-71) protein
(Figure 2.3). The amantadine sensitivity of all the A/M2 variants was determined by bathing the
oocytes in pH 5.5 solution that contained 100 µM amantadine once the oocyte inward current had
become maximal. As depicted in Figure 2.3, the inward currents of the truncation mutants were
almost completely inhibited (~95%) by treatment with 100 µM amantadine, although the inhibition
kinetics were faster for the proteins with a complete ectodomain, suggesting that the ectodomain
may help funnel amantadine to the TM pore. The inhibition of neither wild-type A/M2 nor
truncation mutant proteins was reversible within 2 min.

To probe further the role of the C-terminal helix (residues 47-60), a construct coding for A/M2(2151) was examined, with most of this helix deleted. Although it was observed that oocytes injected
with this mRNA did not show significant membrane current, it appeared likely that such a short
fragment might not be expressed or reach the cell surface (vide infra). Thus, in an alternate
approach we mutated five of the hydrophobic residues (F47, F48, I51, Y52, and F55) in this
region to Ala residues. This construct exhibited activity virtually identical to wild-type A/M2 (Figure
2.3, M2-Penta Ala); a result which will be further discussed in the next chapter.
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Figure 2.3. Proton transport through A/M2, its truncation mutants and the Penta Ala full length
construct. Whole-cell currents (displayed) are induced by bathing oocytes in pH 5.5 buffer. All
constructs are almost fully inhibited by 100 µM amantadine; the inhibition is irreversible within 2
minutes. Uninjected oocytes show minimal currents under these conditions. Figure published in
(Ma, Polishchuk et al. 2009).

2.4.d. Specific activity measurements in oocytes and expression in mammalian cells - results.
To compare activities of ion channels single channel conductance and open probability are
usually measured. However, the single channel conductance of the A/M2 protein is too low to
permit single channel measurements at physiological pH ranges (Mould, Drury et al. 2000; Lin
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and Schroeder 2001). As a surrogate measure of specific activity, A/M2 surface expression in
oocytes was quantified by measuring fluorescence of immuno-stained epitope tagged A/M2
protein after recording the inward current (Ma, Soto et al. 2008; Stouffer, Ma et al. 2008). To
measure the immunofluorescence of A/M2(21-61) protein and of wt A/M2 protein, a FLAG tag
was attached to the C-termini. This modification has the added benefit of increasing the length of
the very short 21-51 construct, which could possibly increase its expression. As shown in Figure
2.4, oocytes expressing both epitope-tagged M2(21-61)-FLAG and full length A/M2 protein
displayed a robust pH activated inward current, similar to that seen for the untagged proteins.
Moreover, the currents of oocytes expressing these FLAG-tagged proteins were amantadine
sensitive. Interestingly, M2(21-51)-FLAG displayed an amantadine sensitive inward proton
current (Figure 2.4), unlike the untagged version of this construct. To determine whether the low
current observed for M2(21-51)-FLAG was a consequence of poor expression or low intrinsic
activity, its expression level and surface orientation were observed.

Figure 2.4. Proton transport by FLAG-tagged A/M2 and shortened constructs in oocytes. The
FLAG tag does not appreciably affect function of full length A/M2 and M2(21-61), but may rescue
expression of M2(21-51), leading to lower, but observable amantadine sensitive current. Figure
published in (Ma, Polishchuk et al. 2009).
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To determine whether the truncated proteins were expressed in the oocyte plasma membrane in
the correct Nout/Cin orientation, oocytes expressing M2(21-51)-FLAG, M2(21-61)-FLAG, and
A/M2-FLAG were observed by immunofluorescence by using anti-FLAG antibody (Figure 2.5 A).
In the absence of saponin, there was almost no fluorescence, whereas, when 0.1% saponin was
included to permeabilize the plasma membrane, bright fluorescence was observed for A/M2FLAG and M2(21-61)-FLAG tagged proteins, especially at the edge of the oocytes. Staining for
M2(21-51)-FLAG was less intense, consistent with lower expression. The FLAG-tagged M2
proteins were also expressed in mammalian cells and subjected to indirect immunohistochemistry
using anti-FLAG antibody (Figure 2.5 B). The results were similar to those observed in oocytes.
Moreover, when the mammalian cell membrane was permeabilized by saponin, it clearly showed
that fluorescence was only at the membrane surface and not in the cytoplasm. These findings
indicate that wt A/M2-FLAG, M2(21-61)-FLAG and M2(21-51)-FLAG proteins are expressed and
appropriately inserted into the cytoplasmic membrane with the C-terminus, where the FLAG tag
was positioned, facing inside the cells.
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Figure 2.5. Immunofluorescent detection of FLAG-tagged A/M2 and deletion mutants expressed
in oocytes (A) and mammalian cells (B). Strong fluorescence signal is observed at the cell
surface and only upon saponin permeabilization, suggesting that the constructs are appropriately
expressed and oriented. Figure published in (Ma, Polishchuk et al. 2009).

Since FLAG-tagged proteins were expressed in the plasma membrane in the correct orientation,
it was feasible to normalize the current observed by the level of expression. The specific activity
was calculated from the ratio of maximum inward current at pH 5.5 to the relative amount of
protein that was expressed at the surface of the same oocyte, measured by immunofluorescence
(Ma, Soto et al. 2008). This experiment was repeated in approximately ten cells for each
construct, because the level of protein expression varies from cell to cell. For a given construct,
the maximal conductance varies linearly with respect to the amount of protein expressed on the
cell surface (Figure 2.6). The slope of the line, obtained by linear regression, reflects the change
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in conductance with respect to surface concentration, and hence is a measure of the specific
activity of a given A/M2 variant protein. The calculated specific activity for M2(21-61)-FLAG was
the same as A/M2-FLAG (Figure 2.6) within experimental error (P = 0.17). The calculated specific
activity of M2(21-51)-FLAG was about 50% of full length A/M2, although the expression level of
M2(21-51)-FLAG was too low to do a fully quantitative assessment of its activity.

Figure 2.6. Specific activity of FLAG-tagged A/M2 (left panel), M2(21-61) (center panel), and
M2(21-51) (right panel). Each point represents the maximum current obtained from a single
oocyte (Y axis) plotted against that oocyte’s immunfluorescence signal (X axis). The slope of the
resulting regression line is the construct’s specific activity. Figure published in (Ma, Polishchuk et
al. 2009).

2.4.e. Ion selectivity of A/M2 fragments measured in oocytes – results.
The reversal voltage, which provides a measure of the ion selectivity of the protein, was
measured to check for the altered ion selectivity of truncated mutant M2 constructs. The currentvoltage relationship of M2(21-61)-FLAG and full length A/M2-FLAG were almost identical (Figure
2.7). Although the macro-conductance of M2(21-51)-FLAG was much lower than that of full length
and M2(21-61)-FLAG proteins, the extrapolated I-V curve of M2(21-51)-FLAG intercepted the
voltage-axis close to the intercepts for full length A/M2 and M2(21-61) proteins (Figure 2.7).
These results indicate that these truncated M2 constructs have similar ion selectivity to the wild
type, full length A/M2 protein.
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Figure 2.7. Current-voltage profiles of full length M2-FLAG and FLAG-tagged truncation mutants.
The extrapolated reversal potential (voltage at which current is zero) is similar for all constructs.
Figure published in (Ma, Polishchuk et al. 2009).

2.4.f. Oocyte results – conclusions.
In summary, expression of A/M2 fragments in Xenopus oocytes and mammalian cells showed
that removal of the N-terminal ectodomain (residues 1-20) and of the C-terminal domain portion
following residue 61 does not markedly affect transport rate, proton selectivity, and extent of
amantadine inhibition (though a slight decrease in the drug’s binding “on” rate was observed).
Expression of C-terminally FLAG-tagged full length A/M2 and M2(21-61) constructs in oocytes
and mammalian yielded similar functional properties as the FLAG-free constructs, and allowed
confirmation of surface expression and correct orientation of constructs in the membrane.
Addition of the C-terminal FLAG tag partially rescued deficient expression or insertion of M2(2151). Full length A/M2-FLAG and M2(21-61)-FLAG had similar specific activities, while the specific
activity of M2(21-51)-FLAG was 2-3 fold lower but could not be precisely quantified because of
low immunofluorescence signal. Thus, while it was clearly shown that M2(21-61) retains the
functional properties of full-length A/M2 and has a similar specific activity (the latter representing
a major advance from the work of Tobler et al. (Tobler, Kelly et al. 1999), the data were less
definitive for M2(21-51). Shorter fragments such as those corresponding to the M2TM peptide
could not be studied, and the functional role of the C-terminal amphiphilic helix (residues 47-61)
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remained ambiguous, although mutation of the hydrophobic residues in that helix to Ala in context
of full-length A/M2 did not affect transport function in oocytes.

2.5. Determination of M2 fragment function in liposomes – experimental background.
While the proteoliposome assay system is less easily manipulated with respect to
electrophysiological parameters (i.e. voltage clamping), it is advantageous in isolating the protein
of interest from other cellular components. It is also useful in giving the experimenter control over
bilayer composition, and the ability to use transport-mediating protein fragments from both
biological as well as chemical (synthetic peptides or peptidomimetics) sources, with in vitro
reconstitution that does not depend on cell-based expression and insertion machinery. The
transport activity, inhibitor sensitivity, and, under appropriate conditions, ion selectivity of proteins
of interest can be determined through proteoliposome reconstitution if the requisite controls are
correctly performed.

Proteoliposomes and artificial membranes have been successfully used to study a wide-ranging
array of ion channels (reviewed by Miller (Miller 1983; Miller 1984)), including full-length A/M2
from bacterial (Moffat, Vijayvergiya et al. 2008) and eukaryotic sources (Schroeder, Ford et al.
1994; Lin and Schroeder 2001), building on work by Dencher in developing experimental
methods for measuring proton flux across lipid bilayers (Dencher, Burghaus et al. 1986). While
there have been reports of M2 transmembrane peptide activity in liposomes and planar lipid
bilayers (Duff and Ashley 1992; Hu, Fu et al. 2006; Pielak, Schnell et al. 2009), these
experiments have several shortcomings. First of all, none of the groups measured the extent of
peptide reconstitution, instead assuming stoichiometric protein incorporation when calculating
specific activity. Not surprisingly, the magnitude of the measured currents differed substantially
between systems and experimenters. Secondly, none of the reports rigorously probed the ion
selectivity of M2 TM under physiological conditions, and finally, none of the work was performed
in parallel with full-length A/M2 as an internal control (Duff and Ashley 1992; Hu, Fu et al. 2006;
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Pielak, Schnell et al. 2009). The present work aims to definitively address these questions by
characterizing full length A/M2 in parallel with the M2 TM peptide, M2(22-46), and intermediate
length fragments when reconstituted in liposomes under similar experimental conditions.

2.5.a. Proteoliposome flux assay – summary of procedure.
A brief summary of the protein reconstitution procedure and the experimental protocol for the
proteoliposome flux assay will be provided in this section; complete protocols for peptide
synthesis and protein purification, details of reconstitution technique, and details of experimental
procedure will be provided in the following sections.

Lipid films consisting of 25 µmol 4:1:2 POPC:POPG:cholesterol were made by drying component
stocks dissolved in chloroform under a stream of nitrogen or argon gas. The films were redissolved in ethanol and mixed with ethanolic stocks of A/M2 or fragments (with a target
protein:lipid ratio of approximately 1:1000 monomer:lipid), then immediately dried down a second
time.

Protein/lipid films made as described above were immediately hydrated with 995 mL of “K” buffer
(100 mM K2SO4, 15 mM KxPO4 pH ~7.5); the samples were then vortexed extensively and frozen.
Upon thawing, the pH indicator dye pyranine (Invitrogen, Carlsbad, CA) was added, and the
mixture was subjected to ten additional freeze-thaw cycles to form dye-containing liposomes.
Liposomes were sized by extrusion to ~100 nm diameter and dialyzed against “K” buffer precisely
pH adjusted to 7.4. XAD-4 Amberlite resin (Supelco, Bellefonte, PA) was added to the dialysis
buffer to bind excess dye. Liposomes were stored at 4°C and used within a week.

Fluorescence proton flux assays were performed at 18°C in a buffer equivalent to “K” buffer
+

except with Na as the counterion (“Na” buffer), in the presence of a membrane-impermeable
pyranine quencher (DPX, Invitrogen). The potassium ionophore valinomycin (Sigma Aldrich)
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and/or amantadine hydrochloride were added to the assay buffer as indicated. Valinomycin
selectively permeabilizes the liposome membrane to potassium, creating a negative potential
inside the liposome as it leaks out. To restore electrical neutrality to the membrane, protons flow
into the liposome if a proton transporting protein is present.

Liposomes (preincubated with desired concentration of inhibitor) were rapidly diluted into the
assay buffer, and pH changes inside the liposome were tracked. The ion fluxes in the experiment
are summarized in Figure 2.8.

Figure 2.8. Summary of the proteoliposome proton flux assay. Proteoliposomes made in K+
+

+

containing buffer are diluted into Na containing buffer with the K ionophore valinomycin (V).
+

Valinomycin-mediated K efflux down its concentration gradient creates a net negative charge
inside the liposome, providing a driving force for proton entry through M2. Changes in
intraliposomal pH are monitored fluorimetrically through entrapped pH indicator dye (pyranine).
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pH changes inside the liposome were measured by monitoring signal decay of the deprotonated
indicator dye form, followed by recording of the signal at the pH-insensitive isosbestic point of the
dye. Intraliposomal pH was calculated from a calibration curve of the deprotonated/isosbestic
fluorescent signals shown in Figure 2.9. Proton flux was calculated by converting intraliposomal
pH to total intraliposomal protons vs. time using the intraliposomal buffering capacity (Dencher,
Burghaus et al. 1986) adjusted for liposome volume; the result was then divided by measured
protein incorporation to obtain per tetramer proton transport.

-

Figure 2.9. HPTS (pyranine) pH calibration. The ratio of the signal of the deprotonated form (F ,
ex 460 nm, em 515 nm) to the signal at the isosbestic point (Fiso, ex 417 nm, em 515 nm) is
+

plotted vs. [H ]. Figure published in (Ma, Polishchuk et al. 2009).

2.5.b. Chemical synthesis of M2 fragment peptides.
Significant progress has been made in the chemical synthesis of hydrophobic peptides (such as
those corresponding to helical transmembrane segments of proteins) (Glover, Martini et al. 1999;
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Fisher and Engelman 2001); nevertheless, these sequences are not trivial to synthesize because
of their propensity to aggregate on the solid support resin, which reduces reaction yields and/or
leads to poorly separable side products. Longer membrane spanning sequences (>40 amino
acids) can be especially difficult to make with common synthesis procedures. Thus, while
standard procedures (with double coupling for difficult parts of the sequence) could be used to
synthesize the shorter M2 fragments, high-temperature microwave synthesis was employed for a
longer fragment encompassing the transmembrane domain and the C-terminal helix. While fulllength A/M2 has previously been synthesized using native chemical ligation of its fragments
(Kochendoerfer, Salom et al. 1999), for this work we employed bacterial expression to produce
large amounts of this protein (described in next section) for use in liposome activity
measurements. For easy reference in the sections below, chemically synthesized peptides will
be prefixed by “syn” to distinguish them from bacterially expressed constructs.

The 25-residue M2 transmembrane peptide synM2(22-46) and the 29 residue peptide synM2(2250) were synthesized using standard solid-phase Fmoc chemistry manually on an Argonaut
Technologies (Foster City, CA) Quest heated reaction/liquid handling system or on a Protein
Technologies (Tucson, AZ) PTI Symphony automated synthesizer, and were C-terminally
amidated. The 44-residue synM2(19-62) was synthesized manually with frequent double
deprotection and double coupling cycles, and constant monitoring of coupling efficiency, in a
CEM (Mathews, NC) Mars reactor with microwave heating during deprotection and coupling.
synM2(19-62) was C-terminally amidated and N-terminally acetylated to protect the N-terminal
Cys sidechain from modification.

Sequences of the full length construct (vide infra) and the

synthetic peptides used in the proteoliposome flux assay are provided in Figure 2.10.
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Figure 2.10. Sequences of A/M2 and synthetic fragments used in proteoliposome assay. The full
length construct has a 6xHis tag for purification, and the following mutations that do not affect
activity but improve culture yields: W15F, C17S, C19S, C50S (vide infra). Figure adapted from
(Ma, Polishchuk et al. 2009).

Peptides were cleaved from the solid support by immersion and stirring in a cocktail of 90%
trifluoroacetic acid, 5% water, and 5% triisopropylsilane (synM2(22-46) and synM2(22-50)), or
90% trifluoroacetic acid, 5% thioanisole, 3% ethanedithiol, and 2% anisole (synM2(19-62)). The
reaction was allowed to proceed for 3-4 hours, after which the solid support was separated by
filtration over glass wool, and the volume of the cleavage cocktail was reduced by evaporation
under a stream of nitrogen gas. The crude peptide was precipitated by dripping the filtered
cleavage reaction mixture into an excess of cold diethyl ether and hexanes.

After centrifuging

and washing the precipitate, and decanting the ether/hexanes supernatant, the white crude
product was dissolved in buffer B (90% acetonitrile, 10% water, 0.1% trifluoroacetic acid), frozen
thoroughly in liquid nitrogen, and lyophilized overnight to yield a fluffy, easily handled white or offwhite solid, which was stored at -20 ºC prior to purification.

Peptides were purified by reverse-phase high performance liquid chromatography (HPLC) over a
C4 silica column. Crude product was dissolved in trifluoroethanol (TFE, Acros Organics, 30-40%
v/v final concentration depending on fragment hydrophobicity) and distilled, deionized water. To
revert trifluoroacetyl adducts (observed by MALDI-mass spectrometry of crude product as series
of peaks with masses of product + 96 Da, product + 192 Da, etc.), 1M ultra-pure aqueous TrisHCl buffer pH 8 (Invitrogen) was added to a final concentration of 100 mM (10% v/v).

For

cysteine-containing synM2(19-62), an excess of the reducing agent triscarboxyethylphosphine
(TCEP-HCl) was added to the final loading mixture. Following thorough mixing and filtration
through a polypropylene syringe filter (Whatman), the crude product was loaded onto the HPLC
column. It was important to keep the TFE concentration in the loading buffer as low as possible
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without precipitating the peptide in order to ensure efficient peptide binding onto the column
material. It was also necessary to keep the dissolved crude product and purified liquid fractions
from the HPLC at or below ~0 ºC to avoid oxidation of the Trp 41 sidechain.

Peptides were eluted from column using linear gradients of the polar buffer A (0.1% TFA in water)
and the hydrophobic buffer B or buffer B’ (90% acetonitrile, 10% water, 0.1% TFA or 60% 2propanol, 30% acetonitrile, 10% water, 0.1% TFA respectively), ramping from 30-50% to 100%
hydrophobic buffer. Peptide fractions were frozen and lyophilized, and their purity assayed by
analytical-scale reverse-phase HPLC, and MALDI or ESI mass spectrometry. Peptides were
stored as solid trifluoracetate salts at -20 ºC or as ethanol stocks at -80 ºC.

2.5.c. Bacterial expression and purification of codon-optimized, cysteine-free A/M2.
A pET23D plasmid with a bacterial codon-optimized synthetic gene sequence encoding a variant
of A/M2 (based on the sequence of A/Udorn/72, accession number CAD22815) followed by a sixresidue C-terminal His tag was kindly provided by Dr. Joshua Rausch at the Pinto laboratory.
This sequence further differs from A/Udorn/72 in that all of its cysteine residues (at positions 17,
19, and 50) have been mutated to serines, and a tryptophan in the N-terminal ectodomain at
position 15 has been mutated to phenylalanine to enable spectroscopic studies of the remaining
“gating” tryptophan at position 41 in the transmembrane domain. The mutation of Cys residues to
Ser has no effect on M2 function (Nguyen, Soto et al. 2008), and, as described in section 4 of this
chapter, the entire M2 ectodomain (containing residue 15) can be removed with minimal impact
on proton transport. This form of full-length A/M2 is advantageous in its ~5-fold higher culture
yields compared to the Cys-containing Udorn sequence, and was used as the full length construct
in proteoliposome experiments.

Recombinant 6XHis-tagged A/M2 protein was produced from BL21(DE3)pLysS E. coli cells
(Invitrogen, Carlsbad, CA) using the pET23D(+) plasmid (EMD Biosciences, San Diego, CA).
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BL21 cells were chemically transformed with the pET23D(+) plasmid containing the M2 gene and
grown in LB media containing 100 mg/ml ampicillin. When OD600 of 0.6-1.0 was achieved, protein
production was induced by addition of 1 mM IPTG to the media. After 4-5 hours of induction, cells
o

were harvested by centrifugation at 4 C for 30 minutes. Pellets were resuspended in 25 ml of 50
mM Tris, pH 8, 0.25 mg/ml lysozyme, 0.02 mg/ml DNase I and 100 µM - 1 mM PMSF. Solutions
were subjected to a minimum of three cycles of freezing and thawing in a dry ice / ethanol bath
o

o

and a 37 C water bath, followed by a further hour at 37 C for full lysis of cells. This solution was
then centrifuged at ~15,000 g for 30 minutes and the pellet resuspended in 50 mM Tris, pH 8,
150 mM NaCl, 40 mM OG, 1 mM DTT and 100 mM – 1 mM PMSF. The octylglucoside (nOG)
solution was then centrifuged at ~15,000 g for 30 minutes and the supernatant was saved for
purification on Ni-NTA columns.

The OG solubilized supernatant containing A/M2 protein was mixed with Ni-NTA agarose
o

(Qiagen, Valencia, CA) and incubated overnight at 4 C with constant agitation. Imidazole was
added to a final concentration of 10 mM to block nonspecific interactions when purifying the Cysfree construct. Columns were washed successively 50 mM Tris, pH 8, 150 mM NaCl, 40 mM OG,
1 mM DTT, then 50 mM Tris, pH 8, 20 mM OG, 20 % (v/v) glycerol, followed by 50 mM Tris pH 8,
4 mM OG, 20% (v/v) glycerol. Finally, the proteins were eluted from the column using ~15 ml 50
mM Tris pH 8, 4 mM OG, 20% (v/v) glycerol and 300 mM imidazole. Fractions were evaluated for
protein content by measuring absorbance at 280 nm or by a Bradford (Sigma-Aldrich, St. Louis,
MO) protein assay. Centrifugal concentrators (Millipore, Billerica, MA) were utilized for
concentrating and rinsing pooled protein fractions into a final solution of 50 mM Tris (pH 8), 4 mM
OG and 20% (v/v) glycerol or 50 mM HEPES (pH 8), 4 mM OG, and 20% (v/v) glycerol. The
protein was then purified from the final buffer by RP-HPLC and lyophilized similarly to the
chemically synthesized peptides. HPLC and mass spectral analysis of the nickel column eluate
showed a clean trace with a single peak corresponding to the protein of interest, and a lateeluting shoulder corresponding to the protein of interest + approximately 40 Da, which may be an
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acetyl group. Trypsin digestion followed by MALDI-mass spectrometry indicated that the adduct
formed at an ectodomain residue (N-terminal to residue 19) and thus was unlikely to influence
function.

Therefore, during preparative HPLC purification, the main peak and the +40 Da

shoulder were collected together and used in further experiments.

2.5.d. Liposome flux assay – experimental considerations and challenges.
When proteoliposomes are formed, the natural machinery of membrane protein chaperones and
translocons is bypassed for the final incorporation of purified membrane protein into the liposome
membrane, and some form of artificial incorporation is instead used. A variety of commonly
accepted strategies exist, including permeabilization of a membrane protein from its source in
detergent micelles followed by transfer to hydrated phospholipids (Allen, Romans et al. 1980;
Miller 1984), co-drying of organic stocks of phospholipids and protein followed by hydration of the
resulting film (Cristian, Lear et al. 2003), or rapid injection of co-dissolved phospholipids and
protein from an organic stock into aqueous buffer (Allen, Romans et al. 1980). In applying these
approaches, great care must be taken to preserve the function of the membrane protein and to
prevent aggregation of the sample components, since it is not uncommon for membrane proteins
to lose a significant degree of function during e.g. detergent solubilization (Seddon, Curnow et al.
2004; Dahmane, Damian et al. 2009; Niu, Doctrow et al. 2009). A given reconstitution method
may be adequate for some proteins but not for others: some detergents may not stably solubilize
certain protein fragments, while organic solvent solubilization may not be applicable to longer,
more complex membrane proteins which can be irreversibly denatured by such treatment.

Not surprisingly, in our trials of reconstitution methods for A/M2 and fragments, we found that the
degree of protein incorporation varied substantially from one procedure to another in a fragmentspecific manner. In previously published, successful, proteoliposome experiments, full-length
A/M2 was introduced into liposomes from n-octylglucoside (nOG) micelles (Schroeder, Ford et al.
1994; Lin and Schroeder 2001), and this was the first method that we attempted.
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While

immediately successful in the case of synM2(22-46) and synM2(22-50), this method led to
sample aggregation when applied to synM2(19-62). The aggregation usually manifested as
clogging of the sizing membranes during liposome extrusion, where a non-uniformly sized
unilamellar proteoliposome population is repeatedly filtered through pores to achieve a more
uniform size distribution. This aggregation was not prevented by addition of reducing agent
(TCEP HCl), dilution of sample prior to the extrusion step, gentle heating of the sample during
extrusion, or brief sonication prior to extrusion.

An alternative reconstitution method described in detail below and involving co-drying of the
protein and lipid out of ethanol, was found to be effective for all constructs tested, generally
yielding reconstitution levels of 75% or greater when compared to starting amounts.

This experience reinforces the absolute necessity of verifying protein incorporation in the final
product (e.g. by HPLC as described below) instead of relying on the input stoichiometries, since
unsuccessful reconstitution methods such as the octylglucoside technique applied to synM2(1962) often led to very low incorporation (10% of target value or below) and would have resulted in
erroneous conclusions with respect to transport activity if a high level of incorporation was
assumed.

Aside from carefully controlled reconstitution, the proteoliposome assay requires additional care
to ensure reliable results, (Szoka Jr and Papahadjopoulos 1980) including: 1) using lipids free of
oxidation products (e.g. by using presealed ampules of polar lipids stored as indicated by
manufacturer); 2) minimizing the time that the protein and lipid are together in a dehydrated state;
3) confirming that a uniform vesicle population is obtained by using light-scattering and/or
electron microscopy; 4) minimizing prolonged incubations below neutral pH. When functionally
reconstituted, the reaction rate is relatively rapid, so we used a rapid mixing device and the
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assays were conducted at pH 7.4 and 18°C to allow convenient measurement of the signal over
20 sec.

2.5.e. Detailed protocol for proteoliposome flux assay.
Sample preparation. Lipid films consisting of 4:1:2 POPC:POPG:cholesterol (25 µmol total) were
made by mixing chloroform stocks of the phospholipids (POPC and POPG, 25 mg/mL, Avanti
Polar Lipids, Alabaster, AL) taken from a freshly opened manufacturer ampule with a freshly
made chloroform stock of powder cholesterol (25 mg/mL, Sigma Aldrich, St. Louis, MO). The
combined chloroform solutions were evaporated without delay under a stream of nitrogen or
argon gas; the resulting lipid films were dried on a lyophilizer for at least two hours.

All handling of chloroform stocks was performed in Teflon-capped glass vials and
metal/glass/Teflon Hamilton (Reno, NV) syringes with Teflon needle hubs. Plastic components
were not used to prevent leaching of plasticizers into the chloroform stocks.

Exposure of

chloroform lipid stocks to room temperature was kept as short as possible.

Protein and fragment concentration was quantified by using absorbance at 280 nm in an ethanol
-1

stock. The calculated extinction coefficient for synM2(22-46) and synM2(22-50) was 5,850 M
-1

-1

-1

cm . The extinction coefficient used for synM2(19-62) was 6,990 M cm , and for the Cys-free
-1

-1

Trp15Phe A/M2 it was 8,480 M cm .

Lyophilized peptides and protein (as trifluoroacetate salts from HPLC purification) were dissolved
in ethanol and the fragment concentration was determined. Stocks were maintained on dry ice or
at -80°C until use. Peptide/protein in ethanol in an amount of 25 nmol monomer was added to a
lipid film (target 1:1000 monomer:lipid ratio); additional ethanol was added to a total volume of
approx. 300 µL. For protein-free control liposomes, only ethanol was added. The mixture was
vortexed to dissolve the dried lipid, then immediately dried under an argon stream.
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The resulting film was immediately hydrated with 995 µL “K” buffer (50 mM K2SO4, 15 mM Kx PO4
pH ~7.5) by vortexing for 2 minutes. The mixture was frozen on dry ice and thawed. 5 µL of 100
mM hydroxypyrene trisulfonic acid trisodium salt (HPTS, pyranine from Invitrogen) was then
added, and the mixture vortexed. Unilamellar liposomes were formed by 10 freeze-thaw cycles
(dry ice/ethanol and 37°C water bath) and sized by repeated passage through 100 nM
polycarbonate filter membranes (Whatman, Piscataway, NJ) in a mini-extruder (Avestin, Ottawa,
Canada). Liposomes were then dialyzed for 8 hours-overnight in a 10K MWCO Pierce Slide-ALyzer cassette against 1.8 L of “K” buffer pH 7.40 (adjusted with H3PO4 or KOH) with 5 g
Amberlite XAD-4 resin (Supelco, Bellefonte, PA) added to bind unincorporated dye. A second
cycle of dialysis under identical conditions was performed for 2-3 hours. Dialyses were performed
at 4°C. Liposomes were stored at 4°C for up to a week following the completion of dialysis.
Results from a selectivity-probing experiment where the reconstitution and dialysis were
performed at pH 6.5 will also be described.

Proton flux assay: Experiments were performed using an Aviv ATF-105 spectrofluorometer (Aviv
Biomedical, Lakewood, NJ) in a 1x1 cm Hellma (Plainview, NY) QS fluorescence cell,
thermostated at 18°C. The ratiometric pH indicator HPTS (pyranine, pKa ~ 7.22) was used to
determine intraliposomal pH. The ratio of fluorescent signal of the deprotonated form (excitation
-

460 nm, emission 515 nm, “F “) to the pH-independent isosbestic point (excitation 417 nm,
emission 515 nm, “Fiso”) as a function of pH was used to calibrate the assay (Fig. 2.9), and was
largely independent of the presence of liposomes. For all samples measured with amantadine,
liposomes were pre-mixed with 100x aqueous amantadine HCl (Sigma Aldrich, St. Louis, MO) in
a 100:1 v/v ratio and allowed to interact overnight so as to achieve equilibrium binding.

Assay buffers: 2.5 mL of assay buffer (50 mM Na2SO4, 15 mM Nax PO4 pH 7.40 adjusted with
H3PO4 or NaOH, “Na buffer”) was added to the fluorescence cuvette. It was critical to establish
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that the “Na” buffer pH precisely matched that of the final dialysis “K” buffer to within 0.05 pH
units. Experiments to probe selectivity and pHout activation in which the same buffer composition
but with different pH values was used, will also be described below.

To the assay “Na” buffer was added 37.5 µL of 1M p-xylene bis-pyridinium bromide (DPX;
Invitrogen, Carlsbad, CA), a membrane impermeable quencher of pyranine fluorescence to
restrict measured signal to intraliposomal dye. For experiments shown in Figure 2.11, 3.5 µL of
18 µM valinomycin (Fluka/Sigma Aldrich, St. Louis, MO) in ethanol and 25 µL of 100x aqueous
amantadine hydrochloride (as indicated), were also added to the assay buffer. We also performed
+

experiments without valinomycin to assess background K leakage; no effect on transport was
observed by adding 3.5 µL of ethanol alone. All fragments (synM2(22-46), synM2(22-50),
synM2(19-62), A/M2) were tested with either no drug or a final drug concentration of 99 µM
amantadine. Sample buffer conditions for a separate, additional amantadine titration experiment
(shown in Figure 2.11 panel D) on synM2(22-46) are described next.

An amantadine titration experiment was performed on a second, independent synM2(22-46)
liposome preparation in order to observe inhibition at a greater range of amantadine
concentrations. Liposome preparation and overnight amantadine incubation for this data set were
performed as described above. For these samples, 25 µL of 100x amantadine hydrochloride or
water (no drug) was added to the assay buffer containing DPX and valinomycin as above to attain
the desired amantadine concentration. This resulted in a duplicate amantadine-free data set for
synM2(22-46), with assay buffer now diluted by <1% by the added water. The results of the two
experiments were essentially identical and are averaged in the final figure. Two data sets were
also obtained from the separate synM2(22-46) liposome preps under inhibition by 99 µM
amantadine; these were also averaged in the final figure.
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Data collection: Prior to data collection, the assay buffer (with DPX, valinomycin and drug as
indicated) was allowed to equilibrate at 18°C for 5 minutes in the fluorometer cell holder.
Liposomes (~20 µL) were injected into the cuvette containing assay buffer from a 1 mL Hamilton
(Reno, NV) glass syringe fitted with a repeat-dispensing system. Injections (at t=0 sec) were
performed through an adapter in the fluorometer cell holder cover that enabled immediate data
acquisition following injection. The sample in the cuvette was vigorously stirred during the
-

experiment. From t=0 sec, kinetic data monitoring the deprotonated form of HPTS (F , ex 460 nm,
em 515 nm, bandwidths 3 nm) were collected for approximately 50 sec at one second intervals.
The first three seconds following injection were omitted from analysis to allow for full mixing of the
sample. At t=~90 sec, kinetic data monitoring the isosbestic point of HPTS (Fiso, ex 417 nm, em
515 nm, bandwiths 3 nm) were collected for approximately 20 sec at one second intervals. An
excitation wavelength scan (ex 480-380 nm, em 515 nm, bandwiths 3 nm) was performed at the
conclusion of each experiment for secondary confirmation of the result. Experiments on each
condition were performed in triplicate. Two outlying runs from the entire data set of 75 runs were
excluded from analysis.

Liposome Flux Assay Data Analysis: The measured isosbestic kinetic signal (Fiso, ex 417 nm, em
515 nm) was averaged to a single value, and each data point from the deprotonated HPTS signal
-

kinetic (F , ex 460 nm, em 515 nm) was divided by the isosbestic signal average to obtain a signal
ratio (deprotonated:isosbestic) as a function of time. The ratios at each time point were averaged
between the three independent experiments run for each condition.

The averaged signal ratio vs. time was converted to intraliposomal pH vs. time based on the
calibration curve (Fig. 2.9) obtained with free dye in “K” buffer.

Intraliposomal pH (-log[H

+

free])

vs. time was converted to total intraliposomal [H+] vs time

+

(including H bound to buffer) by using an estimate of the internal buffering capacity (Dencher
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1986) assuming an intraliposomal [phosphate] of 15 mM, and negligible contribution to buffering
capacity by the dye given its much lower concentration.

Total intraliposomal [H+] vs. time was converted to the total intraliposomal proton count vs. time
through multiplication by NA and intraliposomal volume estimated from dynamic light scattering
measurements (described below) assuming no phospholipid loss during preparation and a single
phospholipid surface area of 6.3x10

-19

2

m . Experiments with tracer amounts of radiolabeled lipid

show that signal loss during typical preparations is <10%.

The initial number of total protons at t=3 sec was subtracted from successive measurements, and
the result was divided by the number of peptide tetramers delivered per experiment, as estimated
by integration of the 280 nm protein peak from chromatography of proteoliposome samples on an
analytical RP-HPLC column (see below).

Results for protein-free control liposomes shown in Figure 2.11 were adjusted for differences in
surface area with protein- or fragment-containing liposomes, and were normalized for the degree
+

of protein reconstitution observed for the fragment in each panel (i.e. the difference total H vs.
time traces for the control liposomes were divided by the same number of peptide tetramers as
determined for the corresponding protein-containing sample shown in each panel).

Estimate of protein reconstitution: Liposome samples were mixed in a 2:1 ratio with a lysis buffer
containing 150 mM nOG and 150 mM Tris pH 8. 100 mM TCEP HCl (~6% v/v) was added to all
samples. The mixture was then injected onto an analytical C4 RP-HPLC column and eluted with a
linear gradient of 2:1 isopropanol:acetonitrile with 0.1% TFA and water with 0.1% TFA.
Reconstitution was estimated by integration of the 280 nm protein peak in the chromatogram
compared to a standard derived from loading synM2(22-46) peptide onto the same column in
known amounts from a mixed organic-aqueous stock.
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Using the peptide incorporation method described, reconstitution was nearly complete for
synM2(22-46), synM2(22-50) and A/M2, and was ~20% reduced for synM2(19-62).

Determination of liposome volume and surface area: Liposome radii were determined using a
Wyatt (Santa Barbara, CA) DynaPro dynamic light scattering instrument at 25°C. Liposomes were
diluted ~1:1,000-1:10,000 into pre-filtered “K” buffer. Measurements were performed in triplicate
for each sample, and the radius distribution peak maxima were averaged.

Volumes and surface areas were determined based on the averaged measured radius. The
software of the instrument was set for analysis based on a Rayleigh sphere model, and the
solvent model was set to phosphate buffered saline.

2.5.f. Proteoliposome flux assay results: flux magnitude and inhibition.
As described in detail in the previous sections, proton flux in proteoliposomes was evaluated in
+

response to the generation of an electrochemical potential by diluting vesicles that contain K
+

buffer, into Na buffer in the presence of the potassium-selective carrier valinomycin (Lin and
Schroeder 2001). If a proton channel is present in the bilayer, protons will diffuse down the
induced electrical field, acidifying the interior of the vesicle. The advantage of measuring proton
flux in this manner (rather than by simply changing the pH of the buffer on the outside of the
liposome and measuring acidification of the interior) (Pielak, Schnell et al. 2009) is that it requires
ion-selectivity. If the channel is not selective for protons or the liposomes are non-selectively
+

+

leaky, then Na , which is present in far greater concentration than the concentration of H , will
+

diffuse into the vesicles as K diffuses out, and no significant acidification occurs.

A number of reconstitution methods were evaluated to discover a single approach that would
allow reconstitution of A/M2 and fragments of various lengths. Ultimately, we found that co-
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solubilization of the peptide or protein with a 1000 to 2000-fold molar excess of polar lipids
provided satisfactory results for the entire set of M2 protein analogues. The results presented in
Figure 2.11 represent the average of three independent measurements, and are reproducible
between different sample preparations to within 20%.

+

Figure 2.11. Cumulative per-protein H flux in valinomycin-driven proteoliposome assay through
A/M2 (A), synM2(19-62) (B), synM2(22-50) (C), and synM2(22-46) (D). Addition of 99 µM
amantadine inhibits all constructs to 80+%. A more extensive amantadine dose-response
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experiment on synM2(22-46) is shown in panel D and in panel D inset. Control liposomes show
minimal flux with or without amantadine. Data published in (Ma, Polishchuk et al. 2009).

-1

The rate of proton flux observed for full-length A/M2 (Figure 2.11 A) is 4.8 sec per tetramer, in
+

good agreement with the value of ~7.5 H /sec previously measured under almost identical
conditions (Lin and Schroeder 2001), and also within an order of magnitude of the rate observed
at neutral pH in a similar system (Moffat, Vijayvergiya et al. 2008), and comparable to rates
obtained from electrophysiological measurements at this pH (Mould, Li et al. 2000). Very similar
rates of proton transport were also observed for the synthetic fragments synM2(19-62),
-1

synM2(22-50), and synM2(22-46) (2.3, 7.6, and 6.1 sec per tetramer, respectively), all of which
are within a factor of ~2 of the value measured for the full-length protein (Figure 2.11 B,C,D).
Typically, proteins reconstituted in this manner are randomly oriented NinCout and NoutCin.
However, because of possible biases in the orientations, it is uncertain whether the two-fold
difference in rate reflects differences in orientational preferences or genuine differences in
conductivity.

The proton flux of A/M2 and the synthetic peptides is inhibited to near background levels by 100
µM amantadine (Figure 2.11). We examined the full dose-response behavior for the shortest
construct, synM2(22-46) (Figure 2.11 D), corresponding to the M2 transmembrane peptide that
has been the subject of extensive structural and biophysical characterization. It showed a halfmaximal effect near 5 µM amantadine (inset Figure 2.11 D), within the range observed of A/M2 in
oocytes (Wang, Takeuchi et al. 1993; Jing, Ma et al. 2008), reaching near completion (~80-90%)
by 100 µM amantadine.

2.5.g. Proteoliposome flux assay: measurement of proton selectivity and pH activation.
Having established that the M2 transmembrane peptide and full length A/M2 have similar proton
transport rates in the proteoliposome assay, and are both susceptible to inhibition by near-
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physiological concentrations of amantadine, we must next determine whether the TM fragment
shows a similar degree of proton selectivity as the full length protein, and whether both
demonstrate an increasing proton transport rate in response to a lower pHout .

In comparison with classical electrophysiological measurements in the oocyte system, it is more
difficult to ascertain reversal potentials in liposomes, since the experimenter has little control over
the protein’s orientation in the membrane, and the starting voltage itself is determined by
permeant ion concentration. For example, when valinomycin is used to provide the driving force
by selectively permeabilizing the liposome membrane to potassium ions, the relative
concentrations of K+ inside and outside the liposome largely determine the starting voltage
according to the Nernst equation

E=

RT [Out]
ln
, assuming that the liposome is not
zF
[In]

intrinsically leaky to other ions. In the equation, E is the driving electrical potential, R is the gas
constant, T is the temperature
! in Kelvin, z is the charge of the permeant ion, F is the Faraday
constant, and [Out] and [In] are the concentrations of the permeant ion inside and outside the
liposome respectively.

In oocyte experiments, the membrane voltage is precisely and rapidly controlled by electrode
clamping, leading to straightforward measurements of reversal potential. In liposomes, the
+

starting voltage can be theoretically be altered by changing the relative concentration of K inside
and outside the liposomes in a series of experiments with changing internal and external buffers,
while controlling for osmolarity effects. However, a more rapid estimate of proton selectivity in
this system can be obtained without measuring a reversal potential, by performing the flux
experiments in the absence of valinomycin.

+

+

In the K in, Na out liposome buffer system such as the one used in this work, one would expect
a perfectly proton-selective protein to result in no internal pH change in the absence of

76

valinomycin if the internal and external buffer pH values are equal. A similar result would also be
+

+

expected for a perfectly non-selective protein, since K and Na would dissolve in and out of the
liposome with equal probability, creating no driving force for net proton translocation. However, in
this latter case, there would also be minimal acidification in the presence of valinomycin, given
+

+

6

the very large excess of Na ions over H (greater than 10 in this system).

+

Let us now consider what would happen if the protein of interest was also permeable to K or Na
but not both to the same extent.

+

+

+

If the protein also transported K in addition to H , then in the

+

absence of valinomycin, K would leak out of the liposome down its concentration gradient (as it
is likely that the orientation of the protein in the membrane is random). This would create a
negative potential inside the liposome, drawing protons in and leading to acidification. If, by
+

+

+

contrast, the protein transported Na and H , then, without valinomycin, Na would diffuse from
the outside into the liposome interior down its concentration gradient, leading to an accumulation
+

of excess positive charge inside the liposome, the extrusion of H , and a more basic
intraliposomal pH.

Experiments without valinomycin at neutral pH on full length A/M2, synM2(19-62), synM2(22-50),
synM2(22-46) all resulted in significant acidification of the liposome interior (data shown for A/M2
and synM2(22-46) in left panel of Figure 2.12), although in every case less than the extent of
acidification with valinomycin. synM2(19-62) showed the smallest degree of acidification, while
+

synM2(22-50) had the largest. Confirmatory experiments on synM2(22-46) where Na was in the
+

inside buffer and K was in the outside buffer led more basic intraliposomal pH as expected (data
not shown). This would suggest that all of the M2 constructs tested are also capable of
+

transporting K , at first glance in possible contradiction with other evidence indicating that A/M2 is
highly proton selective (Chizhmakov, Geraghty et al. 1996; Lin and Schroeder 2001).
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Figure 2.12. Probing selectivity of A/M2 and synM2(22-46) in proteoliposome system. Left panel:
experiments with and without valinomycin, pHin and pHout ~ 7.4 Right panel, pHin and pHout ~
6.5.

However, a more nuanced consideration of these findings has to take into account the very large
+

+

+

+

excess of Na and K to H in the experimental system at hand. The concentration of K and Na

+

in the respective buffers and salts is ~120 mM, whereas at pH 7.4, the free proton concentration
-8

6

is 4x10 , a difference of ~3x10 fold. Previous studies have determined the proton selectivity of
6

A/M2 as approximately 10 fold (Chizhmakov, Geraghty et al. 1996; Lin and Schroeder 2001).
Therefore, since the excess of non-proton cations to protons is in fact somewhat greater than the
previously determined selectivity, the observed valinomycin-free are not inconsistent with the
previously determined high proton selectivity of M2.

That the observed valinomycin-free current was due to the high excess of potassium to protons
+

+

+

could be ascertained by decreasing the excess of Na and K to H (e.g. by performing the
measurement at somewhat lower pH). If the proton selectivity of M2 is high, then the ratio of
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valinomycin-free proton flux (where passive leak of potassium drives liposome acidification) to
proton flux with valinomycin (when protons are driven into the liposomes from an external
potential) should be significantly lower when the proton concentration is higher. This hypothesis
+

+

was tested on A/M2 and synM2(22-46), with both K and Na buffers now set at pH ~ 6.5.

As shown in the right panel of Figure 2.12, addition of valinomycin elicited proportionally larger
inward proton currents through reconstituted A/M2 and synM2(22-46) at lower pH. Therefore, the
results were consistent with high proton selectivities of A/M2 and the M2 TM peptide.

The final functional criterion that must be examined for validation of M2 transmembrane domain
function is the pHout activation of M2: inward currents increase in response to decreasing external
pH (Chizhmakov, Geraghty et al. 1996). To this end, A/M2 and synM2(22-46) were reconstituted
into proteoliposomes in K buffer at pH 7.4.

The inward per-tetramer proton currents were

measured with valinomycin upon dilution into Na buffer at pH 7.4, 7.0, 6.5, and 6.0.

After

subtraction of background current measured in protein-free liposomes under these conditions, the
current ratios at the lower pH values vs. current at pH 7.4 for full length A/M2 and synM2(22-46)
are plotted in Figure 2.13. Both A/M2 and the M2 TM peptide show a similar trend of increasing
inward proton current with decreasing pH out, indicating that the two have a similar pattern of pHout
activation.
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Figure 2.13. Activation of proton flux through A/M2 and synM2(22-46) by decreasing pHout.
Current ratios are normalized to initial current at pHout 7.4.

2.6. Comparison of pH-dependent thermodynamic stability of synM2(22-46) and A/M2.
As described in the introductory chapter, groundbreaking ssNMR experiments in bilayers
established that the M2 TM peptide had unexpectedly high His 37 pKa values (Hu, Fu et al.
2006), which are sure to play into any mechanistic model of proton transport through M2.
However, no evidence of these perturbed pKas has been obtained from the full length A/M2, or
from any M2 constructs studied in micelles, as certain biophysical techniques favor or
necessitate.

The ssNMR pH titration of synM2 22-46 showed that of the tetramer His 37 pKa values (pKa[1]
through pKa[4]); the first two, 8.2 and 8.2, were higher than that of the monomer (app. 6.5)
(Salom, Hill et al. 2000), pKa[3] was similar to that of the monomer at 6.3, and pKa[4] was much
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lower than that of the monomer at <5.0 (Hu, Fu et al. 2006). Thus, relative to the monomer, the
tetramer has much greater affinity for binding the first two protons, approximately the same for the
third and much lower affinity for the fourth. Because proton-binding and tetramerization are
thermodynamically linked it therefore follows that the thermodynamic stability of the tetramer
should peak when it is di- to tri-protonated (near pH 6 – 7), and that it should be destabilized as
the pH is raised or lowered beyond this value. Although it might seem counterintuitive that
protonation of two to three closely placed His residues buried in a membrane protein should
stabilize the protein, this phenomenon is a consequence of thermodynamic coupling between
ligand (proton) binding and its thermodynamic stability. Previously, the destabilization of
tetrameric M2(22-46) at low pH has been well documented (Salom, Hill et al. 2000) by a circular
dichroism spectroscopy assay in DPC micelles. Here, new work by Dr. Amanda Stouffer
demonstrates that the stability reaches a maximum near pH 6.5, and falls off at higher pH.
Furthermore, Amanda demonstrated that the full-length A/M2 shows a similar pH-dependence of
tetramer stability in micelles; her findings are summarized below.

The stability between pH 6 and 9 of synM2(22-46) and A/M2 were determined by analytical
ultracentrifugation as described previously (Stouffer, Nanda et al. 2005). The A/M2 construct
used was a His-tagged A/72/Udorn sequence containing all the WT Cys residues and Trp at
position 15, and was expressed and purified in a very similar fashion to the procedure provided in
section 5.c of this chapter but with lower culture yields.

synM2(22-46) was studied in

dodecylphosphatidylcholine (DPC) micelles, chosen to allow comparison with previous studies
(Stouffer, Nanda et al. 2005). However, full-length A/M2 shows a small degree of high-order
aggregation in DPC (Kochendoerfer, Salom et al. 1999), which was alleviated by switching the
detergent to C14-sulfobetaine whose lower critical micelle concentration allowed measurements
over a larger range of protein/detergent ratios. The degree of association of M2 in micelles
depends on the protein/detergent ratio so the tetramer-monomer dissociation constant (Kapp) is
3

expressed in units of MR (MR is the mole ratio of peptide to detergent).
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The pH dependence of M2 tetramerization involves multiple histidine protonation states in the
monomeric and tetrameric forms of the protein. The observed equilibrium dissociation constant
for tetramerization Kobs at a given pH is related to the corresponding dissociation constant (Ktet)
for the tetramer observed at high pH by:

K obs =

[mon] + [mon " H + ]
[tet] + [tet " H + ] + [tet " H + 2 ] + [tet " H + 3 ] + [tet " H + 4 ]

[H + ]
)
K mon
K obs =
[H + ]
[H + ]2
[H + ]3
[H + ]4
1+
+
+
+
K(1) K(1)K(2) K(1)K(2)K(3) K(1)K(2)K(3)K 4)
K tet (1+

!

in which Kmon is the equilibrium constant for protonation of the monomer, while K[1] through K[4]

!

are for protonation of His37 in the tetramer. To allow the use of published acid dissociation
constants (Hu, Fu et al. 2006), these were treated as ensemble averages as in previous work and
were not corrected for statistical factors associated with the number of permutations of
protonation states for a given charge state. Previously determined values of K[1] through K[4]
were used in fitting curves to the data, leaving only the value of Ktet for synM2(22-46) or Ktet and
Kmon for A/M2 as adjustable parameters.
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Figure 2.14. Thermodynamic stability of synM2(22-46) (panel A, circles) and full length A/M2
(panel B, squares) in micelles as a function of pH. Triangles indicate measurements in the
presence of amantadine. The tetramer stability, plotted as the negative log of the tetramermonomer dissociation constant, is shown to decrease with increasing pH above ~6-6.5. Lines
indicate fits of a monomer-tetramer equilibrium model to the data using known, constrained
values of tetramer (panel B) and monomer and tetramer pKas (panel A). Figure published in (Ma,
Polishchuk et al. 2009).

Plots of pKapp vs. pH for the TM peptide and full-length protein confirm that the tetramer strength
reaches a maximum near pH 6.5 and decreases with increasing pH (Figure 2.14). The
outstanding fit of the curve in Fig. 5A for synM2(22-46), which was generated using the literature
values for pKas of the monomer and tetramer (Salom, Hill et al. 2000; Hu, Fu et al. 2006), is most
encouraging given that they were not treated as adjustable parameters. A more extensive set of
data was collected for A/M2; the titration curve can again be fit using the pKa values reported for
tetrameric synM2(22-46). This finding confirms that the functionally relevant protonation behavior
of His37 is constant over a range of fragment lengths and environments including both micelles
and bilayers. The addition of amantadine to both synM2(22-46) and A/M2 shifts the equilibrium
toward tetramers, as evidenced by an increase in pKapp (Figure 2.14). Consistent with previous
findings (Wang, Takeuchi et al. 1993), the affinity of amantadine for the tetramer, which is
reflected in the difference between the value of pKapp in the presence (▲) versus the absence (●)
of amantadine (Salom, Hill et al. 2000), decreases with decreasing pH, indicating that the drug
binds less strongly as the number of protons on His37 increases.

While the pH dependent assembly trends of synM2(22-46) and A/M2 are similar, the full-length
protein is more thermodynamically stable at each pH studied. Part of the difference arises from
reconstitution of A/M2 in C14-sulfobetaine, which favors the formation of tetramers by
approximately an order of magnitude (relative to the DPC, the detergent used for the TM peptide).
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In DPC the Kapp at pH 7.5 of A/M2 and synM2(22-46) are 10
respectively.

-10

3

MR vs. approximately 10

-6.3

3

MR ,

These values indicate that A/M2 and synM2(22-46) are 50% dissociated at a
1/3

peptide/DPC ratio of approximately 1/1700 (midpoint = (2•Kapp) ) vs. 1/110 at this pH. Thus, by
this measure, A/M2 is about 10 to 20-fold more stable than synM2(22-46), corresponding to
approximately 1.6 kcal/mol of monomer.

In summary, Dr. Stouffer’s analytical ultracentrifugation results and earlier work by Dr. David
Salom (Salom, Hill et al. 2000) have shown that both A/M2 and synM2(22-46) in micelles also
displayed the strongly perturbed pKas of His37 observed in synM2(22-46) bilayers (Hu, Fu et al.
2006), demonstrating the conservation of functionally important properties over a range of
constructs and solution conditions. Complementing the functional equivalency determined from
liposome experiments and described in section 5, the evidence from this section indicates that
pH-dependent protonation and assembly equilibria of these two constructs are also similar.

2.7. Conclusions: Validation of M2 TM peptide as a mechanistic model for full-length A/M2.
The evidence presented in this chapter definitively establishes the M2 transmembrane peptide as
a model system for transport, protonation, and assembly of full-length A/M2.

While oocyte

experiments in the Pinto lab could not address the function of M2 TM because of poor expression
of such a short construct on the oocyte surface, they showed that slightly longer constructs
maintained key functional properties of the full length protein. In agreement with findings from the
Pinto lab, proteoliposome flux experiments on full length A/M2 and intermediate fragments
showed that all constructs were functional and sensitive to amantadine. Furthermore, results
from proteoliposome assays showed that the transport rates, inhibition, ion selectivity and pHout
activation of the M2 TM peptide and full length A/M2 were very similar. This functional
equivalence is further bolstered by thermodynamic analyses indicating a similar pH dependence
of tetramer protonation and assembly in both micelles and bilayers. It is remarkable that a 25residue peptide is capable of assembling into a ligand-activated proton transporter. The results of
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biophysical studies in both micelle and bilayer systems on this functional core can now be
merged with electrophysiological data on the full-length protein in pursuit of a unified transport
mechanism. However, it should be kept in mind that as part of a multi-modular, multi-functional
protein, non-transmembrane sections of M2 are nevertheless important for its non-transport
functions in the viral life cycle (Chen, Leser et al. 2008).
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Chapter 3: A high-resolution structure of the M2 transmembrane
domain yields insights into proton transport pathway and
conduction mechanism
3.1. Membrane protein structure determination – a still-daunting task.
While integral membrane proteins are the products of approximately one-third of known genes,
the determination of their high-resolution structures continues to be a daunting task. The count of
unique high-resolution membrane protein structures was only in the ~200 range as of 2009,
according to one commonly used database (White). A telling analysis involves comparing the
number of cumulative new structures solved vs. time for water soluble proteins (starting in 1960)
and for membrane proteins (starting in 1985). When the temporal “head start” granted to water
soluble proteins is removed and the two curves are synchronized at a single time point, it is clear
that progress on membrane protein structural determination is being attained at a significantly
slower rate (White 2004). As discussed in greater detail in the introduction, this finding is not
surprising, since membrane protein structure determination adds substantial roadblocks:
exceptional care must be taken to preserve protein function when extracting it from the source,
bilayer mimetics such as detergent micelles must be used to generate crystals or allow for
tractable NMR conditions, and high-quality crystals are difficult to obtain since detergent-solvated
transmembrane domains rarely form favorable crystal contacts.

This problem becomes even more difficult for smaller membrane proteins or isolated
transmembrane peptides. Many membrane protein crystals are stabilized by contacts formed by
their water-soluble, extramembrane domains. In fact, successful approaches to ion channel
crystallization have often relied on co-crystallizing the proteins with antibody fragments targeting
their soluble domains in efforts to both stabilize their structure and increase their water-soluble
crystal-packing “footprint” (Dutzler, Campbell et al. 2003; Jiang, Lee et al. 2003). For
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transmembrane peptides lacking water-soluble sequences of significant length, the problem
becomes even more pronounced. In fact, very few structures of such peptides exist, and most
have been determined by solution NMR in micelles or bicelles at more modest resolution
(MacKenzie, Prestegard et al. 1997; Arora, Abildgaard et al. 2001; Bocharov, Mineev et al. 2008).
While antibodies are available to the N-terminal ectodomain of M2, this domain is intrinsically
disordered (as discussed in Chapter 2).

Furthermore, there is a substantial stretch of non-

structured sequence between commonly targeted antibody epitopes (Zhang, Zharikova et al.
2006) and the well structured transmembrane domain, indicating that applying the antibody
strategy to M2 crystallization would likely be difficult.

The DeGrado laboratory has been pursuing the high-resolution 3D structure of the M2
transmembrane domain since the late 1990s. While quality crystals of M2 TM (22-46) were
obtained quite early on in the process, they tended to be anisotropic with weaker diffraction along
the transmembrane “z” axis.

Furthermore, phasing the collected crystallographic data sets

presented a major bottleneck. Various approaches were attempted by previous lab members,
including MAD (multiple anomalous diffraction) phasing via selenomethionine-derivatized
peptides or NaBr soaked native peptide crystals. While anomalous diffraction signals were
obtained from these constructs, the anomalously scattering heavy atoms could not be reliably
located, most likely because of radiation damage, oxidation, or disordered packing. The
crystallization work described below was started and well-diffracting crystals were obtained
before any high resolution M2 structures became available. While the resulting data sets were
solved after the initial X-ray and NMR structures were published (Schnell and Chou 2008;
Stouffer, Acharya et al. 2008), the new structure described below is of substantially improved
resolution, and represents not only a major advance in our understanding of proton transport by
M2, but also sheds light on a new mechanism used by Nature to stabilize large amounts of
electric charge in a small, subnanometer environment.
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3.2. Toward better packed crystals: using bromophenyl-derivatized peptides.
To improve packing of M2 transmembrane peptide tetramers in the crystal lattice, we introduced
an N-terminal 4-bromophenyl group on the M2 transmembrane helix. The reasons for this were
three-fold: the electron-rich bromophenyl ring would stabilize the transmembrane helix dipole by
“capping” the helix with an electronegative group, the bromine atom on the bromophenyl group is
known for strong anomalous scattering and could be used for multiwavelength anomalous
diffraction (MAD) phasing, and the electronegative N-terminal bromophenyl ring could interact
with C-terminal positively charged residues (e.g. Arg 45) on vertically adjacent M2 tetramers to
provide crystal contacts in the “z” direction and lead to thicker, better diffracting, less anisotropic
crystals. The desired effect is shown in Figure 3.1.
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Figure 3.1. Engineering a cation-π interaction to stabilize crystal packing of M2 transmembrane
peptide constructs.

To this end, constructs of two different lengths were synthesized and capped with 4bromobenzoic acid on the N-terminus.

Both constructs, M2 25-46 (M2TM’) and M2 24-46

(M2TM’ + 1), were a few residues shorter than the usual M2 TM peptide (22-46), but both
encompassed the predicted transmembrane helical segment of M2 (residues 25-43).

Both

peptides in the initial trials had a G34A mutation, which in other constructs tested in the lab led to
faster crystallization (a few months vs. a year), thus the sequences made were as follows:
M2TM' G34A
4-bromobenzoyl-PLVVAASIIAILHLILWILDRL-CONH2
M2TM'+1 G34A
4-bromobenzoyl-DPLVVAASIIAILHLILWILDRL-CONH2
The peptides were synthesized as C-terminal amides using strandard Fmoc chemistry methods
either on an Applied Biosystems (Foster City, CA) 433A or on a Protein Technologies (Tucson,
AZ) Symphony synthesizer as previously described (Stouffer, Acharya et al. 2008). For
subsequent crystallization trials, the corresponding wild type M2TM’ (25-46) G34 peptide, was
also made in a similar fashion.

Following the addition and deprotection of the most N-terminal amino acid, 4-bromobenzoic acid
(Sigma Aldrich, St. Louis, MO) was coupled to the amino terminus of the peptide on resin in N,Ndimethylformamide. The product was cleaved from the resin and purified as previously described
to achieve a very high level of purity (98-99% or better) (Stouffer, Acharya et al. 2008). Purity was
verified with analytical RP-HPLC and MALDI-TOF mass spectrometry.

To make aliquots for crystallization, peptide and n-octylglucoside (OG, Sigma Aldrich) were mixed
-1

in an aqueous:isopropanol (1:1) stock using ε280peptide = 5853 M
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-1

cm . To attempt co-

crystallization with inhibitor, amantadine HCl was added to the peptide-octylglucoside mixture.
The mixture was evaporated under reduced pressure in an Eppendorf tube. The resulting film
was dried on a lyophilizer, then taken up in 5% (w/v) xylitol and mixed with precipitant for
crystallization trials. In some cases, the reconstituted peptide-detergent mixture was filtered prior
to crystallization.

3.3. Crystallization trials of bromophenyl-derivatized peptides.
A wide array of crystallization conditions was sampled for the two bromophenyl-derivatized G34A
(M2TM’ and M2TM’+1) constructs.

From experience of other lab members, the detergent

octylglucoside was found to be effective in facilitating M2 TM crystal growth; thus this detergent
was used as a first choice for the crystallization of the new M2TM’ constructs. In the final
reconstituted mix, the target concentration of M2TM’ monomer was 0.8 mM; amantadine, if used,
was added to a final concentration of 0.6 mM. A number of octylglucoside concentrations were
employed, generally ranging from 1:25-1:45 peptide monomer:octylglucoside.

Crystals were

grown using the hanging drop method by mixing 1 µL of well solution with 1 µL of
peptide:detergent stock; the well solution volume was 750 µL. Crystallization experiments were
maintained at or slightly below ambient temperature.

From prior experience of other lab members, crystallization of the longer M2 TM was often
facilitated using transition metal containing precipitant solutions (e.g. Mg, Co, Ni) along with
polyethylene glycol and Tris buffer at moderately basic pH. However, these trials did not lead to
high-quality crystals of the M2TM’ constructs, indicating that successful crystallization conditions
are extremely fragment-specific.

Sparse matrix screens, such as the Hampton Research (Aliso Viejo, CA) MembFac were also
tested with the M2TM’ and M2TM’+1 constructs. While no hits were obtained with M2TM’ + 1
G34A, crude crystals of M2TM’ G34A formed fairly rapidly (within a few weeks) in a number of

90

conditions. The best looking crystals were obtained out of condition #14, a mixture of sodium
citrate and isopropanol at an overall pH of ~ 6.4. These were densely packed, multifaceted rocklike crystals that were not yet of diffraction quality.

Expansion of the citrate/isopropanol screen on M2TM’ G34A generated crystals of improved
appearance. Initially, fuzzy sphere-like precipitates formed, that eventually developed surface
spicules which grew in size to thin, flat plates, that occasionally separated from the spherical
centers. These plates were often difficult to cleanly isolate and were quite thin, but diffracted to a
resolution limit of 3-4 Å on a home source CuKα X-ray generator.

Further attempts to improve crystal thickness and diffraction quality involved replacement of the
isopropanol component of the well solution with ethanol, variation of the peptide:detergent ratio,
and the addition of small amounts of other sparse matrix screen conditions to the citrateisopropanol mixture that previously yielded the best results.

Thicker crystals of M2TM’ G34A that diffracted to ~2.5Å on the home source generator were
obtained from drops containing 0.8 mM M2TM' G34A peptide (as monomer), 28mM OG and 5%
xylitol, mixed in the ratio of 1:1 with a reservoir solution mixture of 95% [100mM sodium citrate pH
5.6, 150mM tri-sodium citrate, 15% v/v isopropanol] and 5% [0.2M MgCl2 6H2O, 0.1M Trishydrochloride pH 8.5, 30% w/v Polyethlene glycol 4000]. Crystals appeared in two weks, and
were grown over a period of 2-5 months. Cryoprotection was effectively achieved by briefly
immersing the crystals in 2-methyl-2,4-pentanediol (MPD).

For M2TM’ G34, reconstituted similarly to M2TM’ G34A, the best crystals were obtained from a
precipitant solution of 100 mM sodium citrate pH 5.6, 100mM tri-sodium citrate, and 15% v/v
isopropanol. M2TM' G34 crystals grew much more slowly, appearing after 5 months, and were

91

grown for an additional two months. These crystals were much smaller than those of M2TM’
G34A and diffracted to a lower resolution. MPD was again used for cryoprotection.

3.4. Data collection and processing.
Many data sets were collected from several crystals of M2TM' G34A, with cryo-cooling to 100K
during data collection. These include MAD data sets recorded at synchrotron beam lines (NSLS,
Brookhaven, NY, USA) and data sets collected at a University of Pennsylvania home source.
Data were collected by the author, and Drs. Steven Stayrook and Rudresh Acharya. The crystals
were usually found to diffract to a maximum resolution of 2.6–1.65 Å. The diffraction images were
indexed, integrated using MOSFLM (Leslie 1999; Powell 1999) and scaled using SCALA (Evans
2006). Table 3.2 shows the data collection statistics for the data sets (1.65 Å) used in the
refinement.

Diffraction data sets for M2TM’ G34 crystals were collected at synchrotron beam line X29 (NSLS,
Brookhaven, NY, USA) by the author and Dr. Rudresh Acharya. The data sets could be
processed up to ~68% completeness and were found to belong to the same unit cell as M2TM'
G34A data sets (Table 3.2).
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Data collection and processing

M2TM'G34A

M2TM'G34

Space group

C2221

C2221

Cell dimension a, b, c (Å)

48.67, 79.09, 48.56

48.74, 77.860, 48.61

Resolution (Å)

48.6-1.65(1.75-1.65)1

41.3-2.50 (2.64-2.5)

Rmerge

0.070 (0.45)

0.098(0.344)

I/σ(I)

19.4 (2.7)

7.1(2.3)

Completeness (%)

99.5 (96.6)

67.5(70.9)

Multiplicity

6.6 (4.5)

2.8(2.7)

Total number of (observation/unique)

76869/11567

6174/2230

Resolution (Å)

31.5-1.65

41.3-2.5

Number of reflections

10998

2130

Rwork/Rfree

0.196/0.205

0.299/0.333

Proteins

7322

728

Ligand/ion

31

0

Waters

25

0

Proteins

13.7

13.2

Ligand/ion

48.4

Waters

24.9

Refinement

Number of atoms

B-factors (Å2)

R.M.S. deviation
Bond lengths (Å)

0.007

Bond angle (°)

0.879

Ramachandran plot
Residues in
Most favorable region (%)
Additional allowed region (%)
Generously allowed region (%)

100.0
0.0
0.0

1

100.0
0.0
0.0

Highest resolution shell is shown in parenthesis.
Including Bromo benzoyl group.
3
Rwork = Σ ||Fobs|-|Fcalc||/ Σ|Fobs| where Fobs and Fcalc are calculated observed and calculated structure factor amplitudes
respectively, Rfree was calculated as Rwork using 5.0% of the randomly selected unique reflections that were not
included in the structure refinement.
2
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Table 3.2. Statistics from data collection and structure determination of M2TM’ G34A and M2TM’.

3.5. Structure determination, model building, and refinement of M2TM’.
Initial attempts to phase M2TM’ G34A data sets using multiwavelength anomalous diffraction
were unsuccessful. While a strong bromine signal was detected in an EXAFS experiment on
M2TM’ crystals, indicating the presence of the anomalously diffracting heavy atom, the location of
the bromine atoms in the unit cell could not be reliably determined presumably because of
disorder or radiation damage.

Following the successful solution of earlier M2 TM data sets from our laboratory using a
molecular replacement approach based on the structure of a monomeric M2 TM helix (Stouffer,
Acharya et al. 2008), Dr. Rudresh Acharya attempted to solve the M2TM’ G34A data sets using
molecular replacement with the newly solved M2 TM structure as a model.

His successful

approach to determine the structure of M2TM’ G34A is described below.

Since initial attempts at molecular replacement using a single alpha-helix or tetramers from a
previously solved structure (PDB code 3BKD) (Stouffer, Acharya et al. 2008) as model probes did
not yield the structure solution, a more nuanced approach to model construction was pursued.
By comparison of cell dimensions, it was intuitive to notice that helices forming the tetramer are
more closely packed in the present data sets than those in 3BKD. Whereas in 3BKD (with cell
dimensions a = 38.753 Å, b = 56.557 Å and c = 56.009Å), helices are oriented along the a
crystallographic axis, and two tetramers lie in the bc plane, in the present data sets (Table 3.2),
tetramer(s) lie(s) in the ac plane with helices oriented along the b axis. Based on this packing
knowledge, tetramer models were generated to use as model probes in molecular replacement.

Tetramer model generation. Using one of the helices of the previously published 2.0 Å resolution
structure (3BKD, chain 'A'), tetramer models were generated with various helical orientations; -
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30º < Xangle < -20º, 7º < Yangle < 10º, 160º < Zangle < 190º and radius of bundle 6.8 < r < 8.0
Å, where Xangle, Yangle and Zangle represents the angle formed by the helix with the X-axis, Yaxis and Z-axis respectively. During tetramer generation, the helix oriented along the Z-axis was
first rotated around the Z-axis (Zangle), then about the X-axis (Xangle) and then about the Y-axis
(Yangle). For this orientated helix, four copies were created by applying four fold symmetry along
the Z- axis and each copy was translated to a radius distance in four fold symmetry on an XYplane.

Among tetramer models generated as described above, only those models having orientation of
Val27 close to that in the 3BKD structure were considered for molecular replacement
calculations.

The molecular replacement calculations were performed using the program

PHASER (Read 2001; McCoy, Grosse-Kunstleve et al. 2005) for data in the resolution range of
15-4.0 Å. The data sets used for initial phasing were processed in the space group P21 with cell
parameters a = 46.41 Å, b = 48.52 Å, c = 46.27 Å and β = 116.97° and were collected at the
home source to a resolution limit of 2.6 Å. The Matthews coefficient (Matthews 1968) (Vm = 2.3
3

Å /Da) indicated the presence of two tetramers in the asymmetric unit.

Initially molecular

replacement calculations were performed using bundles with parameters: radius 8.0 Å, 7.5 Å [26° (Xangle), 10° (Yangle), 160°-190° (Zangle)] and later, models were randomly selected for the
calculations. In evaluating model quality during calculations, importance was given to recognizing
an interpretable electron density map. In general, the resulting maps were not good, but the
model with Xangle = -24°, Yangle = 10°, Zangle = 167°, and radius 7.0 Å had a very clear density
for a dimer. The dimer was used as a model and two tetramers were located in the asymmetric
unit, resulting in an excellent electron density map.

Of several M2TM’ G34A crystals tested for diffraction at the synchrotron beam line (NSLS, X6A),
a crystal belonging to the space group C2221 with cell parameters a = 48.67 Å b = 79.09 Å and c
= 48.56 Å was found to diffract to a maximum resolution of 1.65 Å. With the possibility of a
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3

tetramer in the asymmetric unit as suggested by the Matthews coefficient (Vm = 2.4 Å /Da), the
structure was solved by the molecular replacement technique using one of the above-determined
tetramers as a model. Iterative refinement and model building were carried out, during which all
side chains could be traced in the electron density map. As the refinement progressed water
molecules were located in the map. When the refinement had converged, the model was refined
to Rwork = 19.7% and Rfree = 20.5% (Table 3.2), with all the residues in allowed regions (100%
favorable) of the Ramachandran plot. Details of refinement statistics are shown in Table 3.2.
The refinement was carried out using the CCP4 program suite (Collaborative Computational
Project 1994) (REFMAC) (Murshudov, Vagin et al. 1997) and all model building was done using
COOT (Emsley and Cowtan 2004).

In general, solvent molecules were included only if they were visible at the 3σ level in an FO–FC
map. All were found in full occupancy with the exception of the Br atoms in the bromobenzoyl
group, which were disordered, presumably due to radiation damage. The dimer of water
molecules in the outer cluster (in a region of the pore slightly N-terminal to His 37, described as
the “MPSC” in the discussion below) had two alternate conformations that refined with
occupancies of 0.6 and 0.4.

3.6. Comparison of M2TM’ X-ray diffraction data: G34A and G34.
To assess the similarity between the structure of M2TM' G34A and M2TM’ G34, the partial
dataset from crystals of M2TM’ G34 was submitted to molecular replacement using the structure
of M2TM' G34A.

A satisfactory solution (Rcryst = 0.41, CC = 0.65 (polyala)) was obtained,

resulting in a map of good quality with clearly visible density at the location of the amino acid
sidechains mutated to Ala in the model. In a second trial, initial rigid-body refinement of the
M2TM’ G34 dataset using the structure of M2TM’ G34A with the Ala methyl and all solvent
molecules removed led to a satisfactory initial solution (Table 3.2) with an interpretable density
map showing density attributable to water in e.g. the area of the pore just N-terminal to His 37.
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These findings strongly suggest that the overall structures are very similar, although it would be
inappropriate to fully refine the structure of M2TM’ G34 without collecting more complete data.

3.7. The high-resolution structure of M2TM’: backbone conformation.
M2TM’ G34A (from here on referred to as M2TM’) was crystallized at pH ~ 6.5, under conditions
more acidic than those of the solution NMR structure (pH 7.5-8) and likely more basic than the
earlier, lower resolution X-ray crystal structures (the apo form M2 TM was crystallized with
starting buffer near pH ~ 7, but due to the presence of transition metal ions in the precipitant
buffer and the long time to crystal appearance, the exact pH of crystallization is unknown and
likely lower; the lower-resolution drug-bound structure was crystallized with starting buffer near
pH ~ 5 but similarly uncertain). Not surprisingly, the backbone conformation of M2TM’ is
intermediate between the solution NMR and previous crystal structures. The backbone of the Cterminal segment of the M2TM’ helical bundle is almost completely superimposable on the
solution NMR structure; whereas the N-terminal portion of the helices is more kinked in the crystal
structure and more straight in the NMR structure (Figure 3.3). Overall, the Cα RMSD between
the two structures is a low 1.4 Å. By contrast, in the lower resolution low-pH M2 TM crystal
structure (starting buffer near pH ~ 5), the backbone helices once again straighten out, but now at
a similar angle to the kinked N-terminal section of the pH 6.5 M2TM’. The low pH structure
resembles a teepee or a cone, and the kinked conformation of the new, intermediate pH
structure, forms a bridging intermediate conformation state between the high and the low pH
forms, consistent with the proposed conformational changes in the M2 activation and transport
mechanism (Stouffer, Acharya et al. 2008; Khurana, Dal Peraro et al. 2009).
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Figure 3.3. Comparison of the backbone and key sidechain structures of M2 obtained at different
pH values. Left panel: solution NMR, pH 7.5-8 (PDB ID: 2RLF); middle panel: M2TM’ X-ray; pH
6.5, right panel: M2TM X-ray pH ~5.3 (PDB ID: 3C9J). Val 27 sidechains are in blue, His 37
sidechains are in orange, Trp 41 sidechains are in purple.

3.8. The high-resolution structure of M2TM’: structure of the aqueous pore.
M2TM' assembles into a nearly symmetrical helical bundle, structurally similar to previous lowerresolution models (Pinto, Dieckmann et al. 1997; Tian, Gao et al. 2003; Hu, Asbury et al. 2007;
Schnell and Chou 2008; Stouffer, Acharya et al. 2008). However, the significantly greater
resolution now shows that the pore is formed by five layers of sidechains and three intercalated
water clusters stacked to form a continuous conduction pathway (Fig 3.4). Representative
electron density maps are shown in Appendix A.
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Figure 3.4. Pore lining residues and water molecules define the proton conduction pathway (A) in
a new high-resolution structure of the M2 transmembrane segment. Key portions include a His
box with an N-terminal water cluster (B), a Trp basket with a bridging water cluster (C), and an
exit water cluster lined by Asp and Arg sidechains (D).

The outermost or “top” layer of side chains is composed by the four Val 27 residues, which form a
nearly closed Val 27 valve (2 Å pore radius), leading to a central pore lined by small residues, Ala
30, Ser 31, and Gly/Ala 34. The conduction pathway is next interrupted by the His 37 residues
(forming what we term a His-box, similar to aromatic boxes, but smaller in cross-section due to
the smaller size of the imidazole ring). The His-box needs to expand only slightly (1-2 Å) to allow
passage of a water-sized molecule. Below this motif the sidechains of Trp 41 form a basket (Trpbasket) with the aromatic rings angled by approximately 45° relative to the bundle axis. In a key
difference, the Trp sidechains assume a different rotameric state compared to the high pH
solution NMR structure. In the crystal structure, the indole nitrogens point into the pore as
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opposed to the benzenoid portion of the indole ring in the NMR structure (Schnell and Chou
2008). The other lower-resolution crystal structures, likely corresponding to lower pH
conformations, also have the indole nitrogen facing into the pore (Stouffer, Acharya et al. 2008).
Finally, Asp 44 and Arg 45 line an Asp/Arg box, defining the cytoplasmic end of the channel. The
planar faces of the guanidino groups of Arg 45 form a 7 to 8 Å box stabilized at the corners by
interaction with an oxygen atom of Asp 44, confirming the Asp-Arg salt bridge seen in the NMR
structure and in the predicted high pH forms of lower-resolution crystallographic models; the salt
bridge is broken in the low-pH crystal forms. While the electron density for the Asp 44 residues is
very well-defined, the Arg45 sidechains have higher Debye-Waller factors, suggestive of greater
conformational mobility.

Right below the Val 27 valve is a region of diffuse density, indicative of dynamically or statically
disordered solvent (Figure 3.4 A); beyond this point, the remainder of the pore is filled by three
well-ordered water layers. Above the His-box is an outer cluster of 6 waters (Figure 3.4 A,B) that
consists of a tight water dimer (O – O distance 2.4 Å) atop four waters, which in turn are Hbonded to the Nδ of His37 and the backbone carbonyl of residue 34. In the following, we refer to
the outer cluster and the His-box together as the “multi-proton storage” cluster (MPSC).
Connecting the His-box and Trp- basket is the His 37/Trp 41 bridging cluster of 2 waters (Figure
3.4 A,C), which H-bonds to the Nε of each His 37 residue. This dimer is well positioned to
mediate a π-cation interaction (Okada, Miura et al. 2001) between charged His 37 residues and
the electron-rich faces of Trp 41 residues. Finally, the exit cluster (Figure 3.4 A,D) consists of four
waters that form H-bonds connecting the indole NH of Trp 41 to a carboxylate O of Asp 44. A
fifth, poorly ordered solvent molecule (presumably water) lies below these four waters, displaced
towards the interior of the virus. Throughout the structure, the four-fold symmetry is broken only
by the water dimer found in the outer cluster and the His 37/Trp 41 bridging cluster (Figure 3.4
B,C).

No counterion was detected in the structure, although the density in the central pore

around Ala 30 and Ser 31, as well as the fifth solvent in the exit cluster is sufficiently diffuse that it
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would be difficult to unambiguously rule out disordered chloride ions with partial occupancy at
these positions.

In summary, the pore of M2TM' is populated by water molecules stably H-bonded to the protein,
starting below the Val 27 valve, extending through the MPSC, and broken only at the π-face of
Trp 41, near the interior of the virus. We next asked how charge is stabilized within the MPSC, as
well as how passage of protons is allowed through the Val27 and Trp41 constriction regions.

3.9. Structure of M2TM’ represents 2+ protonation state.
To draw the correct conclusions from the newly discovered water clusters in the structure of
M2TM’, it was important to determine the charge state of His 37 tetrad that the structure
represents. Based on the two-fold symmetry of the water clusters, the most likely state was one
of even protonation (0+, 2+ or 4+). As the crystals grew quite rapidly from a concentrated buffer
at pH ~6.5, comparison to the experimental pKa values determined by Cross et al. (Hu, Fu et al.
2006) indicated that the structure should represent the 2+ state, though quite near to the pKa (6.3)
for the 3

rd

proton. Theoretical analysis of the structure by our collaborators in the Klein lab,

including quantum-chemical calculations of the magnetic shieldings of the MPSC in the 2+ and 3+
state, and classical simulations of the structure of the water cluster, showed that the state with
two histidines with unprotonated Nδ and two doubly protonated histidines (each with a single
positive charge) contributes most to the present structure. This is once again consistent with the
backbone conformation, which is intermediate between the previously determined high-pH NMR
(Schnell and Chou 2008) and low-pH crystal structures (Stouffer, Ma et al. 2008) (Figure 3.3).
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3.10. Quantum mechanical simulations of MPSC suggest mechanism for charge stabilization in
high protonation states.

It is remarkable that two to three His37 residues can be stably charged at near neutral pH,
despite their mutual proximity in a region of presumably low dielectric. Indeed, PoissonBoltzmann (Dutzler, Campbell et al.) calculations (performed by our collaborators in the Klein lab)
on M2TM' embedded in a hydrophobic bilayer and a continuum solvent predict that the first three
pKa’s are 7.0, 4.2, and 1.7 respectively, vs. the experimentally obtained pKa values of 8.2, 8.2,
and 6.3 (Hu, Fu et al. 2006). Thus, the product of the first two experimentally determined proton
5

dissociation constants differs from the PB estimate by 10 , indicating the need to consider proton
mobility and protein polarization, absent in the PB method. The Klein lab therefore used quantum
mechanical (QM) and quantum mechanical/molecular mechanical (QM/MM) methods to examine
how the MPSC in the crystal structure is able to stabilize the 1+ and 2+ states and accept a third
proton. Like a previous empirical valence bond study of a model structure (Smondyrev and Voth
2002), the QM/MM approach allowed them to examine the diffusion of the protons themselves,
which cannot be treated with force-field based molecular mechanics (MM) models.

It is reasonable to suspect that the first and second protons accepted by the MPSC bind to
histidine residues, and indeed geometry optimizations performed by the Klein lab at the QM/MM
level of theory show that these structures are stable. However, the structure of the outer water
cluster (Figure 3.4 A,B) suggests that a simple configuration with three charged His residues may
not be the only significantly populated configuration of the 3+ state of the MPSC. In particular, this
+

structure bears an intriguing resemblance to one of the preferred conformations of a H (H2O)6
cluster, in which the excess proton is shared by the two central water molecules in a barrierless
fashion (Headrick, Diken et al. 2005). To gain further insight into this issue the Klein group carried
out a QM/MM simulation of the 2+ state with a third excess proton moving along a Grotthuss
hopping path across one of the C2 symmetry-related halves of the MPSC.
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Figure 3.5. Energetics of proton transfer across the MPSC. (A) The potential energy surface for
one possible proton transfer pathway is calculated using an MP2 model of the MPSC (filled
circles) and a QM/MM model of M2TM' (empty circles). The MP2 model included the MPSC, the
Ala34-Ile35 peptide groups, the bridging cluster below the His-box, and one additional water
molecule above the MPSC (so that a complete solvation shell is included for any position of the
hydronium). The QM/MM model extended the MP2 model by including the entire peptide
tetramer, lipid, and solvent environment at the MM level of theory. All of the Nε atoms, and the
Nδ of 2nonadjacent histidines are protonated. We added an extra proton at three different
positions (modeling a Grotthuss hopping path from a central water to a nearby water and then to
a histidine), and optimized these 3 structures and interpolated 10 intermediate structures. The
state with the hydronium adjacent to a neutral histidine (replica 6) is stabilized by two nearby
large dipole groups: the Ala34-Ile35 peptide group and the neutral histidine.

The resulting energy profile (Figure 3.5) encompasses two proton transfer events (the first
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between two water molecules; the second from a water molecule to a His residue), and exhibits
low barriers for proton transport, similar to those in bulk water. A first calculation was performed
at the MP2/cc-pvdz level of theory for a cluster system. The resulting surface (Figure 3.5, filled
circles) spans an energy range of 3 kcal/mol, with a maximum barrier of 3 kcal/mol, suggesting a
fast diffusion of protons across the water molecules of the cluster. Particularly noteworthy is the
unexpectedly low energy of the state in which a hydronium is located adjacent to the neutral His,
which is attributed to the local electrostatic environment. The dipoles stabilizing the cation (the
His 37 side chain and the peptide group of Ala 34-Ile 35) are even larger than those provided by
H-bonded water molecules, which themselves stabilize a hydronium state by tens of kcal/mol (Lill
and Helms 2001). A second source of stabilization is that the positive charge keeps a distance of
~5.5 Å from the histidine bound protons when bound to this water. This is about halfway between
a purely His-bound 3+ state (4.5 Å) and the 2+ state (6.5 Å diagonal distance between His
residues).

The inclusion of the remainder of the protein-lipid-water environment may alter the stability of the
hydronium states relative to the His-bound ones. The Klein lab examined this effect by calculating
a QM/MM model based on a DFT-BLYP (quantum mechanical) description of the MPSC and its
surrounding area (the Ala34-Ile35 peptide groups, the bridging cluster below the His-box, and one
additional water molecule above the MPSC) and the rest of the peptide tetramer, lipid and solvent
at the MM (molecular mechanical) level of theory, which predicted a total energy drop of 2
kcal/mol over the course of the path (Figure 3.5, empty circles). However, the barriers were not
greatly affected and were never higher than 4 kcal/mol. Furthermore, additional room temperature
QM/MM MD simulations performed by the Klein lab support the prediction of fast proton transport
kinetics: during a total of 60 ps of simulated time, many proton transfer events were observed,
both between water molecules and from a water molecule to a neutral His (Appendix B).
Consistent with the QM/MM energies, no jumps were observed from the His residues to the water
cluster on the timescale of the simulations.
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Thus, state of the art computational analysis of the His 37 sidechains, the N-terminal water
cluster (the multi-proton storage cluster) and the surrounding areas provides a structural and
physical explanation for the unusually perturbed pKa values previously recorded in ssNMR
experiments (Hu, Fu et al. 2006) with, the emerging detailed structural being more complex than
the imidazole-imidazolium dimers proposed in the ssNMR study. Based on the crystal structure
and QM modeling, the ordered water molecules forming the multi-proton storage cluster
delocalize protons incoming toward the 2+ state in a nearly barrierless fashion, providing
increased entropic terms underlying the unexpected energetic ease with which these excess
protons bind, and giving further credence to mechanistic hypotheses where the slow, ratedetermining step of proton transport is deprotonation. As will be discussed in the next section,
classical simulations show an additional mechanism for charge stabilization in M2TM’ by the
means of reorienting water dipoles. In summary, the highly tuned arrangement of the His 37 box
and the MPSC water cluster form an unprecedented system that stabilizes bound protons by as
many as five orders of magnitude.

It is perhaps not surprising that this very simple yet

remarkably effective nanodevice for charge storage is found in one of the smallest yet most
fascinating membrane transport proteins known to date.

3.11. Modulation of pore water dipoles may contribute to charge stabilization and unidirectional
transport by A/M2.
To determine how protonation states of the His 37 box affect the pore water structure in M2TM’,
the Klein lab performed a thorough exploration of the configurational space of water molecules by
classical MD simulations on M2TM' systems with an increasing number of protons added to the
His-box. The water density distribution from classical MD simulations was always in good
agreement with the positions of the crystallographic waters in the various clusters, in particular in
the 2ε state. The only water that was not stable was the central water in the exit cluster, which
had been observed experimentally to have a high Debye-Waller factor (Figure 3.4 A).
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Figure 3.6. Switching mechanism of the pore waters in the M2TM' bundle, across five
protonation states, postulated to be the sequence of M2 activation (0, 1+, 2+, 3+, 4+). We
considered an order parameter, d, as the average projection along the pore axis of the
water dipole (defined between -2.35 and 2.35 Debye). (A) Average and standard
deviation of d at each state, and (B) free energy profiles f(d), computed by metadynamics
MD runs (each ca. 50 ns long). (C-D) Schematic structures of the pore waters (shown in
blue) immediately below the Val27 valve, in the under-protonated (C) and overprotonated (D) states. In the under-protonated state (C) the four water molecules adjacent
to Ser31 can saturate their H-bond network only if an additional water molecule enters
the valve. When protons accumulate at the His-box, water molecules reorient towards it
(see (A)) and the H-bond network with the protein becomes fully satisfied: without free
acceptors, the valve dehydrates. (E-G) Distribution of the H-bonded water wires in the
neutral (E), 2+ (F), and 4+ (G) states, constructed by joining all of the neighboring Hbonds observed in classical MD simulations. To make the rarely populated wires more visible,
line thicknesses in the picture are proportional to the square root of their population. Red
indicates water wires oriented towards the viral interior (inward wires), blue wires run in the
opposite direction (back-flow wires) and white wires connect adjacent His37 side chains. Three
regions with different behavior can be identified: the Val27 valve, which always features inward
wires of decreasing intensity; the region between the valve and the His-box, where the
equilibrium switches (see also (A)) from inward wires connected to the Val27 valve and back-flow
wires that are disconnected from it; the region between the His-box and the Trp-basket, always

106

featuring inward wires of increasing intensity. (H-J) Average count of H-bonds within
each of the three regions.

The H-bonded water clusters in the channel pore (including the MPSC) exhibited a well-concerted
response to increasing charge (Figure 3.6 A) suggestive of a global control of the proton flow.
The most prominent feature of this mechanism was observed directly at the Val 27 valve.
Although the backbone atoms were restrained in the simulations and therefore the radius of the
valve was approximately constant across the different charge states, a sudden drop in the water
density was observed in this region when the MPSC reached a total charge of 2+ (Figure 3.6 H).

This behavior is explained by the electrostatic interactions between the charged residues and the
water molecules: as already observed in similar systems (de Groot and Grubmuller 2001;
Tajkhorshid, Nollert et al. 2002; Chakrabarti, Roux et al. 2004) the orientation of the dipole
moments of the water molecules filling a hydrophobic pore is highly sensitive to the magnitude
and the position of the charges lying within the pore. In M2TM', the total dipole moment of the
water molecules correlates with the total charge of the His-box, and, in particular, changes its
sign as soon as this charge increases to 2+ (Figure 3.6 A) The two apparent alternate states
(positive or negative) feature different H-bond networks, which, in turn, determine the solvation
properties of the Val valve: in the under-protonated states (neutral, 1+) each of the four water
molecules adjacent to Ser31 can form 4 H-bonds (a complete first solvation shell) only by binding
a water molecule further up towards the top in the Val valve region (Figure 3.6 C,D), while in the
over-protonated states (2+, 3+, 4+) the H-bonding capability of these water molecules is fully
satisfied by intra-cluster H-bonds.

This switch between two different H-bond networks turns out to dramatically affect the population
and the directionality of water wires, required by the Grotthuss hopping mechanism as proton
transport pathways (Agmon 1995). In the neutral and 1+ states, most such water wires connect
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the bulk at the N-terminal part of the protein with the His-box, consistent with the fact that the
channel is activated upon acidification of the medium outside the virus. As the charge is
increased (2+, 3+ and 4+), their relative population decreases by several orders of magnitude.
Instead, wires originating at the His-box and oriented in the back-flow direction become dominant,
but cannot reach the exterior, because they terminate at the Val27 valve (2+ and 3+), or flow
through it with a smaller probability than that of the incoming, forward-flow wires (4+ state). That
is, even when the His-box grows richer in H-bond donor groups looking towards the N-terminal
end, the connectivity of the water wires prevents the protons from easily reaching the exterior,
and the conditions for a net proton influx are always preserved.

At the C-terminal end, instead, water wires from His 37 are connected to the viral interior in all of
the protonation states except the neutral one. Interestingly all these water wires are always
directed toward the virus interior: the H-bonds donated by the indole amino groups of Trp41
impose a stable orientation on the water molecules in the lower cluster.

Thus, as for the

configuration like the NMR structure (in which the indole group physically occludes the pore) the
proton accessibility from the viral interior is low and back-flow currents are prevented. Unlike the
N-terminal end, the effect of increasing charge is to intensify the existing water wires and set the
stage for a prompt release of excess protons from the Nε sites towards the interior. This outcome
appears most favorable at the 4+ state, when each His has an acceptor water molecule at the Cterminal side, constantly connected by a short H-bond (< 3 Å).

In these simulations, the M2TM’ backbone was constrained, preventing additional ratchet-like
gating motions that have been proposed to underlie its conduction mechanism. Nevertheless,
since the backbone conformation obtained from the pH 6.5 crystal structure is likely to be
populated by a significant fraction of M2 tetramers at a range of conducting pH values, the
formation, dehydration, and reorientation of pore water wires described above not only
contributes to the unusual proton stability in the MPSC and His 37 box, but also complements the
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ratchet mechanism in maintaining the unidirectional, inward proton flow through the M2
transmembrane segment. In particular, the dehydration of water density at the Val 27 valve at
high protonation states is consistent with a secondary gating role proposed for those residues
from molecular dynamics simulations performed on other M2 models, where under certain
conditions water wires at the N-terminal pore were interrupted by Val 27 (Yi, Cross et al. 2008).

3.12. Correlation of molecular dynamics results and channel function by modulating pore radius.
To correlate the computational model predictions with M2 function, we can compare calculated
pore water densities from Klein lab molecular dynamics simulations on M2TM’ variants at position
34 with specific activity measurements on full-length protein carrying the same mutations,
determined by Dr. Victoria Balannik in the Pinto Lab.

Figure 3.7. Effect of mutations of pore-lining residues. (A) The density of water oxygens as a
function of the location in the channel pore (z) for the wild type (WT) and 2 mutants (G34A and
G34V) taken from classical molecular dynamics simulations of the 2ε state is reported in black,
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red, and blue respectively. The shape of the channel pore is depicted in light-blue shading along
with the sidechains of pore-lining residues (color coded as in Fig. 3.4). The density in the region
adjacent to residue 34 decreases with the increased size of the sidechain and drops to zero for
the G34V mutant. (B) Specific activity measurements for M2 wild type, G34A and G34V. The
amplitude of the channel activity (I) was plotted as a function of the immunosignal intensity for
each tested oocyte and a straight line was fitted to the data. The slope of each plot represents the
relative specific activity for the protein: 6.6±1.5 for M2; 2.7 ±0.4 for M2-G34A. M2-G34V showed
membrane expression comparable to the wild type, but no detectable channel activity. (C)
Comparison of channel activity and proton selectivity between full-length M2, and the G34A and
G34V mutants. The channel activity was evoked by rapid exchange of non-activating solution (pH
8.5) with activating solution (pH 5.5). The reversal voltages were measured in Na+, K+ and
NMDG+ - based activating solutions showing no significant differences in the ion selectivity and
channel properties between the M2 wild type and the G34A mutant. G34V mutant (marked with *)
did not show any pH induced channel activity. Each bar is the mean (± SD) of 5 independent
experiments.
With respect to WT M2, the introduction of Val at position 34 in computer models sharpened the
distribution of waters attached to His37, and more importantly introduced a 5 Å gap in the water
profile surrounding residue 34 (Fig. 3.7 A). G34A showed intermediate behavior between WT and
G34V in simulations, retaining significant water density through this region of the channel. Thus,
G34V would be predicted to be unable to conduct protons; G34A might have a lower
conductance if the restriction of the channel diameter causes the rate of diffusion of protons to the
MPSC to become slower than the rate of dissociation of protons from this cluster.

The proton conductivity, ion selectivity and surface expression of these mutant channels was
assayed and compared to that of the wild type protein. The specific activity, determined from the
slope of the proton current vs. the amount of protein expressed on the surface, was
approximately 2.5 fold lower for the M2-G34A mutant channel than for the wild type (Fig. 3.7 B).
Although expressed normally, the M2-G34V mutant protein did not show any detectable channel
activity (Fig. 3.7 B). The ion selectivity was assayed by measuring the reversal voltage (Vrev) in
recording solutions containing different cations (Na+, NMDG+, or K+). The reversal voltage of
M2-G34A mutant was comparable to that of the wild type protein indicating that the mutant
channel retains very high proton selectivity (Fig. 3.7 C). We therefore conclude that the G34V
mutation blocks the channel by occluding the conduction pathway, and postulate that the diffusion
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through the Gly34/Ala34 region to the MPSC is permitted, but becomes partially rate-limiting in
the G34A mutant.

These results impart experimental support for the computational techniques used by the Klein lab
to model the water structure of M2TM’, and also provide evidence that the G34A mutation in M2
(as present in the best medium- and low-pH structural models thereof currently available)
(Stouffer, Acharya et al. 2008) has only a minor effect on transport rate and does not affect the
protein’s ion selectivity. This, along with the similarity in crystal parameters from a WT M2TM’
peptide, reinforces the notion that the Ala at position 34 imparts only a local structural change,
and can be mutated to Gly in silico for mechanistic studies or inhibitor docking trials.

3.13. Why was amantadine not observed in the pore of the M2TM’ structure?
A brief digression is warranted to comment on the absence of amantadine in the newly solved
M2TM’ structures.

For M2TM’ G34A, crystal growth in the absence and in the presence of

amantadine was similar, and high-quality diffraction data was obtained for crystals grown in the
presence of the drug. For M2TM’ G34, highest-quality crystals were obtained in drops without
amantadine; experiments with amantadine led to crystals that were too small to manipulate and
mount.

Electron density maps for M2TM’ G34A crystals grown in the absence and presence of
amantadine were essentially identical, with no evidence of the drug. Two possibilities underlying
this observation need to be examined. The first is that G34A mutants bind amantadine poorly
because of additional steric crowding imposed by Ala 34 methyl sidechains in the pore. This
notion is weakened somewhat by the observation of electron density corresponding to
amantadine in a lower-resolution, low pH crystal structure of a G34A variant of M2TM (Stouffer,
Acharya et al. 2008), although it is possible that the more closely-packed conformation adopted
by M2TM’ G34A destabilizes amantadine at more neutral pH values.
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A second reason is evidenced by the lack of high quality M2TM’ G34 crystals grown in the
presence of amantadine. There is ample evidence that amantadine binding stabilizes the M2 TM
tetramer (Salom, Hill et al. 2000), which would presumably facilitate crystallization. However, all
M2TM’ crystals were grown in precipitant solution that contained 2-propanol (crystals were also
obtained from similar well solutions that instead contained ethanol, suggesting that an alkyl
alcohol contributed to crystal formation). Examination of the M2TM’ pore near Ala 30 and Ser 31
(Figure 3.4 A) shows a poorly ordered density that may be consistent with rotationally averaged
2-propanol.

This suggests that 2-propanol (or similar alcohols) bind to the aqueous pore,

occluding the amantadine site. Such an interaction would be consistent with the observations of
Schroeder et al. that fairly short alkylamines inhibit transport through M2 in liposomes (Lin, Heider
et al. 1997). While the binding affinity of M2 for 2-propanol would certainly be much lower than
that for amantadine, the enormous excess of 2-propanol in the crystallization experiment may
have precluded the stable binding of the drug in the protein’s pore; therefore, it appears that the
most likely reason for amantadine’s absence from the crystal is an unfortunate quirk of the
crystallization experiment.

Further work to co-crystallize amantadine with M2TM’ may well start from the neutral pH citrate
conditions that have been successful here, but may avoid short-chain alkyl alcohols and instead
use longer polyethyleneglycols that would be less likely to bind inside the pore.

3.14. Conclusions: lessons learned from a high-resolution structure of the M2 transmembrane
domain.
The new, high-resolution view of the M2 transmembrane domain and the aqueous proton
transport pathway contained therein that was unveiled from M2TM’ crystals represents a major
advance in our understanding of not only the protein and its biological mechanism, but also of the
elegantly simple methods employed by Nature to achieve charge stabilization within membranes
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and membrane proteins. From the mechanistic perspective, we have garnered greater evidence
that changes in helix tilt as a function of pH and the pore’s alternating accessibility to internal and
external water molecules play a role in a transporter-like mechanism of proton conduction by M2.
Focusing in on specific portions of the protein, we see evidence for rotameric switching of the Trp
41 side chain between the high pH and intermediate pH conformations, which perhaps prime or
activate the protein for conduction at lower pH values. Interhelical Asp 44 – Arg 45 salt bridges
stabilize M2 bundle conformations where the C-terminal helix ends are close together and must
be broken to transition to a conformation favored at low pH where these helix ends move apart.
Most importantly, a symmetric network of highly ordered water molecules interacts with incoming
protons and His 37 residues to provide a structural explanation for the highly perturbed His 37
pKa values measured by solid state NMR (Hu, Fu et al. 2006), and points to a transport pathway
where the protons transition through water molecules that bridge clusters of pore-lining residues.
The unusual degree of charge stabilization afforded by the N-terminal water cluster sheds light on
a nanoelectric charge storage device previously unseen in Nature.

Computational studies of

how the pore water molecules respond to changing His 37 protonation states point to a highly
tuned but structurally simple system that regulates and imparts directionality on proton transport,
and suggest an important role for the Val 27 secondary gate (Yi, Cross et al. 2008). With these
new insights in hand, we can now put forth a comprehensive mechanistic hypothesis that links
changes in protein and pore water structures with proton binding and release in the M2 transport
cycle.
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Chapter 4: Evidence for pH-driven structural transitions of M2
transmembrane and C-terminal helices in bilayers
4.1. Proposed mechanism requires dynamic evidence of pH-driven structural changes in bilayers
that are consistent with structural snapshots in micelles.
The currently available high-resolution structures of M2, as discussed in Chapters 1 and 3,
suggest that the transmembrane domain of the protein undergoes pH-driven conformational
changes of its helical backbone structure and also of key residues lining its aqueous pore, such
as His 37 and Trp 41. The former notion is consistent with early cross-linking experiments on fulllength A/M2 performed at two pH points (Bauer, Pinto et al. 1999). There, the pattern of cross-link
formation favored the N-terminal portion of the bundle when the experiment was performed at low
pH, suggesting that the C-terminal ends of the TM helices separate in this regime, as seen in the
pH ~ 5 crystal structure (Stouffer, Acharya et al. 2008).

However, there has been more limited evidence obtained from non-static experiments in bilayers
that suggests that the core amino acids of the aqueous pore – namely, His 37 and Trp 41 –
populate discrete, pH-dependent conformational states. The high-resolution structures available
thus far represent either conformational snapshots that may or may not be favored at equilibrium
(crystallography) or averaged conformations but only from a very narrow pH range (solution
NMR); therefore, it is important to experimentally demonstrate that the protein can significantly
populate and switch between the proposed conformations at equilibrium.

That the evidence

come from protein reconstituted in bilayers is important since it has been previously
demonstrated that the M2 TM bundle can have substantially different conformational stability in
micelle and bilayer systems (Stouffer, Ma et al. 2008).

114

Previous spectroscopic experiments in bilayers to this end have either been interpreted to
indicate a two-state pH-dependent structural transition, or monitored the protonation of His 37
directly or indirectly with a limited ability to describe the immediate environment of that sidechain
(Okada, Miura et al. 2001; Czabotar, Martin et al. 2004).

An experiment to measure the effect of pH on specific sidechains or domains of the protein
necessitates that the pH-driven structural transitions be rapid on the timescale of the experiment.
Fortunately, strong evidence to this end was obtained experimentally by Schnell and Chou, who
monitored the NMR dynamics of Trp 41 in micelles at high pH and observed conformational
transitions on the millisecond timescale (Schnell and Chou 2008).

In addition, molecular

dynamics simulations by Klein on the M2 TM bundle in bilayers showed that certain pH-driven
conformational changes occurred on the nanosecond timescale, indicating that changing the
protonation state of His 37 drives a very rapid structural transition to equilibrium (Khurana, Dal
Peraro et al. 2009).

We therefore set out to observe whether the environment around Trp 41 (probed by its
accessibility to polar small molecule quenchers in fluorescence Stern-Volmer quenching
experiments (Lakowicz 2006)) when M2 is reconstituted in bilayers undergoes distinct pHdependent state changes as the structural snapshots obtained in micelles would indicate. We
also used spectroscopic methods to study the C-terminal amphiphilic helix of M2, where we found
further evidence of pH-driven conformational changes transmitted from the TM domain.

4.2. pH-dependent Stern-Volmer quenching of full length A/M2 in bilayers: materials, methods
and experimental considerations.
Data Collection: For Trp 41 fluorescence quenching experiments, we used the single-Trp, Cysfree full length A/M2 construct, obtained from E. coli cultures as described in Chapter 2. The WT
A/Udorn/72 sequence has two Trp residues (at positions 15 and 41), which would have
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complicated spectral analysis; the single-Trp variant retaining the sidechain at position 41 and
having a Trp15Phe mutation enabled unambiguous interpretation of the results without
compromising protein function (see Chapter 2); in addition, this construct provided the high
culture yields of protein necessary for these experiments.

To enable detection of Trp 41 fluorescence, a target protein monomer:lipid ratio of 1:100 was
used.

Lipid films (25 µmol 4:1:2 POPC:POPG:cholesterol, made from chloroform stocks as

described in Chapter 2) were thoroughly hydrated with ~ 400 µL of MilliQ water and 100 µL of 10x
buffer (at 10x, 500 mM potassium phosphate, 100 mM NaCl, pH-adjusted to 7.0 with HCl). The
actual volume of water added was adjusted so that following the subsequent addition of protein,
the total volume of the sample would be 1 mL. The sample was vigorously vortexed, and the
hydrated, protein-free lipid suspensions were subjected to five freeze-thaw cycles (dry ice-ethanol
bath and 37°C water bath).

Full length A/M2 (non-HPLC purified eluate from nickel column in 50 mM HEPES pH 8 buffer, 4
mM OG, 20% v/v glycerol) was next added dropwise to the experimental sample. The stock
concentration of protein was ~500 µM. For the control liposome sample, an equal volume of
protein-free HEPES/OG/glycerol buffer was added. The mixtures were freeze-thawed an
additional five times and sized to 100 nm liposome target diameter by 33+ passes through a miniextruder (Avestin, Ottawa, Canada). To remove residual octylglucoside from the samples, the
mixtures were dialyzed for 1-2 cycles in 1L of 1x buffer (50 mM potassium phosphate pH 7.0, 10
mM NaCl) in the presence of the detergent-binding resin Amberlite XAD-4 (Supelco, Bellefonte,
PA).

For experiments, 20 µL of liposome suspension was added to 2 mL of buffer set at the desired
pH in a 1cm x 1cm Hellma QS fluorescence cell. 10 µL of a 4 µM ethanolic stock of the proton
uncoupler FCCP (Fluka/Sigma-Aldrich, St. Louis, MO) was added to dissipate the pH gradient.
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The mixture was stirred for five minutes prior to the experiment.

A reference cuvette similarly

configured but with control liposomes added at pH ~7 was used for on-line background signal
subtraction from scatter induced by the vesicles.

Experiments were performed while stirring in an Aviv ATF-105 spectrofluorometer at 25°C by
measuring a baseline Trp fluorescence value at the end of the five minute equilibration period,
-

then adding 50 µL aliquots of a 5 M NaI solution (with 1 mM Na2S2O3 added to prevent I

photooxidation) and taking measurements following the addition of every aliquot. An automated
titrator (Hamilton, Reno, NV) was used to allow for high precision of titrant addition and for careful
control of the timing of titrant addition, equilibration time, and scan time. No titrant was added to
the control cuvette, and the subtracted background signal was not corrected for the small dilution
effect (~10% maximum) that addition of titrant would have caused. To account for any deviation
from the pre-set buffer pH as a result of adding other sample components, pH of the cuvette
contents was measured at the conclusion of each titration and that value was used as the
experimental pH.

To avoid exciting Tyr residues in the protein, fluorescence excitation was performed at 295 nm
rather than the standard Trp wavelength of 280 nm. At 295 nm, the spectrum of Trp shows
substantial absorption while the absorption of Tyr is near zero.

Fluorescence emission was

measured at 340 nm, near the average emission maximum of indole in both hydrophobic and
polar environments.

The measurement of intrinsic Trp fluorescence in bilayers can be complicated by substantial
scatter artifacts from the liposome sample, as analyzed in detail by White et al. (Ladokhin,
Jayasinghe et al. 2000). In initial experiments with this system, very intense periodic scatter
peaks were visible in the emission spectrum (perhaps complicated by an uncommonly high lamp
power on the Aviv instrument), making spectral interpretation difficult and leading to physically
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unreasonable calculated quenching constants. The problem was resolved by installing polarizers
in a cross-polarized configuration (excitation polarizer horizontal, emission polarizer vertical) and
adding an emission filter that blocked light at wavelengths below 300 nm from reaching the
detector. The excitation bandwidth was kept low (2-3 nm) and the emission bandwidth was
allowed to be higher (6-7 nm). Experiments using this configuration with model Trp-like small
molecule compounds quenched by acrylamide and iodide quenching yielded quenching constant
values consistent with those available in the literature (Dvorin, Mantulin et al. 1985; Stoeva,
Dolashka et al. 1995; Alston 2004), and the scatter peaks were substantially diminished.
Experiments on the M2 proteoliposomes were performed with the fluorometer in this configuration
and led to physically reasonable Stern-Volmer quenching constants similar in scale to those
observed in unpublished experiments from the Pinto lab.

A final complicating factor in this experiment was the observation that the steady-state Trp
fluorescence of M2 in liposomes was somewhat unstable (and declining) as a function of time,
especially at certain pH values. A variety of factors were adjusted in an attempt to account for
this phenomenon, including the length and frequency of sample irradiation (to rule out
photooxidation), length of temperature equilibration, as well as the presence and absence of
various ionophores such as FCCP and valinomycin. None of these appeared to be causally
involved. It is also possible that under certain conditions, the liposomes are more likely to more
strongly adhere to the cuvette walls, reducing the signal intensity, but this variable was not
explored. Instead, the experiment was performed under very stringent and consistent timing, and
a constant “noise” parameter obtained from the data set was introduced in the data analysis, as
will be described in the next section.

Data Analysis: Fluorophores such as the indole group of tryptophan, when in their excited
electronic state (which normally leads to fluorescence), can instead non-radiatively transition back
to their ground state through a close encounter (collision or static binding) of a quencher. There

118

is a multitude of known quenchers of indole of varying potency, including molecular oxygen,
protonated imidazole (as observed by Hay et al., for the M2 system (Czabotar, Martin et al.
2004)), acrylamide, cationic cesium, and anionic iodide (Lakowicz 2006). The latter was chosen
for this study because of its charged nature and thus lower accessibility to hydrophobic
environments.

The relative potency of the quencher or, conversely, the relative accessibility of the fluorophore
being quenched, can be determined through Stern-Volmer analysis, where the fluorescence
lifetimes of the fluorophore in the absence of quencher (τ0) and in the presence (τ) of a certain
concentration of quencher [Q] are used to calculate a quenching constant kQ:

"0
= 1+ kQ [Q]
"Q
Assuming that the quenching is purely collisional or dynamic (i.e. that no stable, long-lived
complexes form between the!quencher and the fluorophore), the fluorescence lifetime can be
linearly correlated to the fluorescence intensity (F): τ α F, leading to the following relationship:

F0
= 1+ kQ [Q]
FQ
To account for the uncertainty in the measurement of F0 (as described in the previous section),
the following equation was fitted
! to the pH-dependent quenching data sets, now incorporating a
linear error correction:

FQ =

F0
" k E [Q]
1+ kQ [Q]

This equation represents a rearranged Stern-Volmer equation, with an added quencherdependent error constant!kE.. In this equation, the k E[Q] term represents the time-dependent
variation in baseline fluorescence, where time is represented by the quencher concentration,
which, in the experimental titration, increases by the same amount at evenly spaced timepoints.
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These data were analyzed and the error parameter obtained from the fit was plotted against the
initial fluorescence F0, as shown in Figure 4.1.

Figure 4.1. Fitted error parameter kE from Stern-Volmer experiments plotted vs. initial fluorescent
signal F0. A linear regression function is fitted to the data.

Based on these data, the initial (and experimentally most variable and difficult to measure)
fluorescence value F0 was excluded from further analysis, by finding the predicted value of the
error parameter kE where F0=1 (which based on figure 4.1 is -0.491) and fitting the following
equation to each experiment, where F0 is set to 1, and kE is fixed at kE(F0=1):

FQ =

1
+ 0.491[Q]
1+ kQ [Q]

The resulting data are shown in Figure 4.2. A protonation equilibrium function, defined by the
following two equations,!was fit to the data (solid line). The protein was assumed to be fully
tetrameric under every condition studied.
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kQ,obs =

k q 0 M 0 + k q 2 M 2 + k q 3 M 3 + kq 4 M 4
M0 + M2 + M3 + M4

In the above equation, kq0, kq2, kq3 and kq4. represent the quenching constant of the fully
deprotonated, doubly
protonated, etc. species of the protein. M0, M2, M3 and M4 represent the
!
relative population of each species. When the pKa values governing the protonation events are
considered, the equation is expanded as shown below.

kq 0 +
kQ,obs =

k q 2 [H + ]2

kq 3 [H + ]3

k q 4 [H + ]4

+
+
2
2
2
K a12
K a12 K a 23 K a12 K a 23K a 34
[H + ]2
[H + ]3
[H + ]4
1+
+
+
2
2
2
K a12
K a12 K a 23 K a12 K a 23K a 34

In this function,
it is assumed that every protonation state of the tetramer has a preferred
!
equilibrium structure and therefore a unique kQ determined by that conformation’s Trp 41
sidechain accessibility to water. Therefore, the observed kQ is deconvoluted into components
made up by kQ0, kQ2, kQ3, and kQ4 (assuming that the first two protons bind with the same pKa as
shown by Cross et al. (Hu, Fu et al. 2006)); the contribution of each component depends on the
relative population of that structural state at the pH of the experiment, which the function
computes. The denominator is used as to normalize the value for the total amount of protein
present.

4.3. Stern-Volmer quenching: evidence for pH-driven conformational transitions involving Trp 41
in bilayers.
The Stern-Volmer quenching data in the physiologically relevant pH range of 8-5, collected from
full length M2 reconstituted in bilayers, is shown in Figure 4.2. As discussed in the previous
section, the kQ,obs shown on the y-axis of the plot represents the population-averaged accessibility
of the Trp 41 sidechain to the ionic iodide quencher. A higher kQ indicates greater accessibility.

121

Figure 4.2. pH-dependent Stern-Volmer quenching of Trp 41 by iodide. The fitted black line
represents a protonation equilibrium function with pKa values constrained to those observed by
Cross et al. (Hu, Fu et al. 2006)
The curve fit line shown in Figure 4.2 (solid line) was used to deconvolute the populationaveraged kQ,obs from the experiment into a sum of population-weighted component kQ values
representing each protonation state of the tetramer (where kQ0 is the quenching constant for the
fully deprotonated state of the protein, kQ2 for the 2+ state, etc). The hypothesis being explored
was that different protonation states of the protein correspond to different equilibrium
conformational ensembles that are reflected in the quenching accessibility of Trp 41 (kQ0, kQ2,
etc.), and that the protein is able to transition between these conformational ensembles at
equilibrium in a bilayer environment.

122

To this end, the pKa values observed by Cross et al. (Hu, Fu et al. 2006) are used as constraints
governing the protonation events in the curve fit (n.b. Cross et al. were unable to precisely
determine the lowest pKa value of the tetramer, but it was suggested to be <5; a pKa of 5 was
used in the curve fit, but a similar pattern of results could be obtained using slightly lower values
for the 4

th

pKa).

A good curve fit was obtained using these constraints, suggesting that

protonation events and conformational changes around Trp 41 may be linked. The Stern-Volmer
quenching experiments were performed over the physiological pH range that a virus may
encounter in an infection cycle, therefore few data points were collected at pH ranges where the
fully deprotonated state is significantly populated (given that the pKa of first two protonations is
8.2 (Hu, Fu et al. 2006)). However, the kQ values for the physiologically relevant 2+, 3+ and 4+
states were very well defined and substantially different from each other. A summary of the
computed parameters from the fit is shown in Table 4.3. As will be discussed below, these
results show that changing the protonation state of M2 His 37 residues in bilayers over the
physiological pH range does indeed result in discrete structural transitions of the environment
near Trp 41, consistent with the mechanistic hypothesis being developed in this thesis.

kQ0
kQ2
kQ3
kQ4

3.4 ± 2.2
2.7 ± 0.1
5.1 ± 0.2
1.2 ± 0.4

Table 4.3. Computed conformation-specific Stern-Volmer quenching constants.

The data in Figure 4.2 indicate that the accessibility of the Trp 41 sidechain to aqueous quencher
changes dramatically as a function of pH between pH 5 and 8. The overall Trp accessibility
(represented by the observed kQ) is relatively lower at high pH values, then rises as pH
decreases, peaking at approximately pH 6, before declining again at lower pH values. Further
insights can be gleaned by a comparison of the protonation-state specific quenching constants
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calculated from the curve fit (Table 4.3) with the high-resolution structures of M2 TM determined
at similar pH values.

We did not perform Stern-Volmer experiments under the rather basic conditions where the fully
deprotonated, 0+ state, would predominate, since this pH range would not be encountered by a
virus in vivo. There is thus relatively greater uncertainty for the value of kQ0 calculated in the
fitting (dotted lines in the plot show the fitting function with kQ0 fixed at the high and low ends of its
fitting confidence limit in Table 4.3). Comparing the pH 8 solution NMR structure (Schnell and
Chou 2008) (which would likely correspond to the 0+ state) and the pH 6.5 high resolution crystal
structure (Chapter 3, corresponding to the 2+ state), we note that the rotameric conformation of
Trp 41 is different in these structures in the context of an otherwise well-packed C-terminal aspect
of the bundle. This structural difference likely underlies whatever accessibility differences are
present between these two states, but we are unable to analyze these physiologically less
important changes further because of noise in kQ0. We therefore focus our discussion on the
physiologically encountered transitions between the 2+, 3+ and 4+ states, where the bulk of our
data were collected.

In the high resolution structure (Chapter 3) that we assign to the 2+ state, the Trp sidechains are
exposed to solvent largely through the central pore, and are otherwise located in a tightly packed
area of the helical bundle that restricts solvent access from other directions. It would be unlikely
that a large ion could access the Trp 41 sidechains from the N-terminal side of the aqueous pore,
(Figure 3.4) as it would need to penetrate the constrictions created by the Val 27 and His 37
sidechains. Thus, the predominant means of access is likely from the C-terminal side of the
protein’s aqueous pore. The detailed view of the proton transport pathway in the structure of the
2+ state indicates that the C-terminal face of the Trp basket interacts with four ordered water
molecules in the exit cluster, that are further stabilized by interactions with Arg 45 sidechains that
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line the pore exit. This ordered structural unit may act to restrict access to the sidechain by
quencher, consistent with the relatively low kQ calculated for the 2+ state.

There is less structural certainty with regard to the conformation that is favored in the 3+ and 4+
protonation states of the protein, for which the kQ increases substantially then decreases
dramatically, respectively. The “A” helix structural model from the published pH ~ 7 crystal
structure (Stouffer, Acharya et al. 2008) was proposed to represent a conformation favored at low
pH based on its structural similarity with a lower resolution structure determined from crystals
grown at a starting pH near 5. However, in light of the previously discussed uncertainty with
respect to the actual pH of crystallization for both crystals, it is unclear whether these structures
represent a conformation favored in the 3+ or the 4+ state.

In comparison to the doubly

protonated state represented by the high-resolution structure, the helices making up the
transmembrane domain straighten out, with their C-terminal ends undergoing a dramatic
separation. The overall shape of the transmembrane helical bundle changes from a cylinder in
the 2+ state to a cone at lower pH, and the water accessibility of the C-terminal aqueous pore
where the Trp 41 sidechains reside is dramatically increased. Thus, it is likely that these
structures represent the 3+ state with its correspondingly high calculated Stern-Volmer constant
(Table 4.3); this argument would also suggest that at least in the lower pH structure (Stouffer,
Acharya et al. 2008), the actual pH of crystal formation was close to that set at the beginning of
the experiment. This hypothesis is also consistent with earlier cross-linking results showing
greatly decreased TM helix cross-linking on the C-terminal end at pH 5.2 (where the protein
would be predominantly in the 3+ state) than at neutral pH (Bauer, Pinto et al. 1999).

While a relatively high degree of Trp 41 solvent accessibility is calculated for the 3+ state, this
th

value drops off dramatically with binding of the 4 proton (Table 4.3). The pH-chord conductance
curve of M2 saturates around a pHout of 4 (Chizhmakov, Geraghty et al. 1996), suggesting that
the 4+ state is likely active in conduction. We can only speculate as to its structural identity, but
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some clues may be provided by the structure of the 3+ state, where the Trp 41 sidechain turns
away from facing the center of the pore to pointing into the (now very large) interhelical space.
Perhaps a continuation of this trajectory leads to more complete burrowing of the Trp indole into
the membrane, and/or its occlusion from solvent by neighboring pore-lining residues His 37, Asp
44, and Arg 45, both of which would explain a state with dramatically reduced quencher
accessibility.

In summary, the bilayer Stern-Volmer quenching results presented here are in good agreement
with the structural snapshots of M2 obtained thus far in micelles, and describe a series of shifting
conformational equilibria of the protein that are driven by His 37 protonation at pKa values that
were previously determined by spectroscopy (Hu, Fu et al. 2006). To reinforce this view, we can
visualize the pH-induced changes in the conformational ensembles of M2 as an energy
landscape that shifts with pH, weighting the ensemble toward one predominant conformation or
another (Figure 4.4).
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Figure 4.4. An energy landscape perspective of the pH-driven changes in the structural
ensemble of M2 conformational states. The Out Open form (OO, solution NMR, (Schnell and
Chou 2008)) predominates at high pH, the Intermediate form (Int, high-resolution structure from
Chapter 3) at pH just below neutral, and the Open In form (OI , lower-resolution crystal structre,
(Stouffer, Acharya et al. 2008)) at low pH.

4.4 The C-terminal amphiphilic helix undergoes pH-driven structural transitions coupled to
transitions of transmembrane domain.
In Chapter 2, we demonstrated that the C-terminal amphiphilic helix is not required for the
transmembrane domain to achieve functionally equivalent proton transport to the full length
protein. Removal of this helix did not significantly affect rate of proton transport, amantadine
inhibition, pH activation of transport, and ion selectivity. Furthermore, the His 37 pKa values were
similar between the TM peptide alone and the full length protein.

There is evidence, however, that this helix may play a structural role in stabilizing the protein
tetramer and anchoring it in the membrane (via e.g. a palmitoylation site at Cys 50 (Sugrue,
Belshe et al. 1990)).

Sedimentation measurements show that the full-length protein is

substantially more stable than the TM helix alone, (Kochendoerfer, Salom et al. 1999) and the Cterminal helix is the only other known portion of M2 with a well ordered structure. In this section,
we show that the C-terminal helix interacts with the phospholipid bilayer via its hydrophobic
sidechains and changes conformation in response to changes in pH transmitted by the TM
domain helices.

The structural changes of the C-terminal helix in bilayers were studied by electron paramagnetic
resonance spectroscopy in the context of spin labeled 38-residue peptides (M2TMC) consisting of
residues 23-60, and thus encompassing the transmembrane domain and the C-terminal helix of
the protein. Peptides were chemically synthesized as C-terminal carboxamides using standard
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solid-state methods by the author and other members of the DeGrado lab, Dr. Gregory Caputo
and Dr. Chad Tatko.

A wild-type, cysteine-free sequence was used for dilute spin labeling

experiments, where a small amount of spin-labeled peptide is added to a predominantly nonlabeled population. Peptides for labeling were made as site-specific Cys mutants.

Peptides were purified, spin-labeled with MTSSL (1-oxyl-2,2,5,5-tetramethyl-3-pyrroline-3-methyl
methanethiosulfonate),

reconstituted

in

POPC:POPG

(4:1)

bilayers

and

observed

spectroscopically by Phong Nguyen and Dr. Kathleen Howard at Swarthmore College. More
detailed methods of this work have been previously described (Nguyen, Soto et al. 2008). The
effects of cysteine mutations (with no spin-label) at the residues of interest in the C-terminal helix
were also studied by Dr. Chunlong Ma in the Pinto laboratory, who measured the activity and the
reversal potential of full-length Cys-free A/M2 and site-specific Cys mutants in Xenopus oocytes
using techniques described in Chapter 2. The electrophysiology results are shown in Figure 4.5.

Figure 4.5. Activity and reversal potential (ion selectivity) of M2 C-terminal amphiphilic helix Cys
mutants expressed in Xenopus oocytes. All mutants except K49C showed similar activity to WT;
K49C was almost completely inactive and its reversal potential could not be precisely determined.
However, K49A (not shown) had WT-like properties, suggesting that the loss of activity is specific
to certain amino acid sidechains. Figure published in (Nguyen, Soto et al. 2008).

The electrophysiology data shown in Figure 4.5 are largely consistent with results presented in
Chapter 2, where it was shown that the C-terminal helix was not required for M2 TM activity. All
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mutants except one exhibit largely unchanged transport activity and ion selectivity (reversal
potential).

The exception, at Lys49Cys, results in an almost total loss of channel activity,

although similar experiments on a Lys49Ala mutant (Pinto lab, unpublished) find that its functions
similarly to WT protein. Therefore, introduction of a Cys residue at position 49 (which is normally
a charged Lys) seems to affect M2 structure and function in a highly specific way. Based on EPR
results that will be discussed next, we hypothesize that this mutation may lead to some form of a
structural collapse of the aqueous pore at the C-terminal mouth of the channel.

Figure 4.6. Electron paramagnetic resonance spectroscopy of site-directed spin-labeled M2TMC.
Panel A and B show EPR spectra of each mutant determined at pH 7.8 (panel A) and pH 5.6
(panel B). Dark lines indicate signal from a fully-labeled sample, whereas lighter lines represent a
dilute labeled sample where a small amount of labeled peptide is added to a wild-type, unlabeled
peptide sample. Panel C, label accessibility to lipid and Panel D, label accessibility to water as a
function of pH and labeled site, as measured by interaction with paramagnetic molecular probes.
A sine function is fit to each data set. Panel E, measured spin-spin interaction between peptide
monomers in fully labeled samples. Figure published in (Nguyen, Soto et al. 2008).
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The results of the pH-dependent EPR spectroscopy of spin-labeled M2TMC variants are shown in
Figure 4.6. The EPR spectra of fully labeled or dilute labeled samples are shown in panels A (pH
7.8) and B (pH 5.6). The accessibilities of the label to lipid and water were measured by the
label’s interaction with a lipid-soluble and a water-soluble paramagnetic molecular probe
(molecular oxygen, and nickel (II) ethylenediaminediacetate (NiEDDA), respectively).

Sine

functions (to represent an alpha helical periodicity) were fit to the pH-and residue specific
accessibility profiles in Panels C and D.

The results show that one face of the helix, which is

predominantly lined with hydrophobic sidechains, interacts with the phospholipid bilayer (as
shown by a higher lipid accessibility and a lower water accessibility), whereas the other face,
lined with more polar groups, interacts preferentially with water, with the reverse accessibility
profile.

Interestingly, the lipid-interacting surface of the helix changes somewhat as a function of pH, a
phase shift of approximately one residue or one-third to one-fourth of a helical turn. Furthermore,
at low pH the C-terminal helix penetrates somewhat deeper into the bilayer, likely pulled in that
direction by the decreased transmembrane projection of the TM helix, which is now straightened
and more tilted relative to the membrane normal, as shown in Figure 4.7.

Figure 4.7. Proposed structural mechanism for increased lipid embedding of C-terminal
amphiphilic helix of M2 at lower pH.
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In Figure 4.6 E, comparisons of EPR data from fully-labeled and dilute-labeled samples were
used to determine the extent of interaction between spin labels within the protein tetramer. With
the exception of the highly perturbed result for Cys49Lys that is difficult to interpret given the
functional implication of that mutation, there is a degree of sidechain-sidechain interaction (the
range of detection is 8-20 Å) observed for residues 51, 52, 53, and 55, corresponding to Ile, Tyr,
Arg, and Phe, respectively, falling on one face of the helix, and dropping off in intensity at more
C-terminal residues. This indicates that the helix-helix interaction is most likely hydrophobic/van
der Waals in nature and occurs predominantly at Tyr 52 and its nearest neighbors. The intersubunit interaction past residue 49 can no longer be detected at low pH, suggesting that the Cterminal helices move away from each other in more acidic environments.

In conclusion, the EPR data show that the C-terminal amphiphilic helix of M2 interacts with the
phospholipid bilayer along one face and with water along its other face, consistent with its amino
acid sequence. Inter-subunit interactions are observed at high pH corresponding primarily to the
2+ state of the TM tetramer, but are disrupted at low pH corresponding primarily to the 3+ state,
as the helix twists clockwise along its axis and embeds itself deeper into the membrane. These
conformational transitions are presumably driven by the pH-dependent conformational changes of
the M2 TM helix bundle, where the helices straighten out and take on an increased tilt relative to
the membrane normal at low pH. Structurally, the EPR results indicate a different conformation of
the C-terminal helices as compared to that observed by solution NMR in micelles (Schnell and
Chou 2008).

Whereas in the NMR study, the C-terminal helices interact only with other C-

terminal helices in a four-membered coiled coil, and have no interaction with the micelle, in the
present study the helices interact extensively with the bilayer and have more limited intersubunit
contacts. We attribute this difference to the sample conditions (bilayer vs. short-chain micelle) in
the two experiments.
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4.5. Conclusions: Trp 41 and the C-terminal amphiphilic helices of M2 undergo pH-driven
changes of their conformational equilibria in bilayers.
The evidence presented in this chapter allows the reader to put together the high-resolution
structural snapshots of the M2 transmembrane domain obtained in micelle systems into an
equilibrium ensemble that represents conformations in bilayers. The changing accessibility profile
of Trp 41 to a polar quencher as a function of pH is consistent with its position in M2 structures
obtained at high (Schnell and Chou 2008), intermediate (Chapter 3), and low pH (Stouffer,
Acharya et al. 2008), and is furthermore well described by a protonation equilibrium determined
by the known His 37 pKa values (Hu, Fu et al. 2006). The C-terminal amphiphilic helix, shown in
Chapter 1 to be dispensable from the point of view of transport function, is shown here to interact
with the inner face of the lipid bilayer, and undergoes its own conformational changes in response
to the protonation-induced structural transitions of the TM domain.
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Chapter 5: Developing and testing structure-based mechanistic
models of proton transport through influenza A/M2
5.1. Overview of exercise.
In the previous chapters, we have established that the M2 transmembrane domain is functionally
equivalent to the full length protein (Chapter 2), and that protonation of histidine 37 residues in
this domain leads to significant changes in the protein’s conformational equilibrium in the
membrane (Chapter 4 and Chapter 3). It has been previously hypothesized from molecular
dynamics simulations that the transmembrane domain of M2 may function in a transporter-like
fashion (Khurana, Dal Peraro et al. 2009), by switching between conformations that are able to
bind protons from the N-terminal side of the aqueous pore, and others that are accessible only to
the C-terminal side.

In this chapter, we develop mathematical models of ion transporters that sample multiple
conformational states, each with its own level of proton binding affinity (pKa). We find that a very
simple, two-conformation single-proton model describes most features of transport by the wildtype protein, then build up complexity so that that the model parameters accurately reflect the pKa
values and multiple protonation states observed by Cross et al. (Hu, Fu et al. 2006). From these
exercises, we find that only a model in which the first two protons bound can participate in
conduction (in addition to the third) can describe the entirety of flux data from wild-type A/M2 at
physiologically relevant pH values. This more complex model can also best account for the
rather unusual flux features observed in certain mutant variants of the protein.

5.2. Transport model construction and implementation.
Transporter models were developed to describe flux at steady-state kinetic regimes (i.e.
immediately following the imposition of a driving force for proton transport). Each model was
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constructed as a kinetic cycle of interconverting conformational and protonation states, with the
simplest arrangement shown in Figure 5.1. Each transition is defined by its own rate constant, as
shown.

Figure 5.1. Simplified proton transporter model. The “M” conformation is accessible to extraviral
waters, while the “M*” conformation is accessible to intraviral waters.
The normalized population of each state under steady state conditions was then calculated by
first setting the total rate of change of each state to zero,

d[M] d[MH] d[M*] d[M * H]
=
=
=
=0
dt
dt
dt
dt
which yields the following system of linear equations:

!
d[M]
= k"1[MH] " k1[M][H out ] + k"4 [M*] " k 4 [M]
dt
d[MH]
0=
= k1[M][H out ] " k"1[MH] + k"2 [M * H] " k 2 [MH]
dt
d[M * H]
0=
= k 3 [M*][H in ] " k"3 [M * H] + k 2 [MH] " k"2 [M * H]
dt
d[M*]
0=
= k"3 [M * H] " k 3 [M*][H in ] + k 4 [M] " k"4 [M*]
dt
0=

!
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Solving the system by hand and or with online solver applications (Gang 1997), or for more
complex models, more advanced mathematical software such as Maxima (2009) or Mathematica
(Wolfram Research 2008), provided the populations of each state of the protein under steadystate kinetic conditions; the populations were normalized to reflect an unchanging amount of total
protein.

Proton flux at a given condition was defined by subtracting the difference of extraviral proton
release and binding rates from the difference of intraviral proton release and binding rates, as
follows:

Flux = (Release,in – Binding,in) – (Release,out – Binding,out)
Or, more specifically for this system:

Flux = (k"3 [M * H]ss " k3 [M*][H + ]in ) " (k"1[MH] " k1[M][H + ]out )
where the protein terms are the normalized steady-state populations obtained from solving the
linear
! system described above.

In more complex models, flux was described similarly by

summing all possible internal deprotonation event rates as the “Release, in” term, all possible
internal protonation event rates as the “Binding, in” term, etc.

The resulting flux equation was then globally fit to M2 functional data from a variety of sources,
including the experiments of Chizhmakov et al. ((Chizhmakov, Geraghty et al. 1996; Chizhmakov,
Ogden et al. 2003), where M2 was expressed in CV-1 cells) and Balannik et al. (unpublished,
where M2 was expressed in Xenopus oocytes).

Global fitting was performed using the

Levenberg-Marquardt algorithm implemented in Igor Pro 6.0 (Wavemetrics, Lake Oswego, OR).
Igor Pro procedure files used in the fitting are provided in Appendix C. Rate constants involving a
charged species were modeled as voltage-dependent (unless otherwise indicated), using the
single-conformation electrical distance/barrier model developed by Lear as shown in Figure 5.2,
but extended to provide an additional energy minimum and barrier for a second binding site
conformational state prior to deprotonation.
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Figure 5.2. Approximating electrical distances as geometrical distances in the M2 pore. When a
-d1*V/25.7
voltage V is applied, the rate constant for outside protonation is multiplied by e
, where
1/25.7 is the Nernst equation (eF/RT) constant for protons at 25°C, with the electrical potential
expressed in millivolts. By contrast, reversing the outside protonation process would require the
proton to transit an electrical distance in the opposite direction approximated as (d2-d1); thus the
-((d2-d1)*V/25.7)
respective rate constant would be multipled by e
; the remaining rate constants are
treated similarly with the electrical distance at the protein exit being set to 1. Figure from Lear
(Lear 2003).
Wherever a complete kinetic cycle was present, the zero-voltage value of one of the rate
constants making up the cycle was calculated from the other zero-voltage rate constants in order
to maintain microscopic reversibility.

5.3. Results and discussion: building up from a first-principles transport model to account for
known M2 conformational changes and pKa values.
Since the flux activation profile of M2 ultimately depends on the titration of its His 37 residues,
even a single-proton titration curve (ignoring additional protonation states and all conformational
transitions) such as the one shown in Figure 5.3 can capture the essential features of the
protein’s pH activation; however, this approach breaks down dramatically when attempting to
capture the features of more esoteric A/M2 mutants such as Ser31Gly.

In the following

discussion, we will examine conformation-based transporter models (as described in the methods
section, 5.2) of increasing complexity, with the target of arriving at a model that fully describes the
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features of WT transport and is consistent with its known His pKa values (Hu, Fu et al. 2006), and
also better approximates transport by the unusual pore-lining residue mutant variants of M2.

koff [H + ]
Ka
Figure 5.3. Fitting (solid lines) a single protonation-deprotonation event ( Current =
) to
[H + ]
1+
Ka
the pH activation profile of WT A/M2 and S31G A/M2 . Data from Victoria Balannik, Pinto Lab.
We begin our discussion with the simplest, four-state transporter
! model described in the methods
section (see Figure 5.1), which was developed by the author together with Dr. James Lear. All
subsequent models discussed were implemented and tested by the author alone. This simplified
transporter model was created to test the general applicability of the transporter hypothesis to M2
function. As shown in Figures 5.4 and 5.5, this mechanism fits reasonably well to pH-dependent
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conductance and current-voltage voltage data obtained by Chizhmakov et al. (Chizhmakov,
Geraghty et al. 1996; Chizhmakov, Ogden et al. 2003) for M2 proteins from two commonly
studied influenza A strains, Weybridge (with properties similar to Udorn) and Rostock.
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Figure 5.4. Curve fits (lines) to Weybridge strain current-voltage data obtained from (Chizhmakov,
Ogden et al. 2003) for different pH gradients: pHin/pH out = 6/8 (circles), 7/5 (triangles), and 8/6
(squares). Inset is fit (line) and data (points) of chord conductance versus external pH from an
earlier reference (Chizhmakov, Geraghty et al. 1996). Current-voltage and current-pH data were
fit together using common (global) model parameters. The best fit outside (conformation “M”) and
inside (conformation “M*”) pKa’s were 7.9 and 5.1 respectively; the rates of structural
interconversion were assumed to be rapid and not rate-limiting. Site electrical distances d1, d2,
d3, d4 and d5 were 0.24, 0.24, 0.5 (fixed), 0.23 and 0.49 respectively.
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Figure 5.5. Curve fits (lines) to Rostock strain M2 current-voltage data obtained
from (Chizhmakov, Ogden et al. 2003) for different pH gradients: pHin/pHout =
6/8 (circles), 7/5 (triangles), and 8/6 (squares). Inset is fit (line) and data (points)
of 0 mV current normalized to pHout=3 versus external pH. IV and current-pH
data were fit together using common (global) model parameters. As with Figure
4.4, the “M” and “M*” pKa’s were fixed at 7.9 and 5.1 respectively. The site
electrical distances could not be stably fit, but setting them to 0.5, 0.5, and 0.5,
and 0.9 allowed a reasonable fit. Alternatively, an equally good fit could be gotten
with “M” and “M*” pKa's of 8.9 and 5.4 respectively and different “on” rate
constants for protonation.
From Figures 5.4 and 5.5, we conclude that even a simplified two-conformation, one-proton
transporter model can be globally fit to electrophysiological data from WT A/M2 strains with
reasonable output parameters. Of particular interest are the fitted pKa values “M” and “M*” for the
“open-out” and “open-in” conformation respectively. The “M” pKa is high at ~8-9 depending on
the strain and fit, indicating that the out-open state binds protons very stably. This is generally
consistent with the high pKa values observed for the first two protons bound by Cross et al. (Hu,
Fu et al. 2006), and with the high pKa conformation being a combination of the open-out
structures observed at pH 8 (solution NMR (Schnell and Chou 2008)) and pH 6.5 (high-resolution
X-ray, Chapter 3), the latter with its proton-stabilizing water clusters. By contrast, the “M*” pKa is
much lower at ~5, indicating that once the “open-in” conformation (represented by the low pH
crystal structure (Stouffer, Acharya et al. 2008)) is assumed, the proton is readily released to the
viral interior.

Interestingly, these pKa values also imply that the stable and rapid binding of

protons by the “open-out” form is enough to facilitate what appears structurally to be a highbarrier conformational transition to the “open-in” form, where Arg 44-Asp 45 salt bridges have
been broken. At the minimum, this transition takes place at a fast enough rate so as not to
interfere with conduction. Note also that while the current-pH curve (Figures 5.4 and 5.5, insets)
is not fit above pH 7.5, the curve fit line tends to slightly underestimate the flux at the high pH
limit. This feature of the model will become more apparent in its next iteration, where higher pHout
values are explored.
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We now extend the simple transporter model to one that better reflects our understanding of the
multiple conformational states and proton binding events that M2 undergoes. Chizhmakov et al.
(Chizhmakov, Geraghty et al. 1996) postulated that M2 is activated with the first proton it binds,
and the second (or, according to the measurements of Cross et al. (Hu, Fu et al. 2006), third)
protonation event is required for conduction. This hypothesis is supported by the observation that
outward (reverse) proton transport through M2 is much slower at pHin 6, pHout 8 then at pHin 6,
pHout 6.5, in both cases with an outward-driving electrical potential (Chizhmakov, Ogden et al.
2003). Therefore, according to the hypothesis, the accelerating effects of the outward proton
gradient are negated since more of the protein is trapped in an inactive conformation at higher
pHout. We thus constructed a more complex transporter model (Figure 5.6) where the first
protonation step (a double protonation according to Cross et al. (Hu, Fu et al. 2006)) activates or
primes the protein to enter the transport cycle. We hypothesized that the inactive, “A” state is
represented by the solution NMR structure at pH 8 (Schnell and Chou 2008), whereas the “B” and
“C” states are represented by the high-resolution pH 6.5 (Chapter 3) and lower-resolution pH ~5
crystal structures (Stouffer, Acharya et al. 2008), respectively.

Importantly, the activating protons in this variant of the model can only be bound from or released
to the outside, extraviral compartment, and therefore are nonconducting in the analysis. For the
remaining “open-out” and “open-in” states, we allowed a secondary pathway for protonation and
deprotonation from the non-favored compartment to be fully consistent with the water accessibility
profiles of the crystal structures (see e.g. Chapter 3), although in our fits the contribution of these
pathways was kept very minor and was essentially negligible unless otherwise indicated.
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Figure 5.6. Transporter model with added activation step (A - BH 2). H

+

o

designates outside

+

protons, H i designates inside protons. The M2 TM structures proposed to describe the A, B, and
C conformational states are shown together with the mechanistic hypothesis in the inset on the
lower left. The rate constants of minor pathways defined by k5, k-5, k7, and k-7 were kept to at
most one-tenth the value of those corresponding to the major pathways defined by k3, k-3, k9, and
k-9 when fitting WT flux data.

The global fitting results of the expanded transporter model to wild type protein flux data are
shown in Figure 5.7.
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Figure 5.7. Combined global fit of activating transporter model to Udorn and Weybridge
electrophysiological data. Main panel, pH-dependent inward fluxes of Udorn A/M2 (data from
Victoria Balannik, Pinto Laboratory). Upper inset, current-voltage data from Weybridge A/M2
(Chizhmakov, Ogden et al. 2003) plotted with symbols as in Figure 4.4. Lower inset, pHdependent chord conductance data at -60 mV (upper trace) and +60 mV (lower trace),
normalized to -60 mV, pH 4 (Chizhmakov, Geraghty et al. 1996). The chord conductance
function at +60 mV has a discontinuity that is reflected in the fitted line.

Again, the curve fitting exercise was largely successful in recapitulating the principal functional
trends exhibited by the protein. Changes in the pKa values for binding the first two protons
(modeled as a fully cooperative process) did not significantly influence the fitting results if the sum
of the two pKas was higher than ~15.5. Lower sum values slightly altered the predicted I-V
curves but not the chord conductance and flux-pH relationships, as expected for a non-
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conducting process. These pKa values were therefore held at 8.2 each, as measured by Cross et
al.(Hu, Fu et al. 2006).

Changes to the combined two-proton on-rate did not significantly
17

influence the fit results; this value was held at 5x10
of ~7x10

8

-1

-2 -2

M s reflecting average individual on-rates

-1

M sec , consistent with an unimpeded, near diffusion-limited protonation event.

Because this activation process was non-conducting, the on and off rates for the first two protons
were modeled as voltage-independent, as were the minor rate processes.

A number of pKa values for the “B” and “C” state gave good fits to the data; the rate constants for
7

-1

conformational transitions k2 and k-4 were fixed at 10 sec so as not to be rate-determining; k4
was allowed to float in the fit and k-2 was calculated by applying microscopic reversibility to the
cycle. Multiple minima were found that provided adequate fits to the data. To select the process
most representative of reality, an additional constraint was applied to select a combination of “B”
and “C” pKas and k4 values such that the population-weighted pKa of the “B” and “C” states at
equilibrium was near 6.3, the pKa value observed for the third protonation of the M2 bundle by
Cross et al. (Hu, Fu et al. 2006). A well-fitting solution satisfying this constraint was found, with a
“B” state pKa of 6.6 and a “C” state pKa of 4.4. These results show a similar pKa trend to what
was seen with the basic transporter model discussed above. The pKa values are thus consistent
with the argument that the intermediate pH “open-out” state has a higher affinity for protons than
the low pH favored “open-in” state, thus facilitating inward proton transport over outward.

Electrical distances were fit as for the previous model, with the addition of two more parameters
for the BH2-CH2 transition; in imposing voltage dependence, k2 was multiplied by e
was multiplied by e

-d6*V

, while k-2

d7*V

, with the best fit values for d6 and d7 at 0.26 and 0.23 respectively. For

the BH2-BH3-CH3-CH2 cycle, d1 was 0.59, d2-d4 were 0.69, and d5 was 1. On rates for principal
pathways were allowed to float within reasonable ranges expected for diffusion-limited processes
7

9

-1

-1

(10 -10 M sec ).
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While successful in capturing the key trends in M2 behavior, the fit results from this model also
show a number of limitations. The voltage-current fits in Figure 5.7 are slightly worse than those
in Figure 5.4, most likely because data sets from two similar but not identical M2 strains were
combined in the global fitting. A good fit is seen for the chord conductance at -60 mV, but the fit
to chord conductance at +60 mV is worse, likely because that function involves a discontinuity in
the middle of the data being fit, and also because a fourth protonation state, not considered in the
model, is probably involved at very low pHout values. Finally, the fit to the flux-pH relationship
shown in the main panel significantly underestimates flux at low pH regimes, a problem that
persists even when the rest of the data, plotted in the insets (and obtained from a different M2
strain) are excluded from the fitting. The discrepancy is also not resolved when small changes in
the pHin parameter are permitted (to allow for deviations from the assumed intra-oocyte pH).

In summary, while providing an adequate fit to multi-strain functional data, this model cannot be
made to account for the small degree of conductance that takes place at high pHout regimes, for
which additional pathways must be added. We hypothesized that by allowing the activating two
protons in our model to be conducted, and thus bound and removed from both inside and outside
the membrane, better agreement would be achieved with the WT Udorn flux-pH trace.

We therefore augmented the transporter model as shown in Figure 5.8 to allow the A and B
states to conduct the first two protons bound.
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Figure 5.8. Augmented structure-based M2 transport mechanism. Note that the first two protons
can now be conducted via the A-AH2-BH2-B-A and B-BH2-B cycles.

The augmented model was globally fit to the same mixed Udorn/Weybridge data shown in Figure
5.7 in a similar fashion to the previous mechanism. The results of the fit are shown in Figure 5.9.
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Figure 5.9. Combined global fit of augmented transporter model to functional data, displayed as
in Figure 5.7. The assumed oocyte pHin value for the flux-pH relationship shown in the main
panel was allowed to vary slightly (by ¾ of one unit) to obtain optimal fitting results, as described
in the text.

The rate constants for minor circuits, defined by k4, k-4, k10, and k-10, were again constrained to be
th

at most 1/10 of the values of the corresponding major pathways and were modeled as voltageindependent. A good fit to the data was obtained with k2 and k6 set to 10
diffusion-limited process.
conformational transitions.

k1, k3, k-3, k5, and k-7 were set to 10

7

s

17

-1

-2 -2

M s , indicating a
to represent rapid

The pKa values for A, B, BH2, and CH2 were 16.4, 15.9 (both

cooperative double protonations), 6.6, and 4.4 respectively, and were again constrained to agree
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with the population-normalized pKa values observed by Cross et al. (Hu, Fu et al. 2006). k7, k8,
-1

7

-1 -1

8

-1 -1

and k12 were 70,000 s , 3x10 M s and 2x10 M s

respectively. Electrical distances for the

BH2-BH3-CH2-CH3 circuit were 0.59,0.68,0.69,0.69 and 1, in agreement with those fit by the
simpler activation model. Electrical distances for the A-AH2-BH2-B circuit were 0, 0.05, 0.3, 0.3,
and 0.3, lower than those for the three-proton circuit reflecting the decreased charge of the
species involved. Similarly to the case of the previous model, k5 was multiplied by e
5

was multiplied by e

0.25*V

-0.24*V

, while k-

for best-fit voltage dependence.

An improved fit was obtained to the voltage-current curves from the Weybridge protein, and the fit
was again good for the -60 mV chord conductance-pH relationship. Similarly to the previous
model, the +60 mV chord conductance was more difficult to fit, most likely because of the
involvement of a fourth protonation site at the very low pH regimes where the fit is especially
poor, and a discontinuity in the function at higher pH. Notably, an excellent fit was obtained to the
Udorn flux-pH relationship in oocytes shown in the main panel in Figure 5.9. Since the oocyte
internal pH is not precisely measured during every experiment and instead is based upon a
previously measured reference value, its assigned value in the fit was allowed to vary slightly.
Setting pHin to 7.5 instead of 7.25 resulted in a good curve fit that captured the biphasic nature of
the activation curve with a rise in flux at high pH, and an excellent fit as shown above was
obtained by setting pHin to 8.

By incorporating the ability to conduct the first two protons bound (though at a low level, with
correspondingly high pKa values), the augmented model was able to account for the previously
unexplained current observed at high pH in the flux-pH curve. The pKa values are again higher for
the outside protonation events than for the inside ones, explaining the unidirectional proton flow
facilitated by M2. This structure-based model, unifying conformational changes of the protein with
protonation events governed by spectroscopically defined pKa values (Hu, Fu et al. 2006), is now
successfully able to describe all of the tested electrophysiological data on M2 obtained above pH
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5 with a relatively simple kinetic scheme.

The successful fit of the model reinforces the

mechanistic hypothesis being developed in this and previous chapters, that M2 conducts protons
by pH-driven shifts in its structural equilibrium to select conformations that favor outer proton
binding and inward proton release.

To test our hypothesis further, we attempted to fit the augmented model to the unusual pH
activation profiles observed for certain pore-lining residue mutants of M2, such as the Ser31Gly
variant shown in Figure 5.3. This model was able to give an adequate fit to the mutant data as
shown in Figure 5.10, after changes in protonation rates, pKa values and voltage dependences.

Figure 5.10. Fit of augmented structure-based model to Ser31Gly mutant data (Victoria Balannik,
Pinto lab, unpublished). pHin was set to 8.0, as in the previous example.
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As shown in Figures 5.9 and 5.10, the augmented model is not only able to fully account for the
electrophysiological properties of wild-type A/M2, but can also shed light on the unusual behavior
of Ser31Gly, which has a pH-activation profile similar to that of a number of other pore-lining
residue mutants. The key differences include lower pKa values for A (double pKa of 14) and B
(double pKa of 13.3), BH2 (4.9) and CH2 (3.4) that are consistent with higher off-rates. Also
required was a faster minor pathway protonation rate constant (k4) for the B species from outside
the protein, indicating that a large portion of the high pH conductance must take place across the
B species in the mutant protein. This change accounts for the significantly greater flux observed
through the mutant at higher pHout. The results suggest that the “B” state of the mutant variants is
leakier and less rectifying than that of wildtype, allowing for facile protonation and deprotonation
of the His residues on either side of the membrane.

Therefore, for the intermediate pH B
rd

conformation in both the WT (releases first two protons inside, binds 3 outside) and the mutant
protein, the strict “open-in” – “open-out” ratchet mechanism as previously proposed appears to be
violated, since the His residues in this conformation must be significantly accessible to waters
from both inside and outside the pore in order to fit the data well. This phenomenon was also
suggested by the water wire analysis of the high-resolution crystal structure in Figure 3.6.

5.4. Conclusions: lessons learned from modeling function of WT A/M2 and functionally perturbed
mutants.
In this chapter, we constructed a structure-based model of A/M2 proton transport, informed by our
findings in the previous sections of the thesis that have set the stage for quantitative mechanistic
analysis.

Even a simple, two-conformation one-proton model can capture many of the key

functional properties of M2 and return qualitatively meaningful parameters. However, we needed
to expand our analysis to a three-conformation, three-proton model to reflect our understanding of
the pH-driven structural transitions of the protein, and to take account of the experimentally
observed pKa values for its histidine 37 residues (Hu, Fu et al. 2006). A model that allows for
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conduction of the first two protons bound performs substantially better than one treating these
protons as channel activators only, shedding light on the structural basis of the high-pH flux
observed for WT A/M2 and indicating that certain conformations in the equilibrium may be
significantly accessible to both external and internal waters.

The validity of our modeling

approach was further confirmed by its ability to describe a highly perturbed flux profile of a mutant
A/M2 variant, where the intermediate pH conformational state was found to be considerably less
rectifying.

In summary, we have quantitatively combined our understanding of the structural changes and
protonation events of M2 into a simple, testable kinetic mechanism that performs very well in
describing key attributes of the protein’s structure and function. In the future, these and similar
models can be correlated to the yet-to-be determined structures of functionally interesting mutant
variants to further understand the structure-function correlates of this amazing, minimalistic,
membrane protein.
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Chapter 6: Testing the geometric and electronic determinants of
function at the A/M2 histidine 37 residue
6.1. Review of literature on His 37 mutagenesis and rationale for unnatural amino acid
substitutions.
As discussed throughout this thesis, histidine 37 is the most important residue of the A/M2 protein
from the standpoint of its ion transport function. Its sidechain mediates the external pH activation
of the protein (Wang, Lamb et al. 1995) and its high degree of proton selectivity (Chizhmakov,
Geraghty et al. 1996), while forming a part of a highly tuned proton transport pathway within the
protein’s transmembrane domain through interactions with ordered water molecules in the
aqueous pore (Chapter 3). This unique arrangement underlies the highly perturbed pKa values of
the His 37 sidechains in the protein (Hu, Fu et al. 2006), which enable the tetramer to remain
assembled while stably accommodating at least three positive charges on the imidazole
sidechains.

It has been demonstrated early on that mutations at the His 37 residue abrogate the protein’s pH
regulation and sometimes lead to dramatically altered channel behavior that results in oocyte
death (Wang, Lamb et al. 1995).

More detailed experiments with several mutant constructs

where His 37 was mutated to a small residue (Gly, Ser, Thr) established that the mutant proteins
+

had markedly decreased proton selectivity; in particular His37Gly was shown to conduct Na and
+

-

K , but not Cl (Venkataraman, Lamb et al. 2005). Remarkably, native-like electrophysiological
properties could be largely restored to this mutant by using free imidazole (a molecule of the
same chemical structure as the ring in the His side chain) in the oocyte bathing buffer (Figure
6.1). Partial success in this “chemical rescue” experiment was also observed when adding
methylimidazole (which has a similar solution pKa value).

However, adding much larger,

substituted heterocyclic buffers (morpholine- and pyridine-based) of similar pKa did not result in
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increased currents at low pH; and the use of a triazole ring with a much lower pKa was inhibitory
to both WT and His37Gly proteins.

Figure 6.1. Chemical rescue of M2 His37Gly expressed in Xenopus oocytes with imidazole
bathing buffer. Panel A: Inward currents at pHout 5.5 through WT A/M2 and M2 His37Gly using
the buffers indicated. Panel B: Conductance of WT A/M2 and M2 His37Gly measured under the
same conditions as in panel A. Figure from (Venkataraman, Lamb et al. 2005).
The successful chemical rescues observed with imidazole and methylimidazole indicate that the
M2 aqueous pore is precisely tuned for the His 37 sidechain, but can tolerate some amount of
steric variability, since the methyl substitution in methylimidazole originated from a nitrogen and
not a carbon as in histidine. The lack of rescue observed from much larger heterocycles is not
surprising given the highly tuned arrangement of the imidiazoles in e.g. the high resolution crystal
structure described in Chapter 3; there is most likely not enough room for these molecules to
assume the required conformation for transport. The result with the triazole is difficult to interpret
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given its observed inhibition of the wild type protein when added to bathing buffer, but one might
expect that substituting a heterocycle with a significantly lower pKa would require lower activating
pH values to observe transport activity.

In this chapter, we describe experiments building upon the chemical rescue results that are
designed to test the functional consequences of very subtle geometric alterations at the His 37
sidechain, as well as of changes in the pKa at the imidazole ring of His 37. Peptide chemistry is
used to introduce histidine-like unnatural amino acids (shown in Figure 6.2.) at position 37 into an
M2 fragment. As shown in Figure 6.2, the His 37 sidechain in the wild-type protein is involved in
bilateral hydrogen-bonding interactions with the water molecules that are hypothesized to make
up the proton transport pathway. We must therefore take into account the consequences of the
mutation upon these interactions as well as on the properties of the sidechain itself.
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Figure 6.2. Upper panel, His 37 residue in the high-resolution crystal structure (Chapter 3) and its
interactions with adjacent water clusters (distances are shown). Note that according to
calculations described in Chapter 3, the C-terminal facing nitrogens of the His 37 imidazoles are
fully protonated in this structure. Lower panel, histidine and unnatural amino acids introduced at
position 37, with the approximate solution pKa values of their heterocyclic rings.

As will be discussed below, the substitution of a 3-pyridine ring, with similar size and pKa but with
slightly altered geometry leads to relatively inactive protein, at all but very low activating pH
values. This finding argues against the thermodynamic gate mechanism proposed earlier by
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Sansom et al. (Sansom, Kerr et al. 1997), and indicates that the geometrical nature of the
imidazole sidechain is optimal for effective transport, potentially because of its ability to form
bilateral interactions with water molecules in the aqueous pore.

However, when one of the

imidazole nitrogens is replaced with sulfur, maintaining the geometry of the ring but dramatically
lowering its pKa and changing its ability to form bilateral hydrogen bonds, the result is a
functional, amantadine-sensitive protein with a similarly lowered pKa of activation. This result
further supports the notion that sidechain geometry is key for mediating transport function, and
suggests that the thiazole sidechain is able to take part in the requisite water interactions even
though only its nitrogen atom can be protonated and donate hydrogen bonds.

6.2. Thermodynamic and functional studies of unnatural amino acid substituted M2 variants:
materials and methods.
Peptides (M2 constructs of length 19-46 and 19-62 using the A/Udorn/72 sequence with the
C50S mutation; see Fig. 2.10 for sequences) were synthesized by Fmoc solid-phase chemistry
as C-terminal carboxamides, and were N-terminally amidated to protect the Cys 19 sidechain.
Peptides were synthesized on an Applied Biosystems 433A synthesizer, or, for the longer
constructs, manually using a CEM Mars microwave heated reactor, with frequent reaction
monitoring.

Fmoc-protected L-4-thiazolylalanine and L-3-pyridylalanine were purchased from

Synthetech (Albany, OR) and used without further purification in place of Fmoc-His(Trt)-OH at
position 37 in the mutant peptides. Peptides were cleaved from the resin and purified according
to the procedure used for synM2(19-62) in Chapter 2.5.b.

Functional studies of the WT synM2(19-62) constructs and the corresponding histidine mutants
were performed by the author largely according to the protocol outlined in Chapter 2.5.d-e, with
the exception of the following minor changes: 990 µL of 1x “K” buffer was used to hydrate the
protein/lipid films, and 10 µL of 100 mM HPTS was added; a single overnight cycle of dialysis
against pH 7.4 “K” buffer was performed; a newer, more powerful Ushio (Cypress, CA) lamp on
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the Aviv fluorometer led to the use of narrower excitation and emission bandwidths during
experiments (2 nm instead of 3 nm).

All experiments were performed in the presence of

valinomycin and DPX (amounts as previously specified); experiments with amantadine were on
samples preincubated for at least 3 hours in the presence of the drug, and with drug added to the
sample buffer, both as previously described. Sample buffers during the experiments were “Na”
buffers set at pH 7.4, 4.9, and 2.4 using phosphoric acid and NaOH.

During experiments in this study done at pHout 4.9 and 2.4, noticeable decreases in the isosbestic
signal Fiso (ex 417 nm, em 515 nm) were observed compared to runs performed at pHout 7.4,
which suggests that some dye may be leaking out of the liposomes at low pH conditions, or that
the isosbestic wavelength may not be set with sufficiently high precision. To correct for this
effect, the Fiso signal for a given set of liposomes determined in low pH experiments (e.g. control,
WT, ThiazolylAla) was linearly normalized to its value determined from experiments performed at
pHout 7.4, since a similar volume of liposomes was added for each run.

More specifically, the time-averaged Fiso signals (obtained at ~90-120 seconds following
experiment start) from triplicate runs under each condition were further averaged amongst
themselves, and ratios of these values obtained at pH 4.9 vs. pH 7.4 and pH 2.4 vs. pH 7.4 were
calculated. Recording of the Fiso signal began approximately 90 (t=90-120s) seconds following
-

the start of each run, and the F signal was recorded for the first ~45 seconds (t=0-45s) of each
run. The time-averaged Fiso signal for each low pH run was extrapolated to earlier timepoints with
the following operation:

Fiso (t, pH(X)) = Fiso(t= 90to120, pH (X ))[1+ (

!
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AvgFiso ( pH 7.4)
t
"1)(1" )]
AvgFiso ( pH(X))
90

-

To determine intraliposomal pH, F at a given time t was divided by the calculated value of Fiso(t),
and the ratio used to calculate the pH according to the calibration curve shown in Figure 2.9.

Liposome size was measured using dynamic light scattering as described, and peptide
incorporation was quantified using analytical HPLC. However, the incorporation assays were run
on a different C4 HPLC column and were standardized using injections of known amounts of
synM2(19-62) WT in detergent rather than synM2(22-46) in a mixed aqueous/organic solvent,
resulting in a somewhat different calibration setting compared to that obtained previously
(Chapter 2). The peptide extinction coefficients at 280 nm used for synM2(19-62) constructs were
-1

-1

-1

-1

6990 M cm for WT and thiazole constructs, and 7329 M cm for the pyridylalanine construct.
The NIST WebBook entry for 3-ethylpyridine (NIST 2008) was used to calculate the additional
contribution of the pyridyl ring to the ε280.
6.3. Mutant constructs form stable tetramers in bilayers at high pH.
Thermodynamic studies of tetramer stability of the synM2(19-46) WT and mutant constructs in
DPLC bilayers were performed by Dr. Lidia Cristian according to a previously described protocol
(Cristian, Lear et al. 2003). The shorter constructs and thin bilayer were used for this experiment
so that some amount of dissociated protein was present, in order that the equilibrium constant be
quantified. Longer constructs such as synM2(19-62) and/or thicker bilayers such as POPC result
in virtually complete M2 tetramerization and thus cannot be used to determine dissociation
constants.

The results of thiol-disulfide equilibrium experiments on synM2(19-46) WT and His mutant
constructs in bilayers are shown in Table 6.3.
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Construct

pKtet at pH 8

synM2(19-46) Wild Type

8.4

synM2(19-46) 4-Thiazolylalanine

7.8

synM2(19-46) 3-Pyridylalanine

8.3

Table 6.3. Thermodynamic stabilities of wild type and His37-mutant synM2(19-46) constructs.
pKtet is –log(Ktet), where Ktet is the tetramer dissociation equilibrium constant.
The data show that at pH 8 in bilayers, the wild-type and mutant constructs have roughly similar
tetramer stabilities (within an order of magnitude), indicating that the introduction of the unnatural
amino acid does not substantially destabilize the tetrameric assembly of the protein. This finding
paves the way for functional experiments that will determine the impact of the mutations of proton
transport, activation, and inhibition.

6.4. Results: Proton transport through His-mutant synM2(19-62) constructs in liposomes.
The proteoliposome flux assay described in Chapter 2.5 and modified as discussed in Chapter
6.2 was used by the author to assay function of the histidine mutant constructs. Because of the
requirement for unnatural amino acids, this experiment would be much more difficult to carry out
in cell-based systems that rely on protein expression, such as Xenopus oocytes. A pH gradient
approach is used here because the dynamic range of the indicator dye used precludes reliable
measurements below pH ~ 6. Therefore, liposomes are formed at pH 7.4, and diluted into buffer
of varying pH for experiments.

Fluxes through protein free control liposomes under similar

conditions, corrected for differences in surface area and peptide incorporation, are subtracted to
isolate currents through the wild type and mutant M2 constructs.
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Because the first few data points in the experiment are acquired while sample mixing takes place
and cannot be reliably analyzed, it is important to first examine the calculated intraliposomal pH
as a function of time to determine whether the fluxes of interest are measurable on the timescale
of the experiment. It is possible that under especially large pH gradients, the fastest proton
transport regime may be complete before the mixing time is over. If this were the case, transport
rates calculated by comparing subsequent timepoints (as is typically done in this experiment)
would significantly underestimate the actual velocities. The results of this analysis are presented
in Figure 6.4.
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Figure 6.4. Calculated intraliposomal pH in control (A), synM2(19-62) WT (B), and the His 37
mutants synM2(19-62) 4-thiazolylalanine (C) and 3-pyridylalanine (D) proteoliposome
experiments.

As seen in Figure 6.4, following mixing, the calculated pH values fall within the dynamic range of
the dye, indicating reliable measurements. The starting pH values for thiazolylalanine (Figure 6.4
C) and pyridylalanine (Figure 6.4 D) liposomes do not deviate significantly from those of control
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liposomes (Figure 6.4 A) under similar conditions, indicating that the fluxes can be calculated
from measurements obtained immediately following mixing.

The same holds true for

measurements of wild-type M2 proteoliposomes at pH 7.4 and 4.9; however, a significant drop in
starting pH (to below 7) is observed for the samples studied at pH 2.4.

The pKa of the intraliposomal buffer (taken into account in per-tetramer flux calculations
presented below) is approximately 7.2; this is where the buffering capacity of the liposome is
highest under experimental conditions.

Therefore, pH changes in the pH 7.4-7.0 range are

consistent with relatively higher proton transport rates than pH changes of equivalent magnitude
outside this range, since the buffering becomes less effective. This logic indicates that the wildtype samples observed at pH 2.4 have undergone a very significant and rapid proton uptake
during the mixing period (from a starting pH of ~ 7.5 as observed in other WT samples).
Therefore, per-tetramer fluxes cannot be reliably calculated for the WT, pH 2.4 sample by
comparing post-mixing data points, and are instead to be estimated by quantifying the pH change
from ~ 7.5 to the first post-mixing data point with account for buffering capacity and control
liposome flux.

The calculated per-tetramer fluxes for the remaining experimental conditions are shown in
Figures 6.5, 6.6, and 6.7.
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Figure 6.5. Control-corrected fluxes through synM2(19-62) WT proteoliposomes.
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Figure 6.6. Control-corrected fluxes through synM2(19-62) 4-thiazolylalanine proteoliposomes.
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Figure 6.7. Control-corrected fluxes through synM2(19-62) 3-pyridylalanine proteoliposomes.

The results for synM2(19-62) proteoliposomes (Figure 6.5) show that the construct forms a
functional, amantadine-sensitive tetramer at bathing buffer pH values of 7.4 and 4.9. An initial
transport rate of approximately 1 proton per tetramer is observed at pH 7.4, and increases to
approximately 3 protons per tetramer at pH 4.9. The amantadine sensitivity at ~100 µM is nearly
complete at pH 7.4, but is decreased at pH 4.9. While the initial transport rate at pH 2.4 could not
be calculated from the post-mixing flux curve, it is estimated to be ~15-20 protons per second per
tetramer during the mixing process. This rate is significantly lower than expected from other
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estimates of maximum M2 current in the literature (Mould, Li et al. 2000), and may reflect
dissociation (Salom, Hill et al. 2000) or inactivation of the wild type protein at very acidic pH
values. Flux limitation by the amount of valinomycin used (~30 nM, peptide:valinomycin ~10:1)
4

must also be considered but is less likely given the high (10 ) per second turnover rate of
valinomycin (Franklin and Snow 2005) and saturating potassium concentrations. No inhibitory
effect of amantadine on flux was observed under these conditions.

The synM2(19-62) thiazolylalanine construct (Figure 6.6) was largely inactive at pH 7.4, as may
be expected given the much lower pKa of this sidechain as compared to histidine. However,
progressive activation was observed at pH 4.9 and especially pH 2.4, where significant proton
currents (~1.5 per second per tetramer) were observed. At all pH values tested, the currents
were almost fully amantadine sensitive, indicating a native-like conformation of the tetramer and
its N-terminal aqueous pore where amantadine binds.

The synM2(19-62) pyridylalanine construct has a sidechain pKa similar to that of histidine, but
was essentially inactive (Figure 6.7) at pH 7.4, had low activity at pH 4.9, but was more active at
pH 2.4 (~1.3 protons per second per tetramer). Furthermore, all currents through this construct
were not sensitive to amantadine inhibition at 100 µM.

6.5. Discussion: functional consequences of geometric and electronic changes at His 37
sidechain.
While mutating the His 37 imidazole sidechain to a thiazole or pyridyl ring did not significantly
alter M2 tetramer stability at high pH (Table 6.3), the changes led to dramatic functional
consequences.

In particular, substitution of the pyridyl ring, with a solution pKa that is similar or slightly lower than
that of imidazole, led to a very slow channel at all but the lowest pHout values (Figure 6.7), where
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the current was completely insensitive to amantadine inhibition. This result suggests that the
pore of M2 is highly sensitive to the geometry of the sidechain at position 37. The pyridyl is not
substantially larger than an imidazole, and a 3-pyridyl group was deliberately used to introduce
the nitrogen atom on the side rather than the distal end (4-position) of the ring, so as to mimic the
atomic arrangement of a histidine. Nevertheless, the protein was essentially inactive, perhaps
because the non-nitrogen edge of the ring did not contain a polar group to interact with the
bridging water cluster and Trp 41, or because the pyridine was unable to form the requisite
hydrogen bond interactions with the N-terminal water cluster (Chapter 3). A steric clash seems
less likely, since the high-resolution crystal structure indicates sufficient room for a slightly
enlarged His 37 sidechain.

This finding argues against the mechanistic hypothesis proposed by Sansom et al. in 1997
(Sansom, Kerr et al. 1997), where successive protonation of the M2 tetramer leads to the
establishment of continuous water wires in the M2 pore as the positively charged His 37
sidechains repel each other.

In such a mechanism, channel opening would be dictated by

sidechain pKa, largely irrespective of the precise nature of the substituent. The pyridylalanine
variant, with its similar solution pKa, results in inactive channels at the pH range where WT M2 is
active, indicating that transport is sensitive not only to the sidechain pKa, but to the particulars of
its geometry as well. The caveat with this interpretation is that it is unknown whether the pKa
values of the pyridine groups in the protein are similarly perturbed as those of the imidazoles (Hu,
Fu et al. 2006). Thus, an alternate explanation is that the pyridines do not experience the charge
stabilization afforded by the N-terminal water cluster (perhaps by disrupting it) and therefore bind
successive protons much less favorably than imidazoles in the context of the assembled protein.

By contrast, the calculated fluxes through the thiazolylalanine-substituted protein (Figure 6.6) are
essentially as expected if the geometrically similar thiazole group adopts a similar conformation
and experiences an equivalent extent of charge stabilization as the imidazole, but at an
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appropriately lowered pH. In essence, the M2 pH activation profile is shifted lower by 3-4 pH
units, corresponding to the difference in the pKa of the two rings in solution.

The currents

observed are sensitive to amantadine, indicating that the drug’s binding site in the N-terminal
aqueous pore is intact. Although the thiazole ring has two polar atoms (nitrogen and sulfur), it
can only be protonated on the nitrogen, unlike the histidine imidazole, that can be protonated on
either or both nitrogens, and switch between different tautomeric states. The observed activity of
the thiazole-containing protein indicates that the water-Trp 41 network on the C-terminal side of
the His 37 basket may be stabilized by a polarizable group or atom (e.g. sulfur) but not
exclusively a hydrogen bond donor, as is observed for histidine in the high-resolution crystal
structure (Chapter 3).

This argument is consistent with the observation by Pinto et al.

(Venkataraman, Lamb et al. 2005) that methylimidazole partially rescues function of a His37Gly
M2 mutant, since the methyl group is attached to one of the imidazole nitrogens and eliminates
that site as a hydrogen bond donor.

In summary, the findings with His 37-substituted constructs show that the protein is highly
sensitive to small changes in geometry at this critical residue; since substitution of a similarly
sized heterocyclic ring with a similar solution pKa results in an inactive protein at the physiological
pH range.

However, the finding of pKa-dependent activation upon introduction of a similarly

shaped thiazole group result indicates that as long as an imidazole-like geometry and
arrangement of polar atoms is maintained, the electronic properties of the ring can be changed to
predictably alter the functional properties of the protein.

167

Chapter 7: Conclusions, lessons learned, and further directions.
Through data presented in this thesis, we have built a bridge between the structural biology,
biophysics, and functional electrophysiology of influenza A M2, and unified findings from these
scientific domains into a single, comprehensive proton transport mechanism.

First, we have established that a very simple model system consisting of the M2 transmembrane
peptide

faithfully

reproduces

the

complex

electrophysiological properties

observed

by

electrophysiologists with the full length protein. This finding enabled us to correlate the results of
structural and biophysical studies on this peptide with the known functional parameters of M2.

We obtained high-resolution crystals of the M2 transmembrane fragment, which yielded a highly
detailed picture of the proton transport pathway through the protein’s functional core.

In

conjunction with other structures of M2, the new structure was suggestive of a hypothesis where
changes in pH lead to well-defined structural changes in the M2 helical bundle. From these
crystals, we also discovered the structural basis for the unexpected stability of bound protons in
the M2 tetramer, and learned that highly ordered pore waters play a key functional role in
mediating proton transport and stabilization.

We next put our mechanistic hypothesis to the test in an equilibrium bilayer system to determine
whether the micelle-derived “snapshot” M2 structures were representative of pH-driven changes
in the M2 conformational ensemble in bilayers. We found that the protein indeed undergoes
significant changes in its favored conformation, driven by protonation events that take place
according to previously determined pKa values.

As a final test of our mechanism, we constructed mathematical models of proton flux representing
our hypothesis and fit them to electrophysiological data collected on M2. We found that the
complex functional properties of this protein can be explained by pH-mediated changes in its
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conformational ensemble, where the conformations differ in their accessibility to water molecules
on either side of the membrane, and in the degree of stability with which they bind protons.

Finally, we zeroed in on the structural and electronic properties of the functionally critical His 37
residues. From our high-resolution crystal structure, these sidechains appeared to be precisely
tuned and positioned to mediate interactions with water molecules that we found to be important
for function. Using unnatural amino acids, we subtly changed either the geometry or the proton
affinity of the His 37 sidechains, and determined that the protein’s function and drug sensitivity is
highly dependent on the ring structure, but that the ring’s pKa can be changed with predictable
functional consequences.

As next steps, our transport mechanism model can be further extended to include the binding of a
fourth proton by the M2 tetramer, although the pH ranges at which this process takes place would
be rarely encountered in Nature.

We can also apply our transport model to help inform a

structural basis for the unusual functional properties of certain M2 mutants, as we began to do
with the Ser31Gly variant.

Importantly, we can use the mechanism model results to inform drug design, so that the shapes
of candidate inhibitors can be well-matched to the predominant protein conformation that the drug
will encounter at a given stage of the viral infection cycle. The highly ordered water molecules
that are observed near the amantadine binding site in our new crystal structure, and the drug
resistance imparted by one of the His 37 mutations that we tested indicate that these water
molecules are important from the perspective of transport inhibition, and must be considered
along with the protein itself in the design of a new generation of antivirals.
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Appendix A: Electron density maps from high resolution structure of
M2TM’ G34A

(left) 2F0 – FC map contoured at 1.1 σ, showing density from solvent molecules above and
below the His37 residues. (right) 2F0 – FC map showing the Trp basket and the exit water cluster.
The protein atoms are countered at 1.5 σ. The density from the solvent molecules is contoured at
2
1.1 σ. Note the poorer density for the middle water, which refined with a higher β-factor (53 Å ).
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Appendix B: Proton mobility in the MPSC
The mobility of the proton in the QM/MM simulations is quantified in figure B1 which shows the
RMSD of the approximate location of the excess proton for the various simulations presented in
this work. The large jumps observed in some trajectories correspond to collective Grothuss
hopping motions where several protons jump simultaneously.

Fig. B1. Root mean square displacement (RMSD) of the three excess protons in QM/MM MD
simulations.
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Appendix C: Representative Igor Pro procedure files used in global
fitting of mechanistic models
Single-proton, two state model:
#pragma rtGlobals=1
// Use modern global access method.
#include "JimsmodifiedGlobalFit"
Function xer()
Variable a=.088
Variable b=-.00488
Variable c=-.674
Variable d=-.00488
Variable e=0.008672
Variable f=-.0055
Variable x=(b*f-c*e)/(a*e-b*d)
Variable y=(c*d-a*f)/(a*e-b*d)
print x,y
end
Function AnyFunction(w,xx)
Wave w
Variable xx
if (xx>200)
xx-=200
return M2pH(w,xx)
else
return CurRat(w,xx)
endif
end
Function CurRat(w,xx)
Wave w
Variable xx
Variable k0,k1,k2,k3,k4,k5,k6,k7,Hout,Hin,d1,d2,d3,d4,d5,V,k00,k10,k20,k30,k40,k50,k60,k70
k0=w[0];k1=k0*10^(-w[1]);k2=w[2];k3=w[3];k4=w[5]*10^(-w[4]);k5=w[5];k6=w[6];Hout=exp(2.303*w[8]);Hin=exp(-2.303*w[9]);d1=w[10];d2=w[11];d3=w[12];d4=w[13];d5=w[14]
k00=w[0];k10=k0*10^(-w[1]);k20=w[2];k30=w[3];k40=w[5]*10^(w[4]);k50=w[5];k60=w[6];k70=(k00*k20*k40*k60)/(k10*k30*k50);k7=k70
V=xx/25.7
k0*=exp(-d1*V);k1*=exp((d2-d1)*V);k2*=exp((d2-d3)*V);k3*=exp((d4-d3)*V);k4*=exp((d4d5)*V);k5*=exp((1-d5)*V)
Variable a,b,c,d,e,f,g,h,i,j,k,l
Variable a0,b0,c0,d0,e0,f0,g0,h0,i0,j0,ko,l0
a= -(k0*Hout+k6+k7);b=(k1-k6);c=-k6;d=k6;e=k0*Hout;f=-(k1+k2);g=k3;h=0;i=-k5*Hin;j=(k2k5*Hin);k=-(k3+k4+k5*Hin);l=k5*Hin
a0= -(k00*Hout+k60+k70);b0=(k10-k60);c0=-k60;d0=k60;e0=k00*Hout;f0=(k10+k20);g0=k30;h0=0;i0=-k50*Hin;j0=(k20-k50*Hin);ko=-(k30+k40+k50*Hin);l0=k50*Hin
//print a,b,c,d,e,f,g,h,i,j,k,l
Variable S0,S1,S2,S3,S00,S10,S20,S30
S0 = -(b*(h*k-g*l)+c*(f*l-h*j)+d*(g*j-f*k))/(a*(g*j-f*k)+b*(e*k-i*g)+c*(i*f-e*j))
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S00 = -(b0*(h0*ko-g0*l0)+c0*(f0*l0-h0*j0)+d0*(g0*j0-f0*ko))/(a0*(g0*j0-f0*ko)+b0*(e0*koi0*g0)+c0*(i0*f0-e0*j0))
S1=(a*(h*k-g*l)+c*(e*l-i*h)+d*(i*g-e*k))/(a*(g*j-f*k)+b*(e*k-i*g)+c*(i*f-e* j))
S10=(a0*(h0*ko-g0*l0)+c0*(e0*l0-i0*h0)+d0*(i0*g0-e0*ko))/(a0*(g0*j0-f0*ko)+b0*(e0*koi0*g0)+c0*(i0*f0-e0* j0))
S2 =-(a*(h*j-f*l)+b*(e*l-i*h)+d*(i*f-e*j))/(a*(g*j-f*k)+b*(e*k-i*g)+c*(i*f-e*j))
S20 =-(a0*(h0*j0-f0*l0)+b0*(e0*l0-i0*h0)+d0*(i0*f0-e0*j0))/(a0*(g0*j0-f0*ko)+b0*(e0*koi0*g0)+c0*(i0*f0-e0*j0))
S3=1-S0-S1-S2
S30=1-S00-S10-S20
variable curr=(k0*S0*Hout-k1*S1-k5*S3*Hin+k4*S2)
variable curr0=(k00*S00*Hout-k10*S10-k50*S30*Hin+k40*S20)
//print k10,k40
//Print S0,S1,S2,S3,S0+S1+S2+S3
//return curr
return abs(curr/curr0)
end

Function M2pH(w,xx)
Wave w
Variable xx
variable V=w[7]
w[8]=xx
variable V0=2.303*25.7*(w[9]-w[8])
//print v0
variable cond=IV(w,(V))/(V-V0)
w[8]=4
variable V1=2.303*25.7*(w[9]-4)
variable cond0=IV(w,(V))/(V-V1)
return cond/cond0
end
Function IV(w,xx)
Wave w
Variable xx
Variable k0,k1,k2,k3,k4,k5,k6,k7,Hout,Hin,d1,d2,d3,d4,d5,V,k00,k10,k20,k30,k40,k50,k60,k70
k0=w[0];k1=k0*10^(-w[1]);k2=w[2];k3=w[3];k4=w[5]*10^(-w[4]);k5=w[5];k6=w[6];Hout=exp(2.303*w[8]);Hin=exp(-2.303*w[9]);d1=w[10];d2=w[11];d3=w[12];d4=w[13];d5=w[14]
k00=w[0];k10=k0*10^(-w[1]);k20=w[2];k30=w[3];k40=w[5]*10^(w[4]);k50=w[5];k60=w[6];k70=(k00*k20*k40*k60)/(k10*k30*k50);k7=k70
//print k70
V=xx/25.7
k0*=exp(-d1*V);k1*=exp((d2-d1)*V);k2*=exp((d2-d3)*V);k3*=exp((d4-d3)*V);k4*=exp((d4d5)*V);k5*=exp((1-d5)*V)
Variable a,b,c,d,e,f,g,h,i,j,k,l
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Variable a0,b0,c0,d0,e0,f0,g0,h0,i0,j0,ko,l0
a= -(k0*Hout+k6+k7);b=(k1-k6);c=-k6;d=k6;e=k0*Hout;f=-(k1+k2);g=k3;h=0;i=-k5*Hin;j=(k2k5*Hin);k=-(k3+k4+k5*Hin);l=k5*Hin
a0= -(k00*Hout+k60+k70);b0=(k10-k60);c0=-k60;d0=k60;e0=k00*Hout;f0=(k10+k20);g0=k30;h0=0;i0=-k50*Hin;j0=(k20-k50*Hin);ko=-(k30+k40+k50*Hin);l0=k50*Hin
//print a,b,c,d,e,f,g,h,i,j,k,l
Variable S0,S1,S2,S3,S00,S10,S20,S30
S0 = -(b*(h*k-g*l)+c*(f*l-h*j)+d*(g*j-f*k))/(a*(g*j-f*k)+b*(e*k-i*g)+c*(i*f-e*j))
S00 = -(b0*(h0*ko-g0*l0)+c0*(f0*l0-h0*j0)+d0*(g0*j0-f0*ko))/(a0*(g0*j0-f0*ko)+b0*(e0*koi0*g0)+c0*(i0*f0-e0*j0))
S1=(a*(h*k-g*l)+c*(e*l-i*h)+d*(i*g-e*k))/(a*(g*j-f*k)+b*(e*k-i*g)+c*(i*f-e* j))
S10=(a0*(h0*ko-g0*l0)+c0*(e0*l0-i0*h0)+d0*(i0*g0-e0*ko))/(a0*(g0*j0-f0*ko)+b0*(e0*koi0*g0)+c0*(i0*f0-e0* j0))
S2 =-(a*(h*j-f*l)+b*(e*l-i*h)+d*(i*f-e*j))/(a*(g*j-f*k)+b*(e*k-i*g)+c*(i*f-e*j))
S20 =-(a0*(h0*j0-f0*l0)+b0*(e0*l0-i0*h0)+d0*(i0*f0-e0*j0))/(a0*(g0*j0-f0*ko)+b0*(e0*koi0*g0)+c0*(i0*f0-e0*j0))
S3=1-S0-S1-S2
S30=1-S00-S10-S20
variable curr=-(k0*S0*Hout-k1*S1-k5*S3*Hin+k4*S2)
variable curr0=-(k00*S00*Hout-k10*S10-k50*S30*Hin+k40*S20)//Currebt at zero applied voltage
return (3*9.65*1e5/6.023)*curr
end
Function States(w,xx)
Wave w
Variable xx
Variable k0,k1,k2,k3,k4,k5,k6,k7,Hout,Hin,d1,d2,d3,d4,d5,V,k00,k10,k20,k30,k40,k50,k60,k70
k0=w[0];k1=k0*10^(-w[1]);k2=w[2];k3=w[3];k4=w[5]*10^(-w[4]);k5=w[5];k6=w[6];Hout=exp(2.303*w[8]);Hin=exp(-2.303*w[9]);d1=w[10];d2=w[11];d3=w[12];d4=w[13];d5=w[14]
k00=w[0];k10=k0*10^(-w[1]);k20=w[2];k30=w[3];k40=w[5]*10^(w[4]);k50=w[5];k60=w[6];k70=(k00*k20*k40*k60)/(k10*k30*k50);k7=k70
V=xx/25.7
k0*=exp(-d1*V);k1*=exp((d2-d1)*V);k2*=exp((d2-d3)*V);k3*=exp((d4-d3)*V);k4*=exp((d4d5)*V);k5*=exp((1-d5)*V)
Variable a,b,c,d,e,f,g,h,i,j,k,l
Variable a0,b0,c0,d0,e0,f0,g0,h0,i0,j0,ko,l0
a= -(k0*Hout+k6+k7);b=(k1-k6);c=-k6;d=k6;e=k0*Hout;f=-(k1+k2);g=k3;h=0;i=-k5*Hin;j=(k2k5*Hin);k=-(k3+k4+k5*Hin);l=k5*Hin
a0= -(k00*Hout+k60+k70);b0=(k10-k60);c0=-k60;d0=k60;e0=k00*Hout;f0=(k10+k20);g0=k30;h0=0;i0=-k50*Hin;j0=(k20-k50*Hin);ko=-(k30+k40+k50*Hin);l0=k50*Hin
//print a,b,c,d,e,f,g,h,i,j,k,l
Variable S0,S1,S2,S3,S00,S10,S20,S30
S0 = -(b*(h*k-g*l)+c*(f*l-h*j)+d*(g*j-f*k))/(a*(g*j-f*k)+b*(e*k-i*g)+c*(i*f-e*j))
S00 = -(b0*(h0*ko-g0*l0)+c0*(f0*l0-h0*j0)+d0*(g0*j0-f0*ko))/(a0*(g0*j0-f0*ko)+b0*(e0*koi0*g0)+c0*(i0*f0-e0*j0))
S1=(a*(h*k-g*l)+c*(e*l-i*h)+d*(i*g-e*k))/(a*(g*j-f*k)+b*(e*k-i*g)+c*(i*f-e* j))
S10=(a0*(h0*ko-g0*l0)+c0*(e0*l0-i0*h0)+d0*(i0*g0-e0*ko))/(a0*(g0*j0-f0*ko)+b0*(e0*koi0*g0)+c0*(i0*f0-e0* j0))
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S2 =-(a*(h*j-f*l)+b*(e*l-i*h)+d*(i*f-e*j))/(a*(g*j-f*k)+b*(e*k-i*g)+c*(i*f-e*j))
S20 =-(a0*(h0*j0-f0*l0)+b0*(e0*l0-i0*h0)+d0*(i0*f0-e0*j0))/(a0*(g0*j0-f0*ko)+b0*(e0*koi0*g0)+c0*(i0*f0-e0*j0))
S3=1-S0-S1-S2
S30=1-S00-S10-S20
print k7
return S3
end

Window Surface1() : SurfacePlot
// Mac V. 0.8.0
PauseUpdate; Silent 1

// Building window...

// Do nothing if the Surface Plotter XOP is not available.
if (exists("CreateSurfer") !=4)
DoAlert 0, "Surface Plotter XOP must be installed"
return
endif
CreateSurfer
MoveWindow 419,189,1014,725
ModifySurfer FactoryDefaults, Update=0
ModifySurfer/N=Surface1
ModifySurfer srcWave=root:fit_wave9
ModifySurfer srcType=1,plotType=2
ModifySurfer setControlView=3
ModifySurfer theta=15, phi=317, zScale=1, xStep=1, yStep=2
ModifySurfer frame=3967, drawFrame=1
ModifySurfer drawTicks=5, axisLabels=88
ModifySurfer topRGB={0,0,0}, bottomRGB={0,0,0}, backRGB={65535,65535,65535}
ModifySurfer palette=Grays
ModifySurfer topContourRGB={0,0,0}, bottomContourRGB={0,0,0}
ModifySurfer gridRGB={0,0,0}
ModifySurfer numContourLevels=15, contour=3
ModifySurfer marker=19, markerSize=6
ModifySurfer fillFrame=0, imageInterpolation=1, imageType=1
ModifySurfer Update
End
Window Surface0() : SurfacePlot
// Mac V. 0.8.0
PauseUpdate; Silent 1

// Building window...

// Do nothing if the Surface Plotter XOP is not available.
if (exists("CreateSurfer") !=4)
DoAlert 0, "Surface Plotter XOP must be installed"
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return
endif
CreateSurfer
MoveWindow 519,318,1114,854
ModifySurfer FactoryDefaults, Update=0
ModifySurfer/N=Surface0
ModifySurfer srcWave=(root:wave10,root:wave11,root:wave9)
ModifySurfer srcType=4,plotType=5
ModifySurfer setControlView=3
ModifySurfer theta=15, phi=317, zScale=1, xStep=1, yStep=2
ModifySurfer frame=3967, drawFrame=1
ModifySurfer drawTicks=5, axisLabels=88
ModifySurfer topRGB={0,0,0}, bottomRGB={0,0,0}, backRGB={65535,65535,65535}
ModifySurfer palette=Grays
ModifySurfer topContourRGB={0,0,0}, bottomContourRGB={0,0,0}
ModifySurfer gridRGB={0,0,0}
ModifySurfer numContourLevels=15, contour=3
ModifySurfer marker=19, markerSize=6
ModifySurfer fillFrame=0, imageInterpolation=1, imageType=1
ModifySurfer Update
End
Three-proton, three state model (first two protons nonconducting)
#pragma rtGlobals=1
// Use modern global access method.
#include "JimsmodifiedGlobalFit"
Function AnyFunction(w,xx)
Wave w
Variable xx
if (xx>400)
xx-=400
return specact(w,xx)
elseif (xx>300)
xx-=300
return M2pH(w,xx)
elseif (xx>200)
xx-=200
return M2pH1(w,xx)
else
return CurRat(w,xx)
endif
end
Function specact(w,xx)
Wave w
Variable xx
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Variable c1,c2,c3,c4,c5,c6,c7,c8,c9,c10,c11,c12
Variable cm1,cm2,cm3,cm4,cm5,cm6,cm7,cm8,cm9
Variable c1o,c2o,c3o,c4o,c5o,c6o,c7o,c8o,c9o
Variable cm1o,cm2o,cm3o,cm4o,cm5o,cm6o,cm7o,cm8o,cm9o
Variable Ho,Hi,ed0,ed1,ed2,ed3,ed4,ed5,ed6,ed7,ed8,ed9,ed10,V
Ho=exp(-2.303*xx);Hi=5.62341E-08
c1o=w[2];cm1o=c1o*exp(-2.303*w[3]);c2o=w[4];c3o=w[6];cm3o=c3o*exp(-2.303*w[7])
c4o=w[8];cm4o=w[9];c5o=w[10];c6o=w[12];cm6o=w[13]
c7o=w[14];cm8o=w[16];cm8o=w[17];c9o=w[18];cm9o=c9o*exp(-2.303*w[19])
cm2o=(c2o*c9o*cm4o*cm3o)/(c3o*c4o*cm9o)
w[5]=c10
cm5o=c5o*cm3o/c3o
w[11]=c11
cm7o=c7o*cm9o/c9o
w[15]=c12
ed0=w[20]
ed1=w[21]
ed2=w[22]
ed3=w[23]
ed4=w[24]
ed5=w[25]
ed6=w[26]
ed7=w[27]
ed8=w[28]
ed9=w[29]
ed10=w[30]
V=-20/25.7
c1=c1o
cm1=cm1o
c2=c2o*exp(-ed6*v)
cm2=cm2o*exp(ed7*v)
c3=c3o*exp(-ed1*V)
cm3=cm3o*exp((ed2-ed1)*v)
c4=c4o*exp((ed2-ed3)*v)
cm4=cm4o*exp((ed4-ed3)*v)
c5=c5o
cm5=cm5o
c7=c7o
cm7=cm7o
c9=c9o*exp((1-ed5)*V)
cm9=cm9o*exp((ed4-ed5)*V)
variable A1=c4+cm4
variable A2=cm3+cm5
variable A3=(c5*c7+c3*c9)
variable A4=(c4+cm3+cm4+cm5)
variable A5=(c4+cm5)
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variable A6=(cm7+cm9)
variable A7=(cm4+cm7+cm9)
variable A8=(cm2+cm7+cm9)
variable current
current=(2*ho^2*c1*(hi^2*c5*c9*(cm3*cm4+c4*cm7)+hi*(c2*c9*((c4+cm5)*cm7+cm3*(cm4+cm7))+c5*cm
2*(c4*cm7+cm3*(cm4+cm7+cm9))+ho*(c3*c9*(-cm4*cm5+c4*cm7)+c5*c7*(cm3*cm4-c4*cm9)))ho*(c2*c7*(cm4*cm5+(c4+cm3+cm5)*cm9)+c3*(ho*c7*(cm4*cm5+c4*cm9)+cm2*(cm4*cm5+c4*c
m9+cm5*(cm7+cm9))))))
variable current2
current2=current/(ho^4*c1*c3*c7*A1+ho*c7*cm1*cm4*A2+ho^3*c1*(c3*c4*cm2+c3*cm2*cm4+c7
*cm3*cm4+hi*A3*A1+c7*cm4*cm5+c2*c7*A4+c3*c4*cm7+c3*cm2*cm7+c3*c4*cm9+c3*cm2*cm9
)+cm1*(hi*c9*cm4*A2+cm2*(cm4*cm5+A5*A6+cm3*A7))+ho^2*c1*(hi^2*c5*c9*A1+hi*(c5*cm2*c
m4+c9*cm3*cm4+c9*cm4*cm5+c2*c9*A4+c5*cm2*cm7+c5*cm2*cm9+c4*c5*A8)+(c2+cm2)*(cm
4*cm5+A5*A6+cm3*A7)))
return current2/100
end

Function CurRat(w,xx)
Wave w
Variable xx
Variable c1,c2,c3,c4,c5,c6,c7,c8,c9,c10,c11,c12
Variable cm1,cm2,cm3,cm4,cm5,cm6,cm7,cm8,cm9
Variable c1o,c2o,c3o,c4o,c5o,c6o,c7o,c8o,c9o
Variable cm1o,cm2o,cm3o,cm4o,cm5o,cm6o,cm7o,cm8o,cm9o
Variable Ho,Hi,ed0,ed1,ed2,ed3,ed4,ed5,ed6,ed7,ed8,ed9,ed10,V
Ho=exp(-2.303*w[0]);Hi=exp(-2.303*w[1])
c1o=w[2];cm1o=c1o*exp(-2.303*w[3]);c2o=w[4];c3o=w[6];cm3o=c3o*exp(-2.303*w[7])
c4o=w[8];cm4o=w[9];c5o=w[10];c6o=w[12];cm6o=w[13]
c7o=w[14];cm8o=w[16];cm8o=w[17];c9o=w[18];cm9o=c9o*exp(-2.303*w[19])
cm2o=(c2o*c9o*cm4o*cm3o)/(c3o*c4o*cm9o)
w[5]=c10
cm5o=c5o*cm3o/c3o
w[11]=c11
cm7o=c7o*cm9o/c9o
w[15]=c12
ed0=w[20]
ed1=w[21]
ed2=w[22]
ed3=w[23]
ed4=w[24]
ed5=w[25]
ed6=w[26]
ed7=w[27]
ed8=w[28]
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ed9=w[29]
ed10=w[30]
V=xx/25.7
c1=c1o
cm1=cm1o
c2=c2o*exp(-ed6*v)
cm2=cm2o*exp(ed7*v)
c3=c3o*exp(-ed1*V)
cm3=cm3o*exp((ed2-ed1)*v)
c4=c4o*exp((ed2-ed3)*v)
cm4=cm4o*exp((ed4-ed3)*v)
c5=c5o
cm5=cm5o
c7=c7o
cm7=cm7o
c9=c9o*exp((1-ed5)*V)
cm9=cm9o*exp((ed4-ed5)*V)
variable A1=c4+cm4
variable A2=cm3+cm5
variable A3=(c5*c7+c3*c9)
variable A4=(c4+cm3+cm4+cm5)
variable A5=(c4+cm5)
variable A6=(cm7+cm9)
variable A7=(cm4+cm7+cm9)
variable A8=(cm2+cm7+cm9)
variable current
current=(2*ho^2*c1*(hi^2*c5*c9*(cm3*cm4+c4*cm7)+hi*(c2*c9*((c4+cm5)*cm7+cm3*(cm4+cm7))+c5*cm
2*(c4*cm7+cm3*(cm4+cm7+cm9))+ho*(c3*c9*(-cm4*cm5+c4*cm7)+c5*c7*(cm3*cm4-c4*cm9)))ho*(c2*c7*(cm4*cm5+(c4+cm3+cm5)*cm9)+c3*(ho*c7*(cm4*cm5+c4*cm9)+cm2*(cm4*cm5+c4*c
m9+cm5*(cm7+cm9))))))
current/=(ho^4*c1*c3*c7*A1+ho*c7*cm1*cm4*A2+ho^3*c1*(c3*c4*cm2+c3*cm2*cm4+c7*cm3*c
m4+hi*A3*A1+c7*cm4*cm5+c2*c7*A4+c3*c4*cm7+c3*cm2*cm7+c3*c4*cm9+c3*cm2*cm9)+cm1*
(hi*c9*cm4*A2+cm2*(cm4*cm5+A5*A6+cm3*A7))+ho^2*c1*(hi^2*c5*c9*A1+hi*(c5*cm2*cm4+c9*
cm3*cm4+c9*cm4*cm5+c2*c9*A4+c5*cm2*cm7+c5*cm2*cm9+c4*c5*A8)+(c2+cm2)*(cm4*cm5+
A5*A6+cm3*A7)))
V=0
c1=c1o
cm1=cm1o
c2=c2o*exp(-ed6*v)
cm2=cm2o*exp(ed7*v)
c3=c3o*exp(-ed1*V)
cm3=cm3o*exp((ed2-ed1)*v)
c4=c4o*exp((ed2-ed3)*v)
cm4=cm4o*exp((ed4-ed3)*v)
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c5=c5o
cm5=cm5o
c7=c7o
cm7=cm7o
c9=c9o*exp((1-ed5)*V)
cm9=cm9o*exp((ed4-ed5)*V)
A1=c4+cm4
A2=cm3+cm5
A3=(c5*c7+c3*c9)
A4=(c4+cm3+cm4+cm5)
A5=(c4+cm5)
A6=(cm7+cm9)
A7=(cm4+cm7+cm9)
A8=(cm2+cm7+cm9)
variable current0
current0=(2*ho^2*c1*(hi^2*c5*c9*(cm3*cm4+c4*cm7)+hi*(c2*c9*((c4+cm5)*cm7+cm3*(cm4+cm7))+c5*cm
2*(c4*cm7+cm3*(cm4+cm7+cm9))+ho*(c3*c9*(-cm4*cm5+c4*cm7)+c5*c7*(cm3*cm4-c4*cm9)))ho*(c2*c7*(cm4*cm5+(c4+cm3+cm5)*cm9)+c3*(ho*c7*(cm4*cm5+c4*cm9)+cm2*(cm4*cm5+c4*c
m9+cm5*(cm7+cm9))))))
current0/=(ho^4*c1*c3*c7*A1+ho*c7*cm1*cm4*A2+ho^3*c1*(c3*c4*cm2+c3*cm2*cm4+c7*cm3*c
m4+hi*A3*A1+c7*cm4*cm5+c2*c7*A4+c3*c4*cm7+c3*cm2*cm7+c3*c4*cm9+c3*cm2*cm9)+cm1*
(hi*c9*cm4*A2+cm2*(cm4*cm5+A5*A6+cm3*A7))+ho^2*c1*(hi^2*c5*c9*A1+hi*(c5*cm2*cm4+c9*
cm3*cm4+c9*cm4*cm5+c2*c9*A4+c5*cm2*cm7+c5*cm2*cm9+c4*c5*A8)+(c2+cm2)*(cm4*cm5+
A5*A6+cm3*A7)))
variable relcurr=current/current0
return abs(relcurr)
end
Function M2pH(w,xx)
Wave w
Variable xx
variable Vt=-60
w[0]=xx
variable V0=2.303*25.7*(w[1]-w[0])
//print v0
variable cond=phflux(w,(xx))/(Vt-V0)
w[0]=4
variable V1=2.303*25.7*(w[1]-4)
variable cond0=phflux(w,(4))/(Vt-V1)
return cond/cond0
end
Function M2pH1(w,xx)
Wave w
Variable xx
variable V=60
w[0]=xx
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variable V0=2.303*25.7*(w[1]-w[0])
//print v0
variable cond=phflux1(w,(xx))/(V-V0)
w[0]=4
variable V1=2.303*25.7*(w[1]-4)
variable cond0=phflux(w,(4))/(-60-V1)
return cond/cond0
end

Function phflux(w,xx)
Wave w
Variable xx
Variable c1,c2,c3,c4,c5,c6,c7,c8,c9,c10,c11,c12
Variable cm1,cm2,cm3,cm4,cm5,cm6,cm7,cm8,cm9
Variable c1o,c2o,c3o,c4o,c5o,c6o,c7o,c8o,c9o
Variable cm1o,cm2o,cm3o,cm4o,cm5o,cm6o,cm7o,cm8o,cm9o
Variable Ho,Hi
Variable ed0,ed1,ed2,ed3,ed4,ed5,ed6,ed7,ed8,ed9,ed10,V
Ho=exp(-2.303*xx);Hi=exp(-2.303*w[1])
c1o=w[2];cm1o=c1o*exp(-2.303*w[3]);c2o=w[4];c3o=w[6];cm3o=c3o*exp(-2.303*w[7])
c4o=w[8];cm4o=w[9];c5o=w[10];c6o=w[12];cm6o=w[13]
c7o=w[14];cm8o=w[16];cm8o=w[17];c9o=w[18];cm9o=c9o*exp(-2.303*w[19])
cm2o=(c2o*c9o*cm4o*cm3o)/(c3o*c4o*cm9o)
w[5]=c10
cm5o=c5o*cm3o/c3o
w[11]=c11
cm7o=c7o*cm9o/c9o
w[15]=c12
ed0=w[20]
ed1=w[21]
ed2=w[22]
ed3=w[23]
ed4=w[24]
ed5=w[25]
ed6=w[26]
ed7=w[27]
ed8=w[28]
ed9=w[29]
ed10=w[30]
V=-60/25.7
c1=c1o
cm1=cm1o
c2=c2o*exp(-ed6*v)
cm2=cm2o*exp(ed7*v)
c3=c3o*exp(-ed1*V)
cm3=cm3o*exp((ed2-ed1)*v)
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c4=c4o*exp((ed2-ed3)*v)
cm4=cm4o*exp((ed4-ed3)*v)
c5=c5o
cm5=cm5o
c7=c7o
cm7=cm7o
c9=c9o*exp((1-ed5)*V)
cm9=cm9o*exp((ed4-ed5)*V)
variable A1=c4+cm4
variable A2=cm3+cm5
variable A3=(c5*c7+c3*c9)
variable A4=(c4+cm3+cm4+cm5)
variable A5=(c4+cm5)
variable A6=(cm7+cm9)
variable A7=(cm4+cm7+cm9)
variable A8=(cm2+cm7+cm9)
variable current1
current1=(2*ho^2*c1*(hi^2*c5*c9*(cm3*cm4+c4*cm7)+hi*(c2*c9*((c4+cm5)*cm7+cm3*(cm4+cm7))+c5*cm
2*(c4*cm7+cm3*(cm4+cm7+cm9))+ho*(c3*c9*(-cm4*cm5+c4*cm7)+c5*c7*(cm3*cm4-c4*cm9)))ho*(c2*c7*(cm4*cm5+(c4+cm3+cm5)*cm9)+c3*(ho*c7*(cm4*cm5+c4*cm9)+cm2*(cm4*cm5+c4*c
m9+cm5*(cm7+cm9))))))
variable current2
current2=current1/(ho^4*c1*c3*c7*A1+ho*c7*cm1*cm4*A2+ho^3*c1*(c3*c4*cm2+c3*cm2*cm4+c
7*cm3*cm4+hi*A3*A1+c7*cm4*cm5+c2*c7*A4+c3*c4*cm7+c3*cm2*cm7+c3*c4*cm9+c3*cm2*cm
9)+cm1*(hi*c9*cm4*A2+cm2*(cm4*cm5+A5*A6+cm3*A7))+ho^2*c1*(hi^2*c5*c9*A1+hi*(c5*cm2*
cm4+c9*cm3*cm4+c9*cm4*cm5+c2*c9*A4+c5*cm2*cm7+c5*cm2*cm9+c4*c5*A8)+(c2+cm2)*(c
m4*cm5+A5*A6+cm3*A7)))
return -current2
end

Function phflux1(w,xx)
Wave w
Variable xx
Variable c1,c2,c3,c4,c5,c6,c7,c8,c9,c10,c11,c12
Variable cm1,cm2,cm3,cm4,cm5,cm6,cm7,cm8,cm9
Variable c1o,c2o,c3o,c4o,c5o,c6o,c7o,c8o,c9o
Variable cm1o,cm2o,cm3o,cm4o,cm5o,cm6o,cm7o,cm8o,cm9o
Variable Ho,Hi
Variable ed0,ed1,ed2,ed3,ed4,ed5,ed6,ed7,ed8,ed9,ed10,V
Ho=exp(-2.303*xx);Hi=exp(-2.303*w[1])
c1o=w[2];cm1o=c1o*exp(-2.303*w[3]);c2o=w[4];c3o=w[6];cm3o=c3o*exp(-2.303*w[7])
c4o=w[8];cm4o=w[9];c5o=w[10];c6o=w[12];cm6o=w[13]
c7o=w[14];cm8o=w[16];cm8o=w[17];c9o=w[18];cm9o=c9o*exp(-2.303*w[19])
cm2o=(c2o*c9o*cm4o*cm3o)/(c3o*c4o*cm9o)
w[5]=c10
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cm5o=c5o*cm3o/c3o
w[11]=c11
cm7o=c7o*cm9o/c9o
w[15]=c12
ed0=w[20]
ed1=w[21]
ed2=w[22]
ed3=w[23]
ed4=w[24]
ed5=w[25]
ed6=w[26]
ed7=w[27]
ed8=w[28]
ed9=w[29]
ed10=w[30]
V=60/25.7
c1=c1o
cm1=cm1o
c2=c2o*exp(-ed6*v)
cm2=cm2o*exp(ed7*v)
c3=c3o*exp(-ed1*V)
cm3=cm3o*exp((ed2-ed1)*v)
c4=c4o*exp((ed2-ed3)*v)
cm4=cm4o*exp((ed4-ed3)*v)
c5=c5o
cm5=cm5o
c7=c7o
cm7=cm7o
c9=c9o*exp((1-ed5)*V)
cm9=cm9o*exp((ed4-ed5)*V)
variable A1=c4+cm4
variable A2=cm3+cm5
variable A3=(c5*c7+c3*c9)
variable A4=(c4+cm3+cm4+cm5)
variable A5=(c4+cm5)
variable A6=(cm7+cm9)
variable A7=(cm4+cm7+cm9)
variable A8=(cm2+cm7+cm9)
variable current1
current1=(2*ho^2*c1*(hi^2*c5*c9*(cm3*cm4+c4*cm7)+hi*(c2*c9*((c4+cm5)*cm7+cm3*(cm4+cm7))+c5*cm
2*(c4*cm7+cm3*(cm4+cm7+cm9))+ho*(c3*c9*(-cm4*cm5+c4*cm7)+c5*c7*(cm3*cm4-c4*cm9)))ho*(c2*c7*(cm4*cm5+(c4+cm3+cm5)*cm9)+c3*(ho*c7*(cm4*cm5+c4*cm9)+cm2*(cm4*cm5+c4*c
m9+cm5*(cm7+cm9))))))
variable current2
current2=current1/(ho^4*c1*c3*c7*A1+ho*c7*cm1*cm4*A2+ho^3*c1*(c3*c4*cm2+c3*cm2*cm4+c
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7*cm3*cm4+hi*A3*A1+c7*cm4*cm5+c2*c7*A4+c3*c4*cm7+c3*cm2*cm7+c3*c4*cm9+c3*cm2*cm
9)+cm1*(hi*c9*cm4*A2+cm2*(cm4*cm5+A5*A6+cm3*A7))+ho^2*c1*(hi^2*c5*c9*A1+hi*(c5*cm2*
cm4+c9*cm3*cm4+c9*cm4*cm5+c2*c9*A4+c5*cm2*cm7+c5*cm2*cm9+c4*c5*A8)+(c2+cm2)*(c
m4*cm5+A5*A6+cm3*A7)))
return -current2
end
Window SetGuessTable() : Table
PauseUpdate; Silent 1
// building window...
String fldrSav0= GetDataFolder(1)
SetDataFolder root:Packages:GlobalFit:
Edit/W=(596,169,1395,620) 'Data Sets and Coefficients',AllCoefs,holds,ConWave as "Set
Initial Guesses"
ModifyTable format(Point)=1,width('Data Sets and Coefficients')=200,alignment(holds)=1
ModifyTable width(holds)=40,alignment(ConWave)=1
SetDataFolder fldrSav0
EndMacro
Three-proton, three-state model (first two protons conducting)
#pragma rtGlobals=1
// Use modern global access method.
#include "JimsmodifiedGlobalFit"
Function AnyFunction(w,xx)
Wave w
Variable xx
if (xx>500)
xx-=500
return invchord (w,xx)
elseif (xx>400)
xx-=400
return specact(w,xx)
elseif (xx>300)
xx-=300
return M2pH(w,xx)
elseif (xx>200)
xx-=200
return M2pH1(w,xx)
else
return CurRat(w,xx)
endif
end
Function specact(w,xx)
Wave w
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Variable xx
Variable c1,c2,c3,c4,c5,c6,c7,c8,c9,c10,c12
Variable cm1,cm2,cm3,cm4,cm5,cm6,cm7,cm8,cm9,cm10,cm12
Variable c1o,c2o,c3o,c4o,c5o,c6o,c7o,c8o,c9o,c10o,c12o
Variable cm1o,cm2o,cm3o,cm4o,cm5o,cm6o,cm7o,cm8o,cm9o,cm10o,cm12o
Variable Ho,Hi,ed0,ed1,ed2,ed3,ed4,ed5,ed6,ed7,ed8,ed9,ed10,ed11,ed12,V
Ho=exp(-2.303*xx);Hi=5.62341E-08
c1o=w[2];
c2o=w[3];cm2o=c2o*exp(-2.303*w[4]);
c3o=w[5];cm3o=w[6];
c4o=w[7];
c5o=w[8];
c6o=w[9];cm6o=c6o*exp(-2.303*w[10]);
c7o=w[11];cm7o=w[12];
c8o=w[13];cm8o=c8o*exp(-2.303*w[14]);
c10o=w[15];
c12o=w[16];cm12o=c12o*exp(-2.303*w[17]);
cm1o=(c1o*c6o*cm3o*cm2o)/(c2o*c3o*cm6o);
cm4o=c4o*cm6o/c6o;
cm5o=(c5o*c12o*cm7o*cm8o)/(c8o*c7o*cm12o);
cm10o=c10o*cm8o/c8o;
ed0=w[20]
ed1=w[21]
ed2=w[22]
ed3=w[23]
ed4=w[24]
ed5=w[25]
ed6=w[26]
ed7=w[27]
ed8=w[28]
ed9=w[29]
ed10=w[30]
ed11=w[31]
ed12=w[32]
V=-20/25.7
c1=c1o;cm1=cm1o;
c2=c2o*exp(-ed1*v);cm2=cm2o*exp((ed2-ed1)*v);
c3=c3o*exp((ed2-ed3)*v);cm3=cm3o*exp((ed4-ed3)*v);
c4=c4o;cm4=cm4o;
c5=c5o*exp(-ed6*v);cm5=cm5o*exp(ed7*v);
c6=c6o*exp((1-ed5)*v);cm6=cm6o*exp((ed4-ed5)*v);
c7=c7o*exp((ed9-ed10)*v);cm7=cm7o*exp((ed11-ed10)*v);
c8=c8o*exp(-ed8*v);cm8=cm8o*exp((ed9-ed8)*v);
c10=c10o;cm10=cm10o;
c12=c12o*exp((1-ed12)*v);cm12=cm12o*exp((ed11-ed12)*v);
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variable a1= hi^2*ho*c1*c6*c8*(c3+cm2)*(c7*cm12*cm5+cm10*(cm12*cm5+(hi*c12+cm5)*cm7))
variable a2=-ho^5*c2*c3*c4*c8*(c7*cm12*cm5+cm10*(cm12*cm5+(hi*c12+cm5)*cm7))
variable a3=ho^3*c8*(c2*c3*(hi^2*c6+cm1)+c1*c4*(c3+cm2))
variable a4=(c7*cm12*cm5+cm10*(cm12*cm5+(hi*c12+cm5)*cm7))
variable a5=cm12*cm5+(hi*c12+cm5)*cm7
variable a6=hi^2*c10*c12*cm7-cm5*cm6*(cm12+cm7)
variable a7=cm5*(cm12+cm7)
variable a8=c7*cm12*(c3*cm4+cm2*(cm3+cm4))
variable a9=c5*(c7+cm10+cm7+cm8)
variable a10=hi^4*c10*c12*c2*c3*c6*cm7*cm8
variable a11=c3*cm4+cm2*(cm3+cm4)
variable a12=hi^2*c10*c12*(c3+cm2)
variable a13=cm5*cm6*(c7*cm12+(cm12+cm7)*(cm10+cm8))
variable a14=c12*(c3*(c5+cm4)+cm2*(c5+cm3+cm4))*cm7
variable a15=hi^3*c2*c3*c6*(c10*a7*cm8+c12*cm7*(cm10*cm4+(c5+cm4)*cm8))
variable a16=c7*cm12+(cm12+cm7)*(cm10+cm8)
variable a17=c7*cm12*cm5*cm6
variable a18= c7*(cm12+cm5)
variable a19= cm7*(cm10+cm8)
variable a20= hi^4*c10*c12*c6*(ho^2*c2*c3+c1*(c3+cm2))*(c7+cm7)
variable a21=ho^5*c2*c3*c4*c8
variable a22=(cm3*cm5+c3*(c5+cm5))
variable a23= cm4+cm6
variable a24= cm2+cm3
variable a25=ho^3*c8*(c2*c3*cm1+c1*c4*(c3+cm2))
variable a26= ho^4*c10*c12*c2*c3*c4
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variable a27= c1*c10*c12*c4
variable a28= c7+cm7
variable b1=
c12*(ho*c7*c8*cm2+ho*c8*cm2*cm7+cm10*cm2*cm7+cm10*cm3*cm7+cm2*cm7*cm8+cm3*cm
7*cm8+c5*cm2*(c7+cm10+cm7+cm8)+c3*(ho*c8*(a28)+a19+a9))
variable a29= c3+cm2
variable a30= c5+cm5
variable b2= ho^5*c12*c2*c3*c4*c8*(a28)+ho^3*c12*c8*(c2*c3*cm1+c1*c4*(a29))*(a28)
variable b3= c2*(cm1*cm5*(cm3+a23)+c3*(c5*cm1+cm5*(cm1+a23)))
variable b4= c6*(cm2*cm3*cm5+c1*(c5*cm2+(a24)*cm5+c3*(a30)))
variable b5=
ho^3*c12*c2*c3*c8*(a28)+c12*cm2*cm3*a19+ho^2*c2*(c10*c3*(a18+a7)+c12*(cm3*a19+c3*(a1
9+a9)))
variable b6=((a24)*a19+c5*cm2*(c7+cm10+cm7+cm8)+c3*(a19+a9))
variable b7=a26*(a28)+ho^3*c2*c3*c6*c8*(a18+a7)+ho*c1*c6*c8*(a29)*(a18+a7)+b4*(a16)
variable b8= ho^4*c2*c4*(c10*c3*(a18+a7)+c12*(cm3*a19+c3*(a19+a9)))
variable b9=
c12*(c4*cm2*cm3*a19+c2*(cm1*(cm3+a23)*a19+c3*((cm1+a23)*a19+c5*cm1*(c7+cm10+cm7+c
m8))))
variable b10= c10*c2*c3*cm1*(a18+a7)+c1*c4*(c10*(a29)*(a18+a7)+c12*b6)

variable current
current=-(2*(a2-a1-a3*a4-ho^4*c2*c3*c4*(a17+cm10*cm6*(a5)-(a6+hi*(c12*(c5cm6)*cm7+c10*a7))*cm8)+hi^2*c1*c6*(a8*cm5+cm10*(a11)*(a5)+(a12*cm7+(a11)*a7+hi*(a14+c
10*(a29)*a7))*cm8)+ho^2*(a10-(c2*c3*cm1+c1*c4*(a29))*a13+a15hi*(c2*c3*cm1+c1*c4*(a29))*(-c10*a7*cm8+c12*cm7*(cm10*cm6+(c5+cm6)*cm8))+hi^2*(a27*(a29)*cm7*cm8+c2*c3*(c10*c12*cm1*cm7*cm8+c6*cm4*cm5*(a16))))
))
variable current2
current2=(a20+a21*(a18+a7)+a25*(a18+a7)+ho^4*c2*c4*a22*(a16)+(c1+cm1)*cm5*(c3*(a23)+c
m2*(cm3+a23))*(a16)+ho^2*(c4*cm2*cm3*cm5+c1*c4*(c5*cm2+(a24)*cm5+c3*(a30))+b3)*(a16)
+hi^2*(b7+ho^2*(a27*(a29)*(a28)+c2*(c10*c12*c3*cm1*(a28)+c6*a22*(a16))))+hi^3*c6*(b5+c1*(c
10*(a29)*(a18+a7)+b1))+hi*(b2+c12*(c1+cm1)*(c3*(a23)+cm2*(cm3+a23))*a19+b8+ho^2*(b10+b
9)))
return current/(100*current2)
end
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Function CurRat(w,xx)
Wave w
Variable xx
Variable c1,c2,c3,c4,c5,c6,c7,c8,c9,c10,c12
Variable cm1,cm2,cm3,cm4,cm5,cm6,cm7,cm8,cm9,cm10,cm12
Variable c1o,c2o,c3o,c4o,c5o,c6o,c7o,c8o,c9o,c10o,c12o
Variable cm1o,cm2o,cm3o,cm4o,cm5o,cm6o,cm7o,cm8o,cm9o,cm10o,cm12o
Variable Ho,Hi,ed0,ed1,ed2,ed3,ed4,ed5,ed6,ed7,ed8,ed9,ed10,ed11,ed12,V
Ho=exp(-2.303*w[0]);Hi=exp(-2.303*w[1])
c1o=w[2];
c2o=w[3];cm2o=c2o*exp(-2.303*w[4]);
c3o=w[5];cm3o=w[6];
c4o=w[7];
c5o=w[8];
c6o=w[9];cm6o=c6o*exp(-2.303*w[10]);
c7o=w[11];cm7o=w[12];
c8o=w[13];cm8o=c8o*exp(-2.303*w[14]);
c10o=w[15];
c12o=w[16];cm12o=c12o*exp(-2.303*w[17]);
cm1o=(c1o*c6o*cm3o*cm2o)/(c2o*c3o*cm6o);
cm4o=c4o*cm6o/c6o;
cm5o=(c5o*c12o*cm7o*cm8o)/(c8o*c7o*cm12o);
cm10o=c10o*cm8o/c8o;
ed0=w[20]
ed1=w[21]
ed2=w[22]
ed3=w[23]
ed4=w[24]
ed5=w[25]
ed6=w[26]
ed7=w[27]
ed8=w[28]
ed9=w[29]
ed10=w[30]
ed11=w[31]
ed12=w[32]
V=xx/25.7
c1=c1o;cm1=cm1o;
c2=c2o*exp(-ed1*v);cm2=cm2o*exp((ed2-ed1)*v);
c3=c3o*exp((ed2-ed3)*v);cm3=cm3o*exp((ed4-ed3)*v);
c4=c4o;cm4=cm4o;
c5=c5o*exp(-ed6*v);cm5=cm5o*exp(ed7*v);
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c6=c6o*exp((1-ed5)*v);cm6=cm6o*exp((ed4-ed5)*v);
c7=c7o*exp((ed9-ed10)*v);cm7=cm7o*exp((ed11-ed10)*v);
c8=c8o*exp(-ed8*v);cm8=cm8o*exp((ed9-ed8)*v);
c10=c10o;cm10=cm10o;
c12=c12o*exp((1-ed12)*v);cm12=cm12o*exp((ed11-ed12)*v);
variable a1= hi^2*ho*c1*c6*c8*(c3+cm2)*(c7*cm12*cm5+cm10*(cm12*cm5+(hi*c12+cm5)*cm7))
variable a2=-ho^5*c2*c3*c4*c8*(c7*cm12*cm5+cm10*(cm12*cm5+(hi*c12+cm5)*cm7))
variable a3=ho^3*c8*(c2*c3*(hi^2*c6+cm1)+c1*c4*(c3+cm2))
variable a4=(c7*cm12*cm5+cm10*(cm12*cm5+(hi*c12+cm5)*cm7))
variable a5=cm12*cm5+(hi*c12+cm5)*cm7
variable a6=hi^2*c10*c12*cm7-cm5*cm6*(cm12+cm7)
variable a7=cm5*(cm12+cm7)
variable a8=c7*cm12*(c3*cm4+cm2*(cm3+cm4))
variable a9=c5*(c7+cm10+cm7+cm8)
variable a10=hi^4*c10*c12*c2*c3*c6*cm7*cm8
variable a11=c3*cm4+cm2*(cm3+cm4)
variable a12=hi^2*c10*c12*(c3+cm2)
variable a13=cm5*cm6*(c7*cm12+(cm12+cm7)*(cm10+cm8))
variable a14=c12*(c3*(c5+cm4)+cm2*(c5+cm3+cm4))*cm7
variable a15=hi^3*c2*c3*c6*(c10*a7*cm8+c12*cm7*(cm10*cm4+(c5+cm4)*cm8))
variable a16=c7*cm12+(cm12+cm7)*(cm10+cm8)
variable a17=c7*cm12*cm5*cm6
variable a18= c7*(cm12+cm5)
variable a19= cm7*(cm10+cm8)
variable a20= hi^4*c10*c12*c6*(ho^2*c2*c3+c1*(c3+cm2))*(c7+cm7)
variable a21=ho^5*c2*c3*c4*c8
variable a22=(cm3*cm5+c3*(c5+cm5))
variable a23= cm4+cm6
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variable a24= cm2+cm3
variable a25=ho^3*c8*(c2*c3*cm1+c1*c4*(c3+cm2))
variable a26= ho^4*c10*c12*c2*c3*c4
variable a27= c1*c10*c12*c4
variable a28= c7+cm7
variable b1=
c12*(ho*c7*c8*cm2+ho*c8*cm2*cm7+cm10*cm2*cm7+cm10*cm3*cm7+cm2*cm7*cm8+cm3*cm
7*cm8+c5*cm2*(c7+cm10+cm7+cm8)+c3*(ho*c8*(a28)+a19+a9))
variable a29= c3+cm2
variable a30= c5+cm5
variable b2= ho^5*c12*c2*c3*c4*c8*(a28)+ho^3*c12*c8*(c2*c3*cm1+c1*c4*(a29))*(a28)
variable b3= c2*(cm1*cm5*(cm3+a23)+c3*(c5*cm1+cm5*(cm1+a23)))
variable b4= c6*(cm2*cm3*cm5+c1*(c5*cm2+(a24)*cm5+c3*(a30)))
variable b5=
ho^3*c12*c2*c3*c8*(a28)+c12*cm2*cm3*a19+ho^2*c2*(c10*c3*(a18+a7)+c12*(cm3*a19+c3*(a1
9+a9)))
variable b6=((a24)*a19+c5*cm2*(c7+cm10+cm7+cm8)+c3*(a19+a9))
variable b7=a26*(a28)+ho^3*c2*c3*c6*c8*(a18+a7)+ho*c1*c6*c8*(a29)*(a18+a7)+b4*(a16)
variable b8= ho^4*c2*c4*(c10*c3*(a18+a7)+c12*(cm3*a19+c3*(a19+a9)))
variable b9=
c12*(c4*cm2*cm3*a19+c2*(cm1*(cm3+a23)*a19+c3*((cm1+a23)*a19+c5*cm1*(c7+cm10+cm7+c
m8))))
variable b10= c10*c2*c3*cm1*(a18+a7)+c1*c4*(c10*(a29)*(a18+a7)+c12*b6)

variable current
current=-(2*(a2-a1-a3*a4-ho^4*c2*c3*c4*(a17+cm10*cm6*(a5)-(a6+hi*(c12*(c5cm6)*cm7+c10*a7))*cm8)+hi^2*c1*c6*(a8*cm5+cm10*(a11)*(a5)+(a12*cm7+(a11)*a7+hi*(a14+c
10*(a29)*a7))*cm8)+ho^2*(a10-(c2*c3*cm1+c1*c4*(a29))*a13+a15hi*(c2*c3*cm1+c1*c4*(a29))*(-c10*a7*cm8+c12*cm7*(cm10*cm6+(c5+cm6)*cm8))+hi^2*(a27*(a29)*cm7*cm8+c2*c3*(c10*c12*cm1*cm7*cm8+c6*cm4*cm5*(a16))))
))
current/=(a20+a21*(a18+a7)+a25*(a18+a7)+ho^4*c2*c4*a22*(a16)+(c1+cm1)*cm5*(c3*(a23)+cm
2*(cm3+a23))*(a16)+ho^2*(c4*cm2*cm3*cm5+c1*c4*(c5*cm2+(a24)*cm5+c3*(a30))+b3)*(a16)+h
i^2*(b7+ho^2*(a27*(a29)*(a28)+c2*(c10*c12*c3*cm1*(a28)+c6*a22*(a16))))+hi^3*c6*(b5+c1*(c10
*(a29)*(a18+a7)+b1))+hi*(b2+c12*(c1+cm1)*(c3*(a23)+cm2*(cm3+a23))*a19+b8+ho^2*(b10+b9)
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))
V=0
c1=c1o;cm1=cm1o;
c2=c2o*exp(-ed1*v);cm2=cm2o*exp((ed2-ed1)*v);
c3=c3o*exp((ed2-ed3)*v);cm3=cm3o*exp((ed4-ed3)*v);
c4=c4o;cm4=cm4o;
c5=c5o*exp(-ed6*v);cm5=cm5o*exp(ed7*v);
c6=c6o*exp((1-ed5)*v);cm6=cm6o*exp((ed4-ed5)*v);
c7=c7o*exp((ed9-ed10)*v);cm7=cm7o*exp((ed11-ed10)*v);
c8=c8o*exp(-ed8*v);cm8=cm8o*exp((ed9-ed8)*v);
c10=c10o;cm10=cm10o;
c12=c12o*exp((1-ed12)*v);cm12=cm12o*exp((ed11-ed12)*v);
a1= hi^2*ho*c1*c6*c8*(c3+cm2)*(c7*cm12*cm5+cm10*(cm12*cm5+(hi*c12+cm5)*cm7))
a2=-ho^5*c2*c3*c4*c8*(c7*cm12*cm5+cm10*(cm12*cm5+(hi*c12+cm5)*cm7))
a3=ho^3*c8*(c2*c3*(hi^2*c6+cm1)+c1*c4*(c3+cm2))
a4=(c7*cm12*cm5+cm10*(cm12*cm5+(hi*c12+cm5)*cm7))
a5=cm12*cm5+(hi*c12+cm5)*cm7
a6=hi^2*c10*c12*cm7-cm5*cm6*(cm12+cm7)
a7=cm5*(cm12+cm7)
a8=c7*cm12*(c3*cm4+cm2*(cm3+cm4))
a9=c5*(c7+cm10+cm7+cm8)
a10=hi^4*c10*c12*c2*c3*c6*cm7*cm8
a11=c3*cm4+cm2*(cm3+cm4)
a12=hi^2*c10*c12*(c3+cm2)
a13=cm5*cm6*(c7*cm12+(cm12+cm7)*(cm10+cm8))
a14=c12*(c3*(c5+cm4)+cm2*(c5+cm3+cm4))*cm7
a15=hi^3*c2*c3*c6*(c10*a7*cm8+c12*cm7*(cm10*cm4+(c5+cm4)*cm8))
a16=c7*cm12+(cm12+cm7)*(cm10+cm8)
a17=c7*cm12*cm5*cm6
a18= c7*(cm12+cm5)
a19= cm7*(cm10+cm8)

191

a20= hi^4*c10*c12*c6*(ho^2*c2*c3+c1*(c3+cm2))*(c7+cm7)
a21=ho^5*c2*c3*c4*c8
a22=(cm3*cm5+c3*(c5+cm5))
a23= cm4+cm6
a24= cm2+cm3
a25=ho^3*c8*(c2*c3*cm1+c1*c4*(c3+cm2))
a26= ho^4*c10*c12*c2*c3*c4
a27= c1*c10*c12*c4
a28= c7+cm7
b1=
c12*(ho*c7*c8*cm2+ho*c8*cm2*cm7+cm10*cm2*cm7+cm10*cm3*cm7+cm2*cm7*cm8+cm3*cm
7*cm8+c5*cm2*(c7+cm10+cm7+cm8)+c3*(ho*c8*(a28)+a19+a9))
a29= c3+cm2
a30= c5+cm5
b2= ho^5*c12*c2*c3*c4*c8*(a28)+ho^3*c12*c8*(c2*c3*cm1+c1*c4*(a29))*(a28)
b3= c2*(cm1*cm5*(cm3+a23)+c3*(c5*cm1+cm5*(cm1+a23)))
b4= c6*(cm2*cm3*cm5+c1*(c5*cm2+(a24)*cm5+c3*(a30)))
b5=
ho^3*c12*c2*c3*c8*(a28)+c12*cm2*cm3*a19+ho^2*c2*(c10*c3*(a18+a7)+c12*(cm3*a19+c3*(a1
9+a9)))
b6=((a24)*a19+c5*cm2*(c7+cm10+cm7+cm8)+c3*(a19+a9))
b7=a26*(a28)+ho^3*c2*c3*c6*c8*(a18+a7)+ho*c1*c6*c8*(a29)*(a18+a7)+b4*(a16)
b8= ho^4*c2*c4*(c10*c3*(a18+a7)+c12*(cm3*a19+c3*(a19+a9)))
b9=
c12*(c4*cm2*cm3*a19+c2*(cm1*(cm3+a23)*a19+c3*((cm1+a23)*a19+c5*cm1*(c7+cm10+cm7+c
m8))))
b10= c10*c2*c3*cm1*(a18+a7)+c1*c4*(c10*(a29)*(a18+a7)+c12*b6)

variable current0
current0=-(2*(a2-a1-a3*a4-ho^4*c2*c3*c4*(a17+cm10*cm6*(a5)-(a6+hi*(c12*(c5-
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cm6)*cm7+c10*a7))*cm8)+hi^2*c1*c6*(a8*cm5+cm10*(a11)*(a5)+(a12*cm7+(a11)*a7+hi*(a14+c
10*(a29)*a7))*cm8)+ho^2*(a10-(c2*c3*cm1+c1*c4*(a29))*a13+a15hi*(c2*c3*cm1+c1*c4*(a29))*(-c10*a7*cm8+c12*cm7*(cm10*cm6+(c5+cm6)*cm8))+hi^2*(a27*(a29)*cm7*cm8+c2*c3*(c10*c12*cm1*cm7*cm8+c6*cm4*cm5*(a16))))
))
current0/=(a20+a21*(a18+a7)+a25*(a18+a7)+ho^4*c2*c4*a22*(a16)+(c1+cm1)*cm5*(c3*(a23)+c
m2*(cm3+a23))*(a16)+ho^2*(c4*cm2*cm3*cm5+c1*c4*(c5*cm2+(a24)*cm5+c3*(a30))+b3)*(a16)
+hi^2*(b7+ho^2*(a27*(a29)*(a28)+c2*(c10*c12*c3*cm1*(a28)+c6*a22*(a16))))+hi^3*c6*(b5+c1*(c
10*(a29)*(a18+a7)+b1))+hi*(b2+c12*(c1+cm1)*(c3*(a23)+cm2*(cm3+a23))*a19+b8+ho^2*(b10+b
9)))
variable relcurr=current/current0
return abs(relcurr)
end
Function M2pH(w,xx)
Wave w
Variable xx
variable Vt=-60
w[0]=xx
variable V0=2.303*25.7*(w[1]-w[0])
//print v0
variable cond=phflux(w,(xx))/(Vt-V0)
w[0]=4
variable V1=2.303*25.7*(w[1]-4)
variable cond0=phflux(w,(4))/(Vt-V1)
return cond/cond0
end
Function M2pH1(w,xx)
Wave w
Variable xx
variable V=60
w[0]=xx
variable V0=2.303*25.7*(w[1]-w[0])
//print v0
variable cond=phflux1(w,(xx))/(V-V0)
w[0]=4
variable V1=2.303*25.7*(w[1]-4)
variable cond0=phflux(w,(4))/(-60-V1)
return cond/cond0
end
Function invchord(w,xx)
Wave w
Variable xx
variable Vt=60
w[0]=xx
variable V0=2.303*25.7*(w[1]-w[0])
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//print v0
variable cond=phflux(w,(xx))/(Vt-V0)
w[0]=6
variable V1=2.303*25.7*(w[1]-6)
variable cond0=phflux(w,(6))/(Vt-V1)
return cond/cond0
end
Function phflux(w,xx)
Wave w
Variable xx
Variable c1,c2,c3,c4,c5,c6,c7,c8,c9,c10,c12
Variable cm1,cm2,cm3,cm4,cm5,cm6,cm7,cm8,cm9,cm10,cm12
Variable c1o,c2o,c3o,c4o,c5o,c6o,c7o,c8o,c9o,c10o,c12o
Variable cm1o,cm2o,cm3o,cm4o,cm5o,cm6o,cm7o,cm8o,cm9o,cm10o,cm12o
Variable Ho,Hi,ed0,ed1,ed2,ed3,ed4,ed5,ed6,ed7,ed8,ed9,ed10,ed11,ed12,V
Ho=exp(-2.303*xx);Hi=exp(-2.303*w[1])
c1o=w[2];
c2o=w[3];cm2o=c2o*exp(-2.303*w[4]);
c3o=w[5];cm3o=w[6];
c4o=w[7];
c5o=w[8];
c6o=w[9];cm6o=c6o*exp(-2.303*w[10]);
c7o=w[11];cm7o=w[12];
c8o=w[13];cm8o=c8o*exp(-2.303*w[14]);
c10o=w[15];
c12o=w[16];cm12o=c12o*exp(-2.303*w[17]);
cm1o=(c1o*c6o*cm3o*cm2o)/(c2o*c3o*cm6o);
cm4o=c4o*cm6o/c6o;
cm5o=(c5o*c12o*cm7o*cm8o)/(c8o*c7o*cm12o);
cm10o=c10o*cm8o/c8o;

ed0=w[20]
ed1=w[21]
ed2=w[22]
ed3=w[23]
ed4=w[24]
ed5=w[25]
ed6=w[26]
ed7=w[27]
ed8=w[28]
ed9=w[29]
ed10=w[30]
ed11=w[31]
ed12=w[32]
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V=-60/25.7
c1=c1o;cm1=cm1o;
c2=c2o*exp(-ed1*v);cm2=cm2o*exp((ed2-ed1)*v);
c3=c3o*exp((ed2-ed3)*v);cm3=cm3o*exp((ed4-ed3)*v);
c4=c4o;cm4=cm4o;
c5=c5o*exp(-ed6*v);cm5=cm5o*exp(ed7*v);
c6=c6o*exp((1-ed5)*v);cm6=cm6o*exp((ed4-ed5)*v);
c7=c7o*exp((ed9-ed10)*v);cm7=cm7o*exp((ed11-ed10)*v);
c8=c8o*exp(-ed8*v);cm8=cm8o*exp((ed9-ed8)*v);
c10=c10o;cm10=cm10o;
c12=c12o*exp((1-ed12)*v);cm12=cm12o*exp((ed11-ed12)*v);
variable a1= hi^2*ho*c1*c6*c8*(c3+cm2)*(c7*cm12*cm5+cm10*(cm12*cm5+(hi*c12+cm5)*cm7))
variable a2=-ho^5*c2*c3*c4*c8*(c7*cm12*cm5+cm10*(cm12*cm5+(hi*c12+cm5)*cm7))
variable a3=ho^3*c8*(c2*c3*(hi^2*c6+cm1)+c1*c4*(c3+cm2))
variable a4=(c7*cm12*cm5+cm10*(cm12*cm5+(hi*c12+cm5)*cm7))
variable a5=cm12*cm5+(hi*c12+cm5)*cm7
variable a6=hi^2*c10*c12*cm7-cm5*cm6*(cm12+cm7)
variable a7=cm5*(cm12+cm7)
variable a8=c7*cm12*(c3*cm4+cm2*(cm3+cm4))
variable a9=c5*(c7+cm10+cm7+cm8)
variable a10=hi^4*c10*c12*c2*c3*c6*cm7*cm8
variable a11=c3*cm4+cm2*(cm3+cm4)
variable a12=hi^2*c10*c12*(c3+cm2)
variable a13=cm5*cm6*(c7*cm12+(cm12+cm7)*(cm10+cm8))
variable a14=c12*(c3*(c5+cm4)+cm2*(c5+cm3+cm4))*cm7
variable a15=hi^3*c2*c3*c6*(c10*a7*cm8+c12*cm7*(cm10*cm4+(c5+cm4)*cm8))
variable a16=c7*cm12+(cm12+cm7)*(cm10+cm8)
variable a17=c7*cm12*cm5*cm6
variable a18= c7*(cm12+cm5)
variable a19= cm7*(cm10+cm8)
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variable a20= hi^4*c10*c12*c6*(ho^2*c2*c3+c1*(c3+cm2))*(c7+cm7)
variable a21=ho^5*c2*c3*c4*c8
variable a22=(cm3*cm5+c3*(c5+cm5))
variable a23= cm4+cm6
variable a24= cm2+cm3
variable a25=ho^3*c8*(c2*c3*cm1+c1*c4*(c3+cm2))
variable a26= ho^4*c10*c12*c2*c3*c4
variable a27= c1*c10*c12*c4
variable a28= c7+cm7
variable b1=
c12*(ho*c7*c8*cm2+ho*c8*cm2*cm7+cm10*cm2*cm7+cm10*cm3*cm7+cm2*cm7*cm8+cm3*cm
7*cm8+c5*cm2*(c7+cm10+cm7+cm8)+c3*(ho*c8*(a28)+a19+a9))
variable a29= c3+cm2
variable a30= c5+cm5
variable b2= ho^5*c12*c2*c3*c4*c8*(a28)+ho^3*c12*c8*(c2*c3*cm1+c1*c4*(a29))*(a28)
variable b3= c2*(cm1*cm5*(cm3+a23)+c3*(c5*cm1+cm5*(cm1+a23)))
variable b4= c6*(cm2*cm3*cm5+c1*(c5*cm2+(a24)*cm5+c3*(a30)))
variable b5=
ho^3*c12*c2*c3*c8*(a28)+c12*cm2*cm3*a19+ho^2*c2*(c10*c3*(a18+a7)+c12*(cm3*a19+c3*(a1
9+a9)))
variable b6=((a24)*a19+c5*cm2*(c7+cm10+cm7+cm8)+c3*(a19+a9))
variable b7=a26*(a28)+ho^3*c2*c3*c6*c8*(a18+a7)+ho*c1*c6*c8*(a29)*(a18+a7)+b4*(a16)
variable b8= ho^4*c2*c4*(c10*c3*(a18+a7)+c12*(cm3*a19+c3*(a19+a9)))
variable b9=
c12*(c4*cm2*cm3*a19+c2*(cm1*(cm3+a23)*a19+c3*((cm1+a23)*a19+c5*cm1*(c7+cm10+cm7+c
m8))))
variable b10= c10*c2*c3*cm1*(a18+a7)+c1*c4*(c10*(a29)*(a18+a7)+c12*b6)
variable current1
current1=-(2*(a2-a1-a3*a4-ho^4*c2*c3*c4*(a17+cm10*cm6*(a5)-(a6+hi*(c12*(c5cm6)*cm7+c10*a7))*cm8)+hi^2*c1*c6*(a8*cm5+cm10*(a11)*(a5)+(a12*cm7+(a11)*a7+hi*(a14+c
10*(a29)*a7))*cm8)+ho^2*(a10-(c2*c3*cm1+c1*c4*(a29))*a13+a15hi*(c2*c3*cm1+c1*c4*(a29))*(-c10*a7*cm8+c12*cm7*(cm10*cm6+(-
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c5+cm6)*cm8))+hi^2*(a27*(a29)*cm7*cm8+c2*c3*(c10*c12*cm1*cm7*cm8+c6*cm4*cm5*(a16))))
))
variable current2
current2=current1/(a20+a21*(a18+a7)+a25*(a18+a7)+ho^4*c2*c4*a22*(a16)+(c1+cm1)*cm5*(c3*
(a23)+cm2*(cm3+a23))*(a16)+ho^2*(c4*cm2*cm3*cm5+c1*c4*(c5*cm2+(a24)*cm5+c3*(a30))+b3
)*(a16)+hi^2*(b7+ho^2*(a27*(a29)*(a28)+c2*(c10*c12*c3*cm1*(a28)+c6*a22*(a16))))+hi^3*c6*(b
5+c1*(c10*(a29)*(a18+a7)+b1))+hi*(b2+c12*(c1+cm1)*(c3*(a23)+cm2*(cm3+a23))*a19+b8+ho^2
*(b10+b9)))
return -current2
end

Function phflux1(w,xx)
Wave w
Variable xx
Variable c1,c2,c3,c4,c5,c6,c7,c8,c9,c10,c12
Variable cm1,cm2,cm3,cm4,cm5,cm6,cm7,cm8,cm9,cm10,cm12
Variable c1o,c2o,c3o,c4o,c5o,c6o,c7o,c8o,c9o,c10o,c12o
Variable cm1o,cm2o,cm3o,cm4o,cm5o,cm6o,cm7o,cm8o,cm9o,cm10o,cm12o
Variable Ho,Hi,ed0,ed1,ed2,ed3,ed4,ed5,ed6,ed7,ed8,ed9,ed10,ed11,ed12,V
Ho=exp(-2.303*xx);Hi=exp(-2.303*w[1])
c1o=w[2];
c2o=w[3];cm2o=c2o*exp(-2.303*w[4]);
c3o=w[5];cm3o=w[6];
c4o=w[7];
c5o=w[8];
c6o=w[9];cm6o=c6o*exp(-2.303*w[10]);
c7o=w[11];cm7o=w[12];
c8o=w[13];cm8o=c8o*exp(-2.303*w[14]);
c10o=w[15];
c12o=w[16];cm12o=c12o*exp(-2.303*w[17]);
cm1o=(c1o*c6o*cm3o*cm2o)/(c2o*c3o*cm6o);
cm4o=c4o*cm6o/c6o;
cm5o=(c5o*c12o*cm7o*cm8o)/(c8o*c7o*cm12o);
cm10o=c10o*cm8o/c8o;

ed0=w[20]
ed1=w[21]
ed2=w[22]
ed3=w[23]
ed4=w[24]
ed5=w[25]
ed6=w[26]
ed7=w[27]
ed8=w[28]
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ed9=w[29]
ed10=w[30]
ed11=w[31]
ed12=w[32]
V=60/25.7
c1=c1o;cm1=cm1o;
c2=c2o*exp(-ed1*v);cm2=cm2o*exp((ed2-ed1)*v);
c3=c3o*exp((ed2-ed3)*v);cm3=cm3o*exp((ed4-ed3)*v);
c4=c4o;cm4=cm4o;
c5=c5o*exp(-ed6*v);cm5=cm5o*exp(ed7*v);
c6=c6o*exp((1-ed5)*v);cm6=cm6o*exp((ed4-ed5)*v);
c7=c7o*exp((ed9-ed10)*v);cm7=cm7o*exp((ed11-ed10)*v);
c8=c8o*exp(-ed8*v);cm8=cm8o*exp((ed9-ed8)*v);
c10=c10o;cm10=cm10o;
c12=c12o*exp((1-ed12)*v);cm12=cm12o*exp((ed11-ed12)*v);
variable a1= hi^2*ho*c1*c6*c8*(c3+cm2)*(c7*cm12*cm5+cm10*(cm12*cm5+(hi*c12+cm5)*cm7))
variable a2=-ho^5*c2*c3*c4*c8*(c7*cm12*cm5+cm10*(cm12*cm5+(hi*c12+cm5)*cm7))
variable a3=ho^3*c8*(c2*c3*(hi^2*c6+cm1)+c1*c4*(c3+cm2))
variable a4=(c7*cm12*cm5+cm10*(cm12*cm5+(hi*c12+cm5)*cm7))
variable a5=cm12*cm5+(hi*c12+cm5)*cm7
variable a6=hi^2*c10*c12*cm7-cm5*cm6*(cm12+cm7)
variable a7=cm5*(cm12+cm7)
variable a8=c7*cm12*(c3*cm4+cm2*(cm3+cm4))
variable a9=c5*(c7+cm10+cm7+cm8)
variable a10=hi^4*c10*c12*c2*c3*c6*cm7*cm8
variable a11=c3*cm4+cm2*(cm3+cm4)
variable a12=hi^2*c10*c12*(c3+cm2)
variable a13=cm5*cm6*(c7*cm12+(cm12+cm7)*(cm10+cm8))
variable a14=c12*(c3*(c5+cm4)+cm2*(c5+cm3+cm4))*cm7
variable a15=hi^3*c2*c3*c6*(c10*a7*cm8+c12*cm7*(cm10*cm4+(c5+cm4)*cm8))
variable a16=c7*cm12+(cm12+cm7)*(cm10+cm8)
variable a17=c7*cm12*cm5*cm6
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variable a18= c7*(cm12+cm5)
variable a19= cm7*(cm10+cm8)
variable a20= hi^4*c10*c12*c6*(ho^2*c2*c3+c1*(c3+cm2))*(c7+cm7)
variable a21=ho^5*c2*c3*c4*c8
variable a22=(cm3*cm5+c3*(c5+cm5))
variable a23= cm4+cm6
variable a24= cm2+cm3
variable a25=ho^3*c8*(c2*c3*cm1+c1*c4*(c3+cm2))
variable a26= ho^4*c10*c12*c2*c3*c4
variable a27= c1*c10*c12*c4
variable a28= c7+cm7
variable b1=
c12*(ho*c7*c8*cm2+ho*c8*cm2*cm7+cm10*cm2*cm7+cm10*cm3*cm7+cm2*cm7*cm8+cm3*cm
7*cm8+c5*cm2*(c7+cm10+cm7+cm8)+c3*(ho*c8*(a28)+a19+a9))
variable a29= c3+cm2
variable a30= c5+cm5
variable b2= ho^5*c12*c2*c3*c4*c8*(a28)+ho^3*c12*c8*(c2*c3*cm1+c1*c4*(a29))*(a28)
variable b3= c2*(cm1*cm5*(cm3+a23)+c3*(c5*cm1+cm5*(cm1+a23)))
variable b4= c6*(cm2*cm3*cm5+c1*(c5*cm2+(a24)*cm5+c3*(a30)))
variable b5=
ho^3*c12*c2*c3*c8*(a28)+c12*cm2*cm3*a19+ho^2*c2*(c10*c3*(a18+a7)+c12*(cm3*a19+c3*(a1
9+a9)))
variable b6=((a24)*a19+c5*cm2*(c7+cm10+cm7+cm8)+c3*(a19+a9))
variable b7=a26*(a28)+ho^3*c2*c3*c6*c8*(a18+a7)+ho*c1*c6*c8*(a29)*(a18+a7)+b4*(a16)
variable b8= ho^4*c2*c4*(c10*c3*(a18+a7)+c12*(cm3*a19+c3*(a19+a9)))
variable b9=
c12*(c4*cm2*cm3*a19+c2*(cm1*(cm3+a23)*a19+c3*((cm1+a23)*a19+c5*cm1*(c7+cm10+cm7+c
m8))))
variable b10= c10*c2*c3*cm1*(a18+a7)+c1*c4*(c10*(a29)*(a18+a7)+c12*b6)
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variable current1
current1=-(2*(a2-a1-a3*a4-ho^4*c2*c3*c4*(a17+cm10*cm6*(a5)-(a6+hi*(c12*(c5cm6)*cm7+c10*a7))*cm8)+hi^2*c1*c6*(a8*cm5+cm10*(a11)*(a5)+(a12*cm7+(a11)*a7+hi*(a14+c
10*(a29)*a7))*cm8)+ho^2*(a10-(c2*c3*cm1+c1*c4*(a29))*a13+a15hi*(c2*c3*cm1+c1*c4*(a29))*(-c10*a7*cm8+c12*cm7*(cm10*cm6+(c5+cm6)*cm8))+hi^2*(a27*(a29)*cm7*cm8+c2*c3*(c10*c12*cm1*cm7*cm8+c6*cm4*cm5*(a16))))
))
variable current2
current2=current1/(a20+a21*(a18+a7)+a25*(a18+a7)+ho^4*c2*c4*a22*(a16)+(c1+cm1)*cm5*(c3*
(a23)+cm2*(cm3+a23))*(a16)+ho^2*(c4*cm2*cm3*cm5+c1*c4*(c5*cm2+(a24)*cm5+c3*(a30))+b3
)*(a16)+hi^2*(b7+ho^2*(a27*(a29)*(a28)+c2*(c10*c12*c3*cm1*(a28)+c6*a22*(a16))))+hi^3*c6*(b
5+c1*(c10*(a29)*(a18+a7)+b1))+hi*(b2+c12*(c1+cm1)*(c3*(a23)+cm2*(cm3+a23))*a19+b8+ho^2
*(b10+b9)))
return -current2
end
Window SetGuessTable() : Table
PauseUpdate; Silent 1
// building window...
String fldrSav0= GetDataFolder(1)
SetDataFolder root:Packages:GlobalFit:
Edit/W=(596,169,1395,620) 'Data Sets and Coefficients',AllCoefs,holds,ConWave as "Set
Initial Guesses"
ModifyTable format(Point)=1,width('Data Sets and Coefficients')=200,alignment(holds)=1
ModifyTable width(holds)=40,alignment(ConWave)=1
SetDataFolder fldrSav0
EndMacro
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